<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
      <journal-id journal-id-type="publisher-id">ijms</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Molecular Sciences</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1422-0067</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">36835631</article-id>
      <article-id pub-id-type="pmc">9962262</article-id>
      <article-id pub-id-type="doi">10.3390/ijms24044223</article-id>
      <article-id pub-id-type="publisher-id">ijms-24-04223</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Clocking Epilepsies: A Chronomodulated Strategy-Based Therapy for Rhythmic Seizures</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>Sha</given-names>
          </name>
          <xref rid="af1-ijms-24-04223" ref-type="aff">1</xref>
          <xref rid="af2-ijms-24-04223" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2420-3147</contrib-id>
          <name>
            <surname>Wang</surname>
            <given-names>Han</given-names>
          </name>
          <xref rid="af1-ijms-24-04223" ref-type="aff">1</xref>
          <xref rid="af2-ijms-24-04223" ref-type="aff">2</xref>
          <xref rid="c1-ijms-24-04223" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Okada</surname>
            <given-names>Motohiro</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-ijms-24-04223"><label>1</label>Center for Circadian Clocks, Soochow University, Suzhou 215123, China</aff>
      <aff id="af2-ijms-24-04223"><label>2</label>School of Biology and Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou 215123, China</aff>
      <author-notes>
        <corresp id="c1-ijms-24-04223"><label>*</label>Correspondence: <email>wanghan@suda.edu.cn</email> or <email>han.wang88@gmail.com</email>; Tel.: +86-186-0512-8971</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>2</month>
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>2</month>
        <year>2023</year>
      </pub-date>
      <volume>24</volume>
      <issue>4</issue>
      <elocation-id>4223</elocation-id>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>12</month>
          <year>2022</year>
        </date>
        <date date-type="rev-recd">
          <day>08</day>
          <month>2</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2023 by the authors.</copyright-statement>
        <copyright-year>2023</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Epilepsy is a neurological disorder characterized by hypersynchronous recurrent neuronal activities and seizures, as well as loss of muscular control and sometimes awareness. Clinically, seizures have been reported to display daily variations. Conversely, circadian misalignment and circadian clock gene variants contribute to epileptic pathogenesis. Elucidation of the genetic bases of epilepsy is of great importance because the genetic variability of the patients affects the efficacies of antiepileptic drugs (AEDs). For this narrative review, we compiled 661 epilepsy-related genes from the PHGKB and OMIM databases and classified them into 3 groups: driver genes, passenger genes, and undetermined genes. We discuss the potential roles of some epilepsy driver genes based on GO and KEGG analyses, the circadian rhythmicity of human and animal epilepsies, and the mutual effects between epilepsy and sleep. We review the advantages and challenges of rodents and zebrafish as animal models for epileptic studies. Finally, we posit chronomodulated strategy-based chronotherapy for rhythmic epilepsies, integrating several lines of investigation for unraveling circadian mechanisms underpinning epileptogenesis, chronopharmacokinetic and chronopharmacodynamic examinations of AEDs, as well as mathematical/computational modeling to help develop time-of-day-specific AED dosing schedules for rhythmic epilepsy patients.</p>
      </abstract>
      <kwd-group>
        <kwd>epilepsy</kwd>
        <kwd>epileptic genes</kwd>
        <kwd>circadian clock</kwd>
        <kwd>chronotherapy</kwd>
        <kwd>animal models</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>National Key R&amp;D Program of China</funding-source>
          <award-id>2019YFA0802400</award-id>
        </award-group>
        <award-group>
          <funding-source>National Natural Science Foundation of China (NSFC)</funding-source>
          <award-id>#31961133026</award-id>
          <award-id>#31871187</award-id>
          <award-id>#31030062</award-id>
          <award-id>#81570171</award-id>
          <award-id>#81070455</award-id>
        </award-group>
        <award-group>
          <funding-source>Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions</funding-source>
          <award-id>#YX13400214</award-id>
        </award-group>
        <funding-statement>This research was funded by grants from the National Key R&amp;D Program of China (2019YFA0802400), the National Natural Science Foundation of China (NSFC) (#31961133026, #31871187, #31030062, #81570171, and #81070455), and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (#YX13400214).</funding-statement>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1-ijms-24-04223">
      <title>1. Introduction</title>
      <p>Epilepsy, resulting from neuronal hypersynchronous activities, is a severe neurological disorder that affects approximately 1% of the population worldwide [<xref rid="B1-ijms-24-04223" ref-type="bibr">1</xref>]. The most disabling symptom of epilepsy is its unpredictability. The effective dosages of antiepileptic drugs (AEDs) vary among individual patients [<xref rid="B2-ijms-24-04223" ref-type="bibr">2</xref>]; in particular, AED treatment efficacies for patients with the same epilepsy symptoms differ [<xref rid="B3-ijms-24-04223" ref-type="bibr">3</xref>], and the prognoses among different types of epilepsy vary [<xref rid="B4-ijms-24-04223" ref-type="bibr">4</xref>]. The unpredictability of epilepsy in individual patients may be due to genetic variation and heterogeneity [<xref rid="B5-ijms-24-04223" ref-type="bibr">5</xref>]. Several reviews have discussed epilepsy pharmacogenomics or pharmacogenetics [<xref rid="B6-ijms-24-04223" ref-type="bibr">6</xref>,<xref rid="B7-ijms-24-04223" ref-type="bibr">7</xref>,<xref rid="B8-ijms-24-04223" ref-type="bibr">8</xref>], which investigates different responses of individual patients with distinct genotypes to an AED and develops specific therapeutics for epilepsy patients based on their genotypes [<xref rid="B8-ijms-24-04223" ref-type="bibr">8</xref>]. The effects of genes, for example, <italic toggle="yes">ABCB1</italic> (ATP-binding cassette subfamily B member 1, a drug transporter) [<xref rid="B9-ijms-24-04223" ref-type="bibr">9</xref>], on epilepsy and interactions of <italic toggle="yes">HLA-A</italic> (major histocompatibility complex, class I, A) with adverse AED events [<xref rid="B10-ijms-24-04223" ref-type="bibr">10</xref>] were investigated, highlighting the critical roles of genetic variation and heterogeneity in epilepsy treatment.</p>
      <p>Although seizures are unpredictable, they are not random events. The circadian rhythms of epilepsy have been documented in earlier studies [<xref rid="B11-ijms-24-04223" ref-type="bibr">11</xref>,<xref rid="B12-ijms-24-04223" ref-type="bibr">12</xref>]. Findings in diagnostics using long-term EEG (electroencephalogram) recordings [<xref rid="B13-ijms-24-04223" ref-type="bibr">13</xref>] and self-reported measures [<xref rid="B14-ijms-24-04223" ref-type="bibr">14</xref>] further demonstrated the circadian patterns of epilepsies [<xref rid="B15-ijms-24-04223" ref-type="bibr">15</xref>,<xref rid="B16-ijms-24-04223" ref-type="bibr">16</xref>,<xref rid="B17-ijms-24-04223" ref-type="bibr">17</xref>]. Generally, there are primarily diurnal and nocturnal types of epilepsies [<xref rid="B18-ijms-24-04223" ref-type="bibr">18</xref>]. The sleep&#x2013;wake cycle is also a non-negligible factor [<xref rid="B19-ijms-24-04223" ref-type="bibr">19</xref>]. In addition, different epileptogenic regions display daily occurrences in various temporal epilepsy syndromes [<xref rid="B20-ijms-24-04223" ref-type="bibr">20</xref>].</p>
      <p>Chronotherapy emphasizes that time-of-day-specific treatment is critical for maximizing therapeutic efficacies and minimizing side effects [<xref rid="B21-ijms-24-04223" ref-type="bibr">21</xref>]. In epilepsy, differential dosing of AEDs at the circadian-modulated seizure peak is an effective means of chronotherapy [<xref rid="B22-ijms-24-04223" ref-type="bibr">22</xref>]. Evidence has demonstrated that differentially dosing AEDs improves seizure control and prevents drug resistance [<xref rid="B23-ijms-24-04223" ref-type="bibr">23</xref>,<xref rid="B24-ijms-24-04223" ref-type="bibr">24</xref>]. Hence, the prediction of time-dependent drugs and prevention of potential toxicity, based on chronotherapy testing, should help improve the efficacies of AEDs. Despite well-characterized circadian patterns, little is known about circadian roles in seizures and chronotherapeutics for epilepsy.</p>
      <p>In this review, we compiled as many as 661 epilepsy-related genes from 2 public databases, focused on 192 epileptic driver genes as a cause of epilepsy, and then divided them into 20 KEGG categories. The molecular circadian system and the circadian rhythms of different human and animal seizures are discussed. Studies that link circadian clock genes and epilepsy are then reviewed, highlighting the role of the circadian clock in epilepsy diagnosis and therapy. The development of animal models for epilepsy studies is summarized. Finally, we emphasize targeting the circadian clock and circadian clock-regulated epileptic processes as a chronomodulated strategy for epilepsy therapy. Highlighting the roles of circadian clock genes and the circadian clock in epilepsy provides novel targets for developing AEDs and effective chronotherapy for the large proportion of rhythmic epilepsy patients.</p>
    </sec>
    <sec id="sec2-ijms-24-04223">
      <title>2. Epilepsy Genes</title>
      <p>Even though state-of-the-art medical management with a number of AEDs has been well developed in recent decades, approximately 40% of epilepsy patients treated with an AED fail to reach long-term remission and instead develop drug-resistant epilepsy (DRE) with frequent seizures and increased mortality [<xref rid="B25-ijms-24-04223" ref-type="bibr">25</xref>,<xref rid="B26-ijms-24-04223" ref-type="bibr">26</xref>]. In a long-term study of 144 childhood-onset epilepsy patients, only 23 (16%) patients were cured after 1 year of treatment without a relapse for almost 40 years, 46 (32%) patients took an average of 8.5 years of treatment to reach terminal remission, and 28 (19%) patients followed numerous years of a remitting&#x2013;relapsing course to be cured; whereas 20 (14%) patients displayed remission but failed to reach terminal remission after relapse, and 27 (19%) patients never exhibited remission and were regarded as DRE [<xref rid="B27-ijms-24-04223" ref-type="bibr">27</xref>]. In other words, approximately one-third of epilepsy patients eventually developed drug-resistant or refractory epilepsy. Among several hypotheses postulated for unraveling the pathogenesis of DRE, the &#x201C;genetic hypothesis&#x201D; assumes that single-nucleotide polymorphism (SNP) variants underpin the differential susceptibility to drug resistance in epilepsy patients [<xref rid="B28-ijms-24-04223" ref-type="bibr">28</xref>,<xref rid="B29-ijms-24-04223" ref-type="bibr">29</xref>]. Pharmacogenetics refers to designing a specific treatment for a patient based on his/her genotype [<xref rid="B30-ijms-24-04223" ref-type="bibr">30</xref>]. Therefore, genetic variations affect the efficacy of drugs, and genetic testing has become necessary for clinical research [<xref rid="B31-ijms-24-04223" ref-type="bibr">31</xref>]. Studies from twins have shown that the rate of generalized epilepsy and focal epilepsy is higher in monozygotic twins than in dizygotic twins [<xref rid="B32-ijms-24-04223" ref-type="bibr">32</xref>,<xref rid="B33-ijms-24-04223" ref-type="bibr">33</xref>]. The first epilepsy gene, <italic toggle="yes">CHRNA4</italic> (cholinergic receptor nicotinic alpha 4 subunit), one of the genes responsible for focal epilepsy, was reported in 1995 [<xref rid="B34-ijms-24-04223" ref-type="bibr">34</xref>]. <italic toggle="yes">CHRNA4</italic> belongs to the ligand-gated ion channel family [<xref rid="B35-ijms-24-04223" ref-type="bibr">35</xref>], and its mutations cause nocturnal frontal-lobe epilepsy [<xref rid="B36-ijms-24-04223" ref-type="bibr">36</xref>]. These studies underscore the importance of genes and genetics for epilepsy diagnosis and treatment [<xref rid="B37-ijms-24-04223" ref-type="bibr">37</xref>].</p>
      <sec id="sec2dot1-ijms-24-04223">
        <title>2.1. Compilation of 661 Epilepsy-Related Genes from 2 Public Databases</title>
        <p>Next-generation sequencing (NGS) has facilitated the advancement of human genetics and genomics over the last decade [<xref rid="B38-ijms-24-04223" ref-type="bibr">38</xref>]. In 2014, the Epilepsy Genetics Initiative (EGI) was established to help discover novel epilepsy genes and to identify new molecular diagnoses [<xref rid="B39-ijms-24-04223" ref-type="bibr">39</xref>]. The Public Health Genomics and Precision Health Knowledge Base (PHGKB, <uri xlink:href="https://phgkb.cdc.gov/">https://phgkb.cdc.gov/</uri>, accessed on 9 March 2021) has compiled disease genes from published studies. Approximately 526 genes associated with epilepsy have been listed in the PHGKB&#x2014;for instance, <italic toggle="yes">SCN1A</italic> (sodium voltage-gated channel alpha subunit 1) as a drug target gene [<xref rid="B40-ijms-24-04223" ref-type="bibr">40</xref>,<xref rid="B41-ijms-24-04223" ref-type="bibr">41</xref>,<xref rid="B42-ijms-24-04223" ref-type="bibr">42</xref>] and <italic toggle="yes">CYP2C9</italic> (cytochrome P450 family 2 subfamily C member 9), which is involved in drug metabolism [<xref rid="B43-ijms-24-04223" ref-type="bibr">43</xref>,<xref rid="B44-ijms-24-04223" ref-type="bibr">44</xref>], have been examined in epilepsy studies. Furthermore, the Online Mendelian Inheritance in Man (OMIM, <uri xlink:href="https://www.omim.org/">https://www.omim.org/</uri>, accessed on 9 March, 2021) database also catalogs epilepsy-related genes, listing 194 epileptic-associated genes. We compared epilepsy-related genes from PHGKB and OMIM and obtained a total of 661 epilepsy-related genes (overlapping genes + nonoverlapping genes of the 2 databases; <xref rid="app1-ijms-24-04223" ref-type="app">Supplementary Table S1</xref>), which is comparable with previous efforts to assemble epilepsy-related genes [<xref rid="B45-ijms-24-04223" ref-type="bibr">45</xref>,<xref rid="B46-ijms-24-04223" ref-type="bibr">46</xref>]. Interestingly, the circadian clock pathway was enriched in GO analysis, and several circadian clock genes, such as <italic toggle="yes">PER2</italic> and <italic toggle="yes">PER3,</italic> were regarded as epilepsy-related genes (<xref rid="ijms-24-04223-f001" ref-type="fig">Figure 1</xref>A, <xref rid="app1-ijms-24-04223" ref-type="app">Supplementary Table S2</xref>), indicative of circadian involvement in epilepsies/seizures.</p>
      </sec>
      <sec id="sec2dot2-ijms-24-04223">
        <title>2.2. Epileptic Driver Genes, Passenger Genes, and Undetermined Genes</title>
        <p>Through interrogating the published relevant studies, these 661 genes were then divided into 3 groups: 192 driver genes, 176 passenger genes, and 293 undetermined genes (<xref rid="app1-ijms-24-04223" ref-type="app">Supplementary Table S1</xref>). A driver gene is defined as one whose mutation or loss causes seizures. In contrast, the passenger gene is defined as one that exhibits altered expression during seizures or causes neurological diseases accompanying epilepsy. We classified the remaining genes into undetermined genes, which do not yet play a clear role in epilepsy, including those involved in drug metabolism. For example, protein SZT2 (seizure threshold 2) deficiency resulted in hyperactivation of mTORC1 (mechanistic/mammalian target of rapamycin complex 1) signaling in HEK293 and HeLa cells, leading to neonatal death in mice [<xref rid="B47-ijms-24-04223" ref-type="bibr">47</xref>], and the homozygous mutation of its gene is responsible for epilepsy in a Saudi family [<xref rid="B48-ijms-24-04223" ref-type="bibr">48</xref>]. Therefore, we classify this gene as an epilepsy driver gene. Even though the mutations of some genes were revealed in epileptic patients, whether these genetic mutations are responsible for epilepsy is unclear. For instance, <italic toggle="yes">GNAO1</italic> (G protein subunit alpha o1), whose loss-of-function (LOF) mutations are associated with epileptic encephalopathy but whose gain-of-function (GOF) and synonymous mutations are associated with patients with movement disorders that may not display epilepsy [<xref rid="B49-ijms-24-04223" ref-type="bibr">49</xref>] or <italic toggle="yes">SLC7A6OS</italic> (solute carrier family 7 member 6 opposite strand), has recently been found in two unrelated progressive myoclonus epilepsy families, but its role in epilepsy is unknown [<xref rid="B50-ijms-24-04223" ref-type="bibr">50</xref>]. Hence, the two genes are regarded as epilepsy passenger genes. Furthermore, some genes were associated with epilepsy, such as <italic toggle="yes">SLC22A1</italic> (solute carrier family 22 member 1), a cation transporter gene essential for removing environmental toxins and drugs [<xref rid="B51-ijms-24-04223" ref-type="bibr">51</xref>]. <italic toggle="yes">SLC22A1</italic> was shown to contribute to altered lamotrigine (LTG) plasma concentrations during AED treatment [<xref rid="B52-ijms-24-04223" ref-type="bibr">52</xref>], but no <italic toggle="yes">SLC22A1</italic> variants have been shown to cause or affect epilepsy to date; thus, we regard it as an undetermined gene.</p>
        <p>We then employed KOBAS (KEGG Orthology-Based Annotation System, <uri xlink:href="http://kobas.cbi.pku.edu.cn/kobas3">http://kobas.cbi.pku.edu.cn/kobas3</uri>, accessed on 8 August 2022) to classify these 192 epilepsy driver genes into several clusters based on biological processes (<xref rid="ijms-24-04223-t001" ref-type="table">Table 1</xref>). The top 20 ranked pathways were sorted and merged according to upper-level categories (<xref rid="ijms-24-04223-f001" ref-type="fig">Figure 1</xref>B). We then focus on discussing the epileptic driver genes involved in ion channels, the mTOR pathway, synaptic support proteins, and transcription regulation, as well as the effects of some epileptic genes on circadian rhythms and the sleep&#x2013;wake cycle [<xref rid="B37-ijms-24-04223" ref-type="bibr">37</xref>], as many of the same pathways are also enriched in epileptic passenger genes.</p>
        <sec id="sec2dot2dot1-ijms-24-04223">
          <title>2.2.1. Ion Channel Genes</title>
          <p>Not surprisingly, numerous nervous-system-related processes/pathways are enriched in these epilepsy driver genes, and we first focus on genes involved in the cholinergic and GABAergic synapses. As described above, <italic toggle="yes">CHRNA4</italic> involved in the cholinergic synapse was the first identified epilepsy gene causing autosomal dominant nocturnal frontal-lobe epilepsy (ADFLE), which occurs mainly during NREM (non-rapid eye movement) sleep [<xref rid="B34-ijms-24-04223" ref-type="bibr">34</xref>]. Ever since, <italic toggle="yes">CHRNA2</italic> and <italic toggle="yes">CHRNB2</italic>, as well as an additional <italic toggle="yes">CHRNA4</italic> mutation, have been reported in sleep-related FLE (frontal lobe epilepsy) [<xref rid="B53-ijms-24-04223" ref-type="bibr">53</xref>,<xref rid="B54-ijms-24-04223" ref-type="bibr">54</xref>,<xref rid="B55-ijms-24-04223" ref-type="bibr">55</xref>] (<xref rid="ijms-24-04223-f001" ref-type="fig">Figure 1</xref>B). The 3 genes <italic toggle="yes">CHRNA2</italic>, <italic toggle="yes">CHRNA4</italic>, and <italic toggle="yes">CHRNB2</italic> encode the &#x3B1;2, &#x3B1;4, and &#x3B2;2 subunits of the nicotinic acetylcholine receptor (nAChR), respectively, which, as members of a family of ligand-gated ion channels, form cation-selective ion channels for sodium and potassium in response to ligands such as nicotine and acetylcholine [<xref rid="B56-ijms-24-04223" ref-type="bibr">56</xref>]. Although the 3 subunits &#x3B1;2, &#x3B1;4, and &#x3B2;2 are all highly expressed in the cerebral cortex of monkeys [<xref rid="B57-ijms-24-04223" ref-type="bibr">57</xref>,<xref rid="B58-ijms-24-04223" ref-type="bibr">58</xref>], only &#x3B1;2 is highly expressed in GABAergic cells of the deep layers in rodents [<xref rid="B59-ijms-24-04223" ref-type="bibr">59</xref>,<xref rid="B60-ijms-24-04223" ref-type="bibr">60</xref>,<xref rid="B61-ijms-24-04223" ref-type="bibr">61</xref>]. A <italic toggle="yes">CHRNB2</italic> mutation (V287M) near the extracellular end of the M2 (second transmembrane) domain of the nAChR &#x3B2;2 subunit likely destroys the walls of the ion channel and was revealed in a Scottish family [<xref rid="B54-ijms-24-04223" ref-type="bibr">54</xref>], indicating that the structural integrity of ion channels/receptors is important for resisting seizures. Furthermore, GABAergic synapses have been reported to contribute to seizure regulation (<xref rid="ijms-24-04223-f001" ref-type="fig">Figure 1</xref>B, <xref rid="ijms-24-04223-t001" ref-type="table">Table 1</xref>) [<xref rid="B62-ijms-24-04223" ref-type="bibr">62</xref>]. As one of the first targets of epilepsy gene therapy, increasing GABA levels in the epileptogenic area elevates the threshold of neuronal excitability, which reduces seizures [<xref rid="B63-ijms-24-04223" ref-type="bibr">63</xref>]. GAD (glutamic acid decarboxylase), the catalytic enzyme of GABA biosynthesis, has been used to enhance GABA levels [<xref rid="B64-ijms-24-04223" ref-type="bibr">64</xref>]. <italic toggle="yes">GAD1</italic> encodes a 67 KD molecular weight protein, i.e., GAD67, which produces up to 90% of the GABA in the CNS [<xref rid="B65-ijms-24-04223" ref-type="bibr">65</xref>,<xref rid="B66-ijms-24-04223" ref-type="bibr">66</xref>]. <italic toggle="yes">GAD1</italic> mutations are associated with neurodegenerative diseases such as schizophrenia, bipolar disorder, and other movement disorders [<xref rid="B67-ijms-24-04223" ref-type="bibr">67</xref>,<xref rid="B68-ijms-24-04223" ref-type="bibr">68</xref>], and <italic toggle="yes">Gad67</italic><sup>&#x2212;/&#x2212;</sup> knockout mice display neonatal death [<xref rid="B65-ijms-24-04223" ref-type="bibr">65</xref>]. A recent study found that biallelic <italic toggle="yes">GAD1</italic> mutation was associated with seizures and reduced muscle tone in six unrelated families [<xref rid="B69-ijms-24-04223" ref-type="bibr">69</xref>]. Animal studies have also shown that <italic toggle="yes">GAD1</italic> mutations result in reduced GABA synthesis and induce seizures that reduce GABA release and, in turn, cause imbalanced brain activity [<xref rid="B70-ijms-24-04223" ref-type="bibr">70</xref>]. In addition, GABA receptors mediate the activity of downstream neurons. GABA<sub>(A)</sub> receptors possess 18 subunits, including &#x3B1;(1&#x2013;6), &#x3B2;(1&#x2013;3), &#x3B3;(1&#x2013;3), &#x3B4;, &#x3B5;(1&#x2013;3), &#x3B8;, and &#x3C0;, and they mediate fast inhibitory actions in the brain [<xref rid="B71-ijms-24-04223" ref-type="bibr">71</xref>,<xref rid="B72-ijms-24-04223" ref-type="bibr">72</xref>]. While malfunction of GABA<sub>(A)</sub> receptors (such as &#x3B1;1) has been shown to contribute to human epilepsy disorders [<xref rid="B73-ijms-24-04223" ref-type="bibr">73</xref>], downregulation of synaptic GABA<sub>(A)</sub> receptors, as well as the reduced phosphorylation of the &#x3B2;3 subunit, was observed in lithium-pilocarpine-induced status epilepticus rats [<xref rid="B74-ijms-24-04223" ref-type="bibr">74</xref>,<xref rid="B75-ijms-24-04223" ref-type="bibr">75</xref>]. However, upregulation of the GABA<sub>(A)</sub> receptors has been observed in the dentate gyrus of temporal lobe epilepsy (TLE) mice [<xref rid="B76-ijms-24-04223" ref-type="bibr">76</xref>]. Thus, GABA<sub>(A)</sub> receptors have become a therapeutic target of epilepsy.</p>
          <p>In addition to the ligand-gated ion channels, the voltage-gated ion channels, including sodium (Na<sup>+</sup>), potassium (K<sup>+</sup>), and calcium (Ca<sup>2+</sup>) channels [<xref rid="B77-ijms-24-04223" ref-type="bibr">77</xref>], are also involved in epilepsy. Genetic variants in <italic toggle="yes">SCN1A</italic>, <italic toggle="yes">SCN2A</italic>, and <italic toggle="yes">SCN1B</italic>, encoding voltage-gated sodium channels, contributed to early-onset epilepsy [<xref rid="B78-ijms-24-04223" ref-type="bibr">78</xref>]. Missense mutations or deletion of <italic toggle="yes">SCN1A</italic> have been shown to lead to loss of sodium current in GABA-mediated inhibitory interneurons, resulting in Dravet syndrome (DS), which often occurs in the first year of life) [<xref rid="B79-ijms-24-04223" ref-type="bibr">79</xref>,<xref rid="B80-ijms-24-04223" ref-type="bibr">80</xref>]. In contrast, gain-of-function <italic toggle="yes">SCN2A</italic> missense mutations have recently been reported to be associated with early infantile seizures, such as developmental and epileptic encephalopathy (DEE), which usually occur as early as three months of life) [<xref rid="B78-ijms-24-04223" ref-type="bibr">78</xref>,<xref rid="B81-ijms-24-04223" ref-type="bibr">81</xref>]. The patient with early infantile seizures was also shown to harbor the <italic toggle="yes">SCN1B p.C121W</italic> mutation [<xref rid="B82-ijms-24-04223" ref-type="bibr">82</xref>], and mice engineered to carry the <italic toggle="yes">SCN1B p.C121W</italic> mutation display reduced dendrites of pyramidal neurons and hyperexcitability of the specific brain region [<xref rid="B83-ijms-24-04223" ref-type="bibr">83</xref>]. Benign familial neonatal seizures (BFNS) as another early-onset epilepsy have been revealed to be associated with loss-of-function mutations of voltage-gated potassium channel genes, including <italic toggle="yes">KCNQ2</italic> (potassium voltage-gated channel subfamily Q member 2) and <italic toggle="yes">KCNQ3</italic> [<xref rid="B84-ijms-24-04223" ref-type="bibr">84</xref>]. KCNQ2 and KCNQ3 are expressed in the whole brain region, form homo- and heterotetrameric channels, and produce the M-current important for controlling membrane potentials [<xref rid="B85-ijms-24-04223" ref-type="bibr">85</xref>]. Whereas homozygous <italic toggle="yes">Kcnq2</italic><sup>&#x2212;/&#x2212;</sup> knockout mice die after birth due to pulmonary atelectasis, heterozygous <italic toggle="yes">Kcnq2<sup>+/</sup></italic><sup>&#x2212;</sup> mice are viable and sensitive to pentylenetetrazole (PTZ) [<xref rid="B86-ijms-24-04223" ref-type="bibr">86</xref>]. <italic toggle="yes">CACNA1A</italic> (Ca<sub>v</sub>2.1 &#x3B1;1 subunit) encodes P/Q type channels, whose mutations are associated with absence seizures [<xref rid="B87-ijms-24-04223" ref-type="bibr">87</xref>]. Thus, various mutations of ion channel genes have been shown to result in epilepsies [<xref rid="B88-ijms-24-04223" ref-type="bibr">88</xref>].</p>
        </sec>
        <sec id="sec2dot2dot2-ijms-24-04223">
          <title>2.2.2. Genes Involved in the mTOR Pathway</title>
          <p>In recent years, inhibition of the mTOR pathway has become a new therapeutic strategy in epilepsy [<xref rid="B89-ijms-24-04223" ref-type="bibr">89</xref>,<xref rid="B90-ijms-24-04223" ref-type="bibr">90</xref>] because the mTOR pathway is associated with malformations of cortical development (MCD) coupled with intractable epilepsy [<xref rid="B91-ijms-24-04223" ref-type="bibr">91</xref>]. <italic toggle="yes">DEPDC5</italic> (DEP domain containing 5), <italic toggle="yes">NPRL2</italic> (nitrogen permease regulator-like 2), and <italic toggle="yes">NPRL3</italic> (nitrogen permease regulator-like 3) are 3 components of the GATOR1 (GTPase-activating protein (GAP) activity toward Rags 1) protein complex, and their loss-of-function mutations have been identified in MCD-associated epilepsies [<xref rid="B92-ijms-24-04223" ref-type="bibr">92</xref>,<xref rid="B93-ijms-24-04223" ref-type="bibr">93</xref>,<xref rid="B94-ijms-24-04223" ref-type="bibr">94</xref>]. In particular, these mutations lead to the upregulation of mTORC1, thereby contributing to focal epilepsy [<xref rid="B95-ijms-24-04223" ref-type="bibr">95</xref>].</p>
        </sec>
        <sec id="sec2dot2dot3-ijms-24-04223">
          <title>2.2.3. Genes Encoding Synaptic Support Proteins</title>
          <p>The synaptic vesicle cycle is also included in the top 20 KEGG pathways in our analysis (<xref rid="ijms-24-04223-f001" ref-type="fig">Figure 1</xref>B). We will discuss several genes, such as <italic toggle="yes">DNM1</italic>, <italic toggle="yes">STX1B,</italic> and <italic toggle="yes">STXBP1</italic>. <italic toggle="yes">DNM1</italic> (dynamin 1) encodes a GTP-binding protein involved in synaptic vesicle fission on the presynaptic membrane [<xref rid="B96-ijms-24-04223" ref-type="bibr">96</xref>]. Mutations in the GTPase and the middle domains of DNM1 result in impaired endocytosis of synaptic vesicles, leading to severe seizures with intellectual disability and hypotonia [<xref rid="B97-ijms-24-04223" ref-type="bibr">97</xref>]. <italic toggle="yes">STX1B</italic> (syntaxin 1b) and <italic toggle="yes">STXBP1</italic> (syntaxin-binding protein 1) play a role in exocytosis; specifically, STX1B mainly mediates releasing the Ca<sup>2+</sup>-dependent synaptic vesicle, whereas STXBP1 secures the correct position of syntaxin-1 [<xref rid="B98-ijms-24-04223" ref-type="bibr">98</xref>]. <italic toggle="yes">STX1B</italic> mutations result in tonic&#x2013;clonic seizures, absence seizures, and myoclonic seizures [<xref rid="B99-ijms-24-04223" ref-type="bibr">99</xref>]. <italic toggle="yes">STX1B</italic> and <italic toggle="yes">STXBP1</italic> mutations are often found in infant seizures [<xref rid="B98-ijms-24-04223" ref-type="bibr">98</xref>].</p>
        </sec>
        <sec id="sec2dot2dot4-ijms-24-04223">
          <title>2.2.4. Transcriptional Regulators</title>
          <p>Several epileptic driver genes involved in transcription have also been studied. The <italic toggle="yes">ARX</italic> (Aristaless-related homeobox) encodes a transcription factor important for neuronal development [<xref rid="B100-ijms-24-04223" ref-type="bibr">100</xref>], whose loss-of-function variants/mutations contribute to X-linked intellectual disability and epilepsy [<xref rid="B101-ijms-24-04223" ref-type="bibr">101</xref>,<xref rid="B102-ijms-24-04223" ref-type="bibr">102</xref>], while increasing the gene copy number of the other X-linked gene <italic toggle="yes">MECP2</italic> (methyl-CpG binding protein 2) leads to MECP2 duplication syndrome (MDS) [<xref rid="B103-ijms-24-04223" ref-type="bibr">103</xref>]. Up to 90% of children with MDS have been shown to have seizures during adolescence [<xref rid="B104-ijms-24-04223" ref-type="bibr">104</xref>]. These studies suggest that transcription regulation also contributes to epileptogenesis.</p>
        </sec>
        <sec id="sec2dot2dot5-ijms-24-04223">
          <title>2.2.5. Effects of Epileptic Genes on Circadian Rhythms and the Sleep&#x2013;Wake Cycle</title>
          <p>Several epileptic driver genes have been known to affect circadian rhythms and the sleep&#x2013;wake cycle. <italic toggle="yes">Scn1a<sup>+/</sup></italic><sup>&#x2212;</sup> DS mice display impaired sleep, characteristic of an extended sleep period and fragmented non-rapid eye movement (NREM) sleep [<xref rid="B105-ijms-24-04223" ref-type="bibr">105</xref>], whereas <italic toggle="yes">Scn2a</italic><sup>&#x2212;/&#x2212;</sup> mice result in reduced NREM sleep and increased wakefulness, accompanied by a disrupted spontaneous firing pattern in SCN and altered expression of core circadian clock genes [<xref rid="B106-ijms-24-04223" ref-type="bibr">106</xref>]. Epileptic <italic toggle="yes">Kcna1</italic><sup>&#x2212;/&#x2212;</sup> mice exhibit a lengthened circadian period with an extended wake period and reduced sleep time, as well as damped oscillations of core circadian clock genes such as <italic toggle="yes">Clock</italic>, <italic toggle="yes">Bmal1</italic>, and <italic toggle="yes">Per1</italic> [<xref rid="B107-ijms-24-04223" ref-type="bibr">107</xref>]. Similarly, loss of <italic toggle="yes">Drosophila cac</italic> (<italic toggle="yes">cacophony</italic>) (an ortholog of CACNA1A) also results in reduced sleep time [<xref rid="B108-ijms-24-04223" ref-type="bibr">108</xref>]. Furthermore, <italic toggle="yes">MECP2</italic> is likely regulated by the circadian clock, and its disrupted expression is expected to be responsible for sleep disorders during pathological stages [<xref rid="B109-ijms-24-04223" ref-type="bibr">109</xref>]. Therefore, identifying these circadian-clock-related epileptic genes and further elucidating their functions should shed light on the reciprocal effects between epileptogenesis and the circadian clock, provide novel targets for drug development, and contribute to precise epilepsy treatment.</p>
        </sec>
      </sec>
    </sec>
    <sec id="sec3-ijms-24-04223">
      <title>3. Circadian Rhythms in Human Epilepsies</title>
      <p>As early as 1885, William R. Gowers observed three groups of epilepsy patients in daily patterns: diurnal, nocturnal, and diffuse [<xref rid="B12-ijms-24-04223" ref-type="bibr">12</xref>]. Diurnal seizures occur at certain times of the day, whereas nocturnal seizures tend to occur primarily at bedtime and at night [<xref rid="B110-ijms-24-04223" ref-type="bibr">110</xref>]. Recently, SeizureTracker (Springfield, VA, USA) and NeuroVista (Melbourne, VIC, Australia) were employed to analyze the rhythmic patterns of seizures and found that the seizure rates of approximately 80% of 1118 patients displayed daily variations [<xref rid="B111-ijms-24-04223" ref-type="bibr">111</xref>]. The mechanisms underpinning why seizures display daily variation are not clear. A legitimate hypothesis is that the circadian clock contributes to seizure rhythmicity. However, little is known about the circadian roles in epilepsy and seizures.</p>
      <p>The International League Against Epilepsy (ILAE) broadly categorizes seizures into focal seizures, generalized seizures, and seizures of unknown onset [<xref rid="B112-ijms-24-04223" ref-type="bibr">112</xref>,<xref rid="B113-ijms-24-04223" ref-type="bibr">113</xref>,<xref rid="B114-ijms-24-04223" ref-type="bibr">114</xref>]. Focal seizures occur only in discrete brain regions limited to one hemisphere, generalized seizures involve large bilateral brain areas, even the whole brain cortex, and seizures of unknown onset do not belong to the focal or generalized categories (<xref rid="ijms-24-04223-f002" ref-type="fig">Figure 2</xref>) [<xref rid="B112-ijms-24-04223" ref-type="bibr">112</xref>,<xref rid="B114-ijms-24-04223" ref-type="bibr">114</xref>,<xref rid="B115-ijms-24-04223" ref-type="bibr">115</xref>]. EEG recordings of generalized seizures have been revealed to be significantly more robust in the morning than in the afternoon [<xref rid="B116-ijms-24-04223" ref-type="bibr">116</xref>]. Furthermore, focal seizures have been shown to manifest a predictable daily pattern (<xref rid="ijms-24-04223-t002" ref-type="table">Table 2</xref>) [<xref rid="B16-ijms-24-04223" ref-type="bibr">16</xref>]. Parietal lobe epilepsy (PLE) occurs primarily around the end of sleep in the morning [<xref rid="B15-ijms-24-04223" ref-type="bibr">15</xref>,<xref rid="B20-ijms-24-04223" ref-type="bibr">20</xref>]. Two peaks of PLE were found in Hofstra&#x2019;s study of 450 times of seizures: one peaking around 05:00 to 11:00, and the other peaking around 17:00&#x2013;23:00 [<xref rid="B117-ijms-24-04223" ref-type="bibr">117</xref>]. In contrast, occipital and temporal lobe epilepsy often occurs in the afternoon [<xref rid="B18-ijms-24-04223" ref-type="bibr">18</xref>,<xref rid="B20-ijms-24-04223" ref-type="bibr">20</xref>,<xref rid="B118-ijms-24-04223" ref-type="bibr">118</xref>]. Temporal lobe epilepsy has been classified into mesial (MTLE), lesional (LTLE), and neocortical temporal lobe (NTLE) epilepsy. MTLE displays two peaks, 07:00&#x2013;08:00 and 16:00&#x2013;17:00 [<xref rid="B20-ijms-24-04223" ref-type="bibr">20</xref>,<xref rid="B117-ijms-24-04223" ref-type="bibr">117</xref>,<xref rid="B119-ijms-24-04223" ref-type="bibr">119</xref>,<xref rid="B120-ijms-24-04223" ref-type="bibr">120</xref>], respectively, whereas LTLE peaks around 11:00, and NTLE peaks around 11:00&#x2013;17:00 [<xref rid="B117-ijms-24-04223" ref-type="bibr">117</xref>] and early morning [<xref rid="B120-ijms-24-04223" ref-type="bibr">120</xref>]. On the other hand, interictal epileptiform discharges (IEDs), sharp waves in the EEG background between seizures, show a nocturnal predominance and often occur during NREM sleep [<xref rid="B16-ijms-24-04223" ref-type="bibr">16</xref>,<xref rid="B121-ijms-24-04223" ref-type="bibr">121</xref>,<xref rid="B122-ijms-24-04223" ref-type="bibr">122</xref>]. However, recent studies have shown that the peak of nocturnal predominance in interictal epileptiform activity (IEA) was independent of the region of seizure irritability, monitored by an implantable brain stimulator (RNS<sup>&#xAE;</sup> system, Neuropace, Mountain View, CA, USA) continuously for a more extended period [<xref rid="B120-ijms-24-04223" ref-type="bibr">120</xref>,<xref rid="B123-ijms-24-04223" ref-type="bibr">123</xref>]. Together, these studies indicated that the circadian rhythm of seizures was robust and endogenous, independent of antiseizure dosing [<xref rid="B111-ijms-24-04223" ref-type="bibr">111</xref>,<xref rid="B124-ijms-24-04223" ref-type="bibr">124</xref>], indicating a possible circadian role in epileptic pathogenesis.</p>
      <p>However, relatively little is known about disrupted circadian rhythms in epilepsy patients. Analysis of the sleep&#x2013;wake cycle of 20 patients with TLE and 20 patients with juvenile myoclonic epilepsy (JME) showed that JME patients tend to sleep later at night and get up later in the morning, whereas TLE patients are morning-types [<xref rid="B19-ijms-24-04223" ref-type="bibr">19</xref>]. Twenty-four-hour EEG (electrocardiography) recording of the interictal circadian rhythm of heart rate (HR) variability revealed no nocturnal increase in heart rate variability in TLE patients, highlighting the attenuated circadian heart rate rhythm in TLE patients [<xref rid="B125-ijms-24-04223" ref-type="bibr">125</xref>]. Furthermore, epileptic patients produced significantly elevated melatonin levels during the nighttime with an altered phase, even though they maintained melatonin secretion rhythms [<xref rid="B126-ijms-24-04223" ref-type="bibr">126</xref>]. Hence, elucidation of the mechanisms underlying circadian roles in epileptic pathogenesis is critically important for providing novel targets for AED development and developing a novel chronomodulated strategy-based treatment for these rhythmic epilepsy patients.</p>
      <table-wrap position="anchor" id="ijms-24-04223-t002">
        <object-id pub-id-type="pii">ijms-24-04223-t002_Table 2</object-id>
        <label>Table 2</label>
        <caption>
          <p>Circadian rhythms of human epilepsies.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin;background:#ED7D31" rowspan="1" colspan="1">Seizures</th>
              <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin;background:#ED7D31" rowspan="1" colspan="1">Peak in 24-h Cycle</th>
              <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin;background:#ED7D31" rowspan="1" colspan="1">Subjects No. (Seizure No.)</th>
              <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin;background:#ED7D31" rowspan="1" colspan="1">References</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">
<bold>TLE</bold>
</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">11:00&#x2013;17:00<break/>11:00&#x2013;19:00<break/>11:00&#x2013;15:00</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">176 (808)<break/>26 (90)<break/>1 (694)</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">Hofstra et al. (2009) [<xref rid="B118-ijms-24-04223" ref-type="bibr">118</xref>]<break/>Pavlova et al. (2004) [<xref rid="B18-ijms-24-04223" ref-type="bibr">18</xref>]<break/>Quigg et al. (2000) [<xref rid="B15-ijms-24-04223" ref-type="bibr">15</xref>]</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>LTLE</bold>
</td>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Morning</td>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 (48)</td>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quigg et al. (1998) [<xref rid="B127-ijms-24-04223" ref-type="bibr">127</xref>]</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">
<bold>MTLE</bold>
</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">05:00&#x2013;11:00 and 11:00&#x2013;17:00<break/>15:00<break/>07:00&#x2013;10:00 and 16:00&#x2013;19:00<break/>06:00&#x2013;08:00 and 15:00&#x2013;17:00<break/>03:00 and 17:00&#x2013;20:00</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">33 (450)<break/>64 (774)<break/>131 (669)<break/>60 (694)<break/>72 (No mention)</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">Hofstra et al. (2009) [<xref rid="B117-ijms-24-04223" ref-type="bibr">117</xref>]<break/>Quigg et al. (1998) [<xref rid="B127-ijms-24-04223" ref-type="bibr">127</xref>]<break/>Durazzo et al. (2008) [<xref rid="B20-ijms-24-04223" ref-type="bibr">20</xref>]<break/>Karafin et al. (2010) [<xref rid="B119-ijms-24-04223" ref-type="bibr">119</xref>]<break/>Spencer et al. (2016) [<xref rid="B120-ijms-24-04223" ref-type="bibr">120</xref>]</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>NTLE</bold>
</td>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11:00&#x2013;17:00<break/>03:00&#x2013;07:00</td>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33 (450)<break/>18 (No mention)</td>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hofstra et al. (2009) [<xref rid="B117-ijms-24-04223" ref-type="bibr">117</xref>]<break/>Spencer et al. (2016) [<xref rid="B120-ijms-24-04223" ref-type="bibr">120</xref>]</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">
<bold>XTLE</bold>
</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">Morning</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">26 (465)</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">Quigg et al. (1998) [<xref rid="B127-ijms-24-04223" ref-type="bibr">127</xref>]</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>FLE</bold>
</td>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23:00&#x2013;05:00<break/>19:00&#x2013;23:00<break/>04:00&#x2013;07:00<break/>around 03:00</td>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33 (450)<break/>26 (90)<break/>131 (669)<break/>17 (No mention)</td>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hofstra et al. (2009) [<xref rid="B117-ijms-24-04223" ref-type="bibr">117</xref>]<break/>Pavlova et al. (2004) [<xref rid="B18-ijms-24-04223" ref-type="bibr">18</xref>]<break/>Durazzo et al. (2008) [<xref rid="B20-ijms-24-04223" ref-type="bibr">20</xref>]<break/>Spencer et al. (2016) [<xref rid="B120-ijms-24-04223" ref-type="bibr">120</xref>]</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">
<bold>PLE</bold>
</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">05:00&#x2013;11:00 and 17:00&#x2013;23:00<break/>04:00&#x2013;07:00<break/>01:00&#x2013;06:00</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">33 (450)<break/>131 (669)<break/>1 (315)</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">Hofstra et al. (2009) [<xref rid="B117-ijms-24-04223" ref-type="bibr">117</xref>]<break/>Durazzo et al. (2008) [<xref rid="B20-ijms-24-04223" ref-type="bibr">20</xref>]<break/>Quigg et al. (2000) [<xref rid="B15-ijms-24-04223" ref-type="bibr">15</xref>]</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>OLE</bold>
</td>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19:00&#x2013;23:00<break/>16:00&#x2013;19:00</td>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26 (90)<break/>131 (669)</td>
              <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pavlova et al. (2004) [<xref rid="B18-ijms-24-04223" ref-type="bibr">18</xref>]<break/>Durazzo et al. (2008) [<xref rid="B20-ijms-24-04223" ref-type="bibr">20</xref>]</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">
<bold>GED</bold>
</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">Morning</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">29 (No mention)</td>
              <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">Labate et al. (2007) [<xref rid="B116-ijms-24-04223" ref-type="bibr">116</xref>]</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>MTLE = mesial temporal lobe epilepsy; XTLE = extratemporal lobe epilepsy; LTLE = lesional temporal lobe epilepsy; NTLE = neocortical temporal lobe epilepsy; FLE = frontal lobe epilepsy; PLE = parietal lobe epilepsy; OLE = occipital lobe epilepsy; GED = generalized epileptiform discharge.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="sec4-ijms-24-04223">
      <title>4. The Circadian Clock</title>
      <p>Circadian rhythms, as biological rhythms with a period of approximately 24 h, are regulated and controlled by an endogenous time-keeping mechanism, i.e., the circadian clock [<xref rid="B128-ijms-24-04223" ref-type="bibr">128</xref>,<xref rid="B129-ijms-24-04223" ref-type="bibr">129</xref>,<xref rid="B130-ijms-24-04223" ref-type="bibr">130</xref>,<xref rid="B131-ijms-24-04223" ref-type="bibr">131</xref>]. In mammals, the central clock is situated at the suprachiasmatic nuclei (SCN) of the anterior hypothalamus [<xref rid="B132-ijms-24-04223" ref-type="bibr">132</xref>]. The mammalian SCN neurons exhibit higher activity in electrical physiology and metabolism during the daytime [<xref rid="B133-ijms-24-04223" ref-type="bibr">133</xref>,<xref rid="B134-ijms-24-04223" ref-type="bibr">134</xref>]. External light is received by intrinsically photosensitive retinal ganglion cells (ipRGCs) and transmitted to the SCN via the retinohypothalamic tract (RHT) [<xref rid="B135-ijms-24-04223" ref-type="bibr">135</xref>]. The efferent from the SCN projects to the pineal gland and drives the rhythmic release of melatonin, a sleep-promoting hormone. Since light is known to inhibit melatonin synthesis, the daily oscillation of melatonin is similar in both diurnal and nocturnal animals [<xref rid="B136-ijms-24-04223" ref-type="bibr">136</xref>,<xref rid="B137-ijms-24-04223" ref-type="bibr">137</xref>] and helps to synchronize peripheral organs in the body [<xref rid="B138-ijms-24-04223" ref-type="bibr">138</xref>]. Intriguingly, most organs, tissues, and cells display circadian rhythmicity, regulated by the local peripheral clock, as well as neural, hormonal, and metabolic cues from the SCN [<xref rid="B139-ijms-24-04223" ref-type="bibr">139</xref>].</p>
      <p>Three transcription-translation feedback loops as molecular time-keeping mechanisms are known to generate, regulate, and maintain circadian rhythms [<xref rid="B140-ijms-24-04223" ref-type="bibr">140</xref>,<xref rid="B141-ijms-24-04223" ref-type="bibr">141</xref>]. In the primary loop, the CLOCK: BMAL1 heterodimer as the positive limb activates the expression of target genes, including <italic toggle="yes">Per</italic> genes (<italic toggle="yes">Per1</italic>, <italic toggle="yes">Per2,</italic> and <italic toggle="yes">Per3</italic> ) and <italic toggle="yes">Cry</italic> genes (<italic toggle="yes">Cry1</italic> and <italic toggle="yes">Cry2</italic>) via binding to E-box (5&#x2032;-CACGTG-3&#x2032;) and E&#x2019;-box (5&#x2032;-CACGTT-3&#x2032;) in their promoter regions [<xref rid="B142-ijms-24-04223" ref-type="bibr">142</xref>], whereas the PER: CRY heterodimer as the negative limb interferes with the transcriptional activity of the CLOCK-BMAL1 heterodimer and turns off their expression [<xref rid="B143-ijms-24-04223" ref-type="bibr">143</xref>]. In the second loop, <italic toggle="yes">Ror&#x3B1;/&#x3B2;</italic> and <italic toggle="yes">Rev-erb&#x3B1;/&#x3B2;</italic> are regulated by CLOCK and BMAL1 via E-box, whereas their proteins ROR&#x3B1;/&#x3B2; and REV-ERB&#x3B1;/&#x3B2; activate and suppress <italic toggle="yes">Bmal1</italic> by competing for binding to the RORE (retinoic-acid-related orphan receptor response element) in the <italic toggle="yes">Bmal1</italic> promoter region (<xref rid="ijms-24-04223-f003" ref-type="fig">Figure 3</xref>). In the third loop, D-box-containing proline and acidic amino-acid-rich basic leucine zipper (PAR bZip) genes <italic toggle="yes">Dbp</italic> (albumin D-box-binding protein), <italic toggle="yes">Hlf</italic> (hepatic leukemia factor), <italic toggle="yes">Tef</italic> (thyrotroph embryonic factor), and <italic toggle="yes">E4bp4/Nfil3</italic> (E4 promoter-binding protein 4/nuclear factor interleukin-3-regulated protein/nuclear factor, interleukin 3 regulated) are all regulated by CLOCK and BMAL1 via E-box, whereas their proteins DBP, HIF, TEF, and E4BP4/NFIL3 bind to D-box in the promoter regions of their target genes, where DBP, HIF, and TEF activate D-box-containing genes and E4BP4/NFIL3 represses them [<xref rid="B144-ijms-24-04223" ref-type="bibr">144</xref>]. Among these three circadian-clock-controlled <italic toggle="yes">cis</italic>-elements-mediated transcriptional feedback loops, the E/E&#x2019;-box-mediated loop plays the dominant role in the circadian clock [<xref rid="B145-ijms-24-04223" ref-type="bibr">145</xref>]. However, the E/E&#x2019;-box-mediated loop, combined with the RORE-mediated loop and the D-box-mediated loop, forms the necessary transcriptional repression and delays for oscillating approximately 24 h a day. In particular, E/E&#x2019;-box, D-box, and RORE act in the morning, evening, and night, respectively [<xref rid="B146-ijms-24-04223" ref-type="bibr">146</xref>,<xref rid="B147-ijms-24-04223" ref-type="bibr">147</xref>]. In addition, the mechanistic/mammalian target of the rapamycin (mTOR) pathway, implicated in numerous neurological disorders, has been shown to contribute to circadian regulation [<xref rid="B148-ijms-24-04223" ref-type="bibr">148</xref>,<xref rid="B149-ijms-24-04223" ref-type="bibr">149</xref>] by activating circadian clock genes through the phosphorylation of the translation factor S6K1 [<xref rid="B148-ijms-24-04223" ref-type="bibr">148</xref>,<xref rid="B150-ijms-24-04223" ref-type="bibr">150</xref>,<xref rid="B151-ijms-24-04223" ref-type="bibr">151</xref>]. Specifically, S6K1 phosphorylates GSK3&#x3B2;, which, in turn, phosphorylates CLOCK, BMAL1, and REV-ERB [<xref rid="B152-ijms-24-04223" ref-type="bibr">152</xref>].</p>
    </sec>
    <sec id="sec5-ijms-24-04223">
      <title>5. The Roles of Circadian Clock Genes in Epilepsies</title>
      <p>Two mechanisms have been proposed to account for the effects of the circadian clock on seizures [<xref rid="B4-ijms-24-04223" ref-type="bibr">4</xref>]: one is that canonical clock genes such as <italic toggle="yes">BMAL1</italic> and <italic toggle="yes">CLOCK</italic> contribute directly to epilepsies, and the other is that the circadian clock acts through certain signaling pathways to exert its effect on epilepsy. Loss of the circadian PAR bZip transcription factors DBP, HIF, and TEF resulted in lethal spontaneous epileptic seizures in mice [<xref rid="B144-ijms-24-04223" ref-type="bibr">144</xref>]. TEF was shown to regulate the expression of pyridoxal kinase involved in converting B6 vitamers into pyridoxal phosphate (PLP) [<xref rid="B144-ijms-24-04223" ref-type="bibr">144</xref>], and downregulation of PLP is associated with the susceptibility of seizures [<xref rid="B153-ijms-24-04223" ref-type="bibr">153</xref>]. The CLOCK protein was revealed to be significantly downregulated in the neurons of human focal epilepsy patients, and the seizure threshold was reduced in excitatory pyramidal neuron-specific <italic toggle="yes">Clock</italic><sup>&#x2212;/&#x2212;</sup> knockout mice. Similarly, downregulation of BMAL1 was found in hippocampal sclerosis (HS) patients with HS International League Against Epilepsy (ILAE) type I and III [<xref rid="B154-ijms-24-04223" ref-type="bibr">154</xref>], and the threshold of seizures was also reduced in <italic toggle="yes">Bmal1</italic><sup>&#x2212;/&#x2212;</sup> knockout mice [<xref rid="B140-ijms-24-04223" ref-type="bibr">140</xref>]. REV-ERB&#x3B1; was shown to be upregulated in the brain tissues of epileptic human patients and mice, while downregulation of <italic toggle="yes">Rev-erb&#x3B1;</italic> in mice reduced their seizure susceptibility, and REV-ERB&#x3B1; activated GABA transporters <italic toggle="yes">Slc6a1</italic> (<italic toggle="yes">Gat1</italic>) and <italic toggle="yes">Slc6a11</italic> (<italic toggle="yes">Gat3</italic>) through repressing <italic toggle="yes">E4bp4/Nfil3</italic> to downregulate GABA signaling [<xref rid="B155-ijms-24-04223" ref-type="bibr">155</xref>]. This study illuminates how circadian clock genes act through GABA signaling to exert their role in epilepsy. Together, these genetic studies have provided strong support for the functional links between the circadian clock and epilepsy.</p>
    </sec>
    <sec id="sec6-ijms-24-04223">
      <title>6. Mutual Effects between Epilepsy and Sleep</title>
      <p>Sleep and epilepsy are reciprocally affected. On the one hand, NREM sleep, especially NREM stage 1 (N1) and stage 2 (N2) sleep, facilitates epileptogenesis, while REM sleep inhibits it [<xref rid="B156-ijms-24-04223" ref-type="bibr">156</xref>]. Specifically, REM sleep has the most suppressive effect during the EEG desynchronization period [<xref rid="B157-ijms-24-04223" ref-type="bibr">157</xref>], whereas NREM sleep facilitates seizures due to the effect of the synchronous discharge of the thalamocortical network [<xref rid="B158-ijms-24-04223" ref-type="bibr">158</xref>,<xref rid="B159-ijms-24-04223" ref-type="bibr">159</xref>], as evidenced by the fact that 95% of seizures occur in NREM sleep [<xref rid="B160-ijms-24-04223" ref-type="bibr">160</xref>]. An interesting study demonstrated that a small lesion in focal cortical dysplasia (FCD) type II patients is highly associated with sleep-related epilepsy [<xref rid="B161-ijms-24-04223" ref-type="bibr">161</xref>]. Interictal epileptiform discharges (IEDs) have been used to evaluate seizure exploding [<xref rid="B162-ijms-24-04223" ref-type="bibr">162</xref>]. Melatonin, a sleep-promoting hormone, appears to contribute to the nocturnal predominance of IEDs during sleep [<xref rid="B163-ijms-24-04223" ref-type="bibr">163</xref>], and reduced melatonin levels with shifted phases were reported in epilepsy patients [<xref rid="B126-ijms-24-04223" ref-type="bibr">126</xref>,<xref rid="B164-ijms-24-04223" ref-type="bibr">164</xref>,<xref rid="B165-ijms-24-04223" ref-type="bibr">165</xref>]. In adult patients, frontal lobe epilepsy is the archetypal sleep-related epilepsy that tends to occur during sleep, whereas juvenile myoclonic epilepsy often occurs in the morning [<xref rid="B166-ijms-24-04223" ref-type="bibr">166</xref>]. Furthermore, sleep deprivation has been known to cause seizures in generalized epilepsies and juvenile myoclonic epilepsy [<xref rid="B167-ijms-24-04223" ref-type="bibr">167</xref>]. Obstructive sleep apnea (OSA) has been reported to display a high prevalence in epilepsy patients, especially in drug-resistant epilepsy [<xref rid="B168-ijms-24-04223" ref-type="bibr">168</xref>]. Conversely, increasing sleep duration by 1.6 h can reduce seizure risk by 27% in focal drug-resistant epilepsy [<xref rid="B169-ijms-24-04223" ref-type="bibr">169</xref>].</p>
      <p>On the other hand, epileptic activity has been shown to affect sleep continuity, which increases waking time after sleep onset, reduces REM sleep quality, and delays the first REM sleep episode in epilepsy patients [<xref rid="B169-ijms-24-04223" ref-type="bibr">169</xref>]. Epilepsy patients often suffer from severe sleep disturbances such as excessive daytime sleepiness, sleep fragmentation, and insomnia [<xref rid="B170-ijms-24-04223" ref-type="bibr">170</xref>]. Nocturnal seizures may lead to severe sleep fragmentation and even NREM parasomnia [<xref rid="B171-ijms-24-04223" ref-type="bibr">171</xref>], and diurnal seizures also result in the alteration of the sleep architecture [<xref rid="B172-ijms-24-04223" ref-type="bibr">172</xref>]. The epileptic activity also alters the sleep oscillations, likely through desynchronizing hippocampal IED and remote cortical spindles [<xref rid="B173-ijms-24-04223" ref-type="bibr">173</xref>]. The sleep architecture of JME patients is severely altered with prolonged REM onset latency and decreased REM percentage [<xref rid="B174-ijms-24-04223" ref-type="bibr">174</xref>]. Furthermore, most AEDs have been known to result in sleepiness, whereas some AEDs, such as levetiracetam and lamotrigine, have been shown to lead to severe insomnia [<xref rid="B175-ijms-24-04223" ref-type="bibr">175</xref>].</p>
      <p>Hence, sleep problems are prevalent among epilepsy patients, and reciprocal interactions between epilepsy and sleep should be underscored in epilepsy treatment. Various questionnaire-based instruments, such as the Pittsburgh Sleep Quality Index (PSQI) and the Sleep Condition Indicator, should be employed to evaluate the sleep status of patients, and possible comorbid sleep disorders also must be assessed. In particular, comorbid sleep disorders, once verified, should be treated separately. Generally, after epileptic patients are cured with drug treatment or surgeries, their sleep quality is expected to be improved with normal sleep patterns and melatonin levels [<xref rid="B166-ijms-24-04223" ref-type="bibr">166</xref>]. Good quality of sleep helps contain seizures.</p>
    </sec>
    <sec id="sec7-ijms-24-04223">
      <title>7. Animal Models for Epilepsies</title>
      <p>Animal models have played important roles in epileptic studies, especially in genetic and molecular mechanistic investigations [<xref rid="B176-ijms-24-04223" ref-type="bibr">176</xref>]. In addition to human and some monkey epileptic studies, rodents, primarily mice and rats, are often used, and zebrafish have been increasingly used in recent years (<xref rid="ijms-24-04223-f004" ref-type="fig">Figure 4</xref>). In the following, we focus on pharmacological and genetic models of mice and zebrafish for epilepsies, even though electrical or acoustic stimulation of the brain has been employed to induce rodent models of seizures/epilepsies [<xref rid="B177-ijms-24-04223" ref-type="bibr">177</xref>], which are not reviewed here.</p>
      <sec id="sec7dot1-ijms-24-04223">
        <title>7.1. Pharmacological Models</title>
        <p>Several drugs have been widely used to evoke seizures in rodents and zebrafish (<xref rid="ijms-24-04223-t003" ref-type="table">Table 3</xref>). Pentylenetetrazole (PTZ) as a GABAA receptor antagonist is the early convulsant drug [<xref rid="B178-ijms-24-04223" ref-type="bibr">178</xref>], while (D, L)-allylglycine (AG) reduces the level of GABA biosynthesis key enzyme glutamic acid decarboxylase (GAD), leading to the depletion of GABA and the accumulation of glutamate [<xref rid="B179-ijms-24-04223" ref-type="bibr">179</xref>]. In mice, a 300 mg/kg dose of AG is sufficient to induce 100% recurrent clonic seizures, similar to 20 mM PTZ-induced seizures. Picrotoxin, a chloride-channel blocker, can result in seizures in zebrafish with a 300 &#x3BC;M dose [<xref rid="B180-ijms-24-04223" ref-type="bibr">180</xref>] and in mice with a 12 mg/kg dose [<xref rid="B181-ijms-24-04223" ref-type="bibr">181</xref>]. Seizures evoked by picrotoxin can be suppressed by methanolic extracts of <italic toggle="yes">Hyoscyamus niger</italic> L. in mice [<xref rid="B181-ijms-24-04223" ref-type="bibr">181</xref>]. Kainic acid (KA) causes excitotoxicity as an agonist of glutamatergic receptors and induces dosage-dependent clonus-like convulsions in zebrafish with an intraperitoneal injection at 1&#x2013;8 mg/kg [<xref rid="B182-ijms-24-04223" ref-type="bibr">182</xref>] and seizures in rats with an intracerebral injection of 0.4&#x2013;2 ug [<xref rid="B183-ijms-24-04223" ref-type="bibr">183</xref>]. Pilocarpine as a cholinergic agonist has been used to induce temporal lobe epilepsy in mice [<xref rid="B184-ijms-24-04223" ref-type="bibr">184</xref>] but is rarely used in zebrafish [<xref rid="B185-ijms-24-04223" ref-type="bibr">185</xref>]. Ginkgotoxin, purified from <italic toggle="yes">Ginkgo biloba</italic>, is hypothesized to inhibit GABA synthesis and can induce seizure-like behavior in zebrafish larvae [<xref rid="B186-ijms-24-04223" ref-type="bibr">186</xref>,<xref rid="B187-ijms-24-04223" ref-type="bibr">187</xref>]. In addition, tetanus toxin (TT) induces severe neurological disease manifested by generalized muscular convulsion in rats [<xref rid="B188-ijms-24-04223" ref-type="bibr">188</xref>]. Adult rats displayed seizures 1&#x2013;2 days after ablating interneurons by TT injection into the Cornu Ammonis 3 (CA3) hippocampal region [<xref rid="B189-ijms-24-04223" ref-type="bibr">189</xref>]. Finally, caffeine and strychnine also induce seizures in rodents. An overdose of caffeine (400 mg/kg) as a nonselective antagonist of adenosine receptors induces epilepsy by reducing the threshold of convulsive seizures [<xref rid="B190-ijms-24-04223" ref-type="bibr">190</xref>], and a low dose of strychnine as an antagonist of cholinergic and glycinergic receptors also induces epilepsy in mice [<xref rid="B191-ijms-24-04223" ref-type="bibr">191</xref>]. These drugs are commonly used to establish pharmacological epilepsy models in rodents and zebrafish.</p>
      </sec>
      <sec id="sec7dot2-ijms-24-04223">
        <title>7.2. Genetic Models</title>
        <p>Next-generation sequencing technology has helped uncover many new epilepsy genes [<xref rid="B242-ijms-24-04223" ref-type="bibr">242</xref>]. Elucidation of these epilepsy genes is of great importance for the diagnosis and treatment of epilepsy. Well-established animal models for these epilepsy genes provide an efficient way to understand human pathology. Genetic models have been generated with sophisticated genetic manipulations (<xref rid="ijms-24-04223-t003" ref-type="table">Table 3</xref>). Remarkably, a mutation in <italic toggle="yes">SCN1A</italic>, voltage-gated sodium channel alpha subunit 1 (VGSC), causes over 80% of Dravet syndrome cases [<xref rid="B40-ijms-24-04223" ref-type="bibr">40</xref>,<xref rid="B243-ijms-24-04223" ref-type="bibr">243</xref>]. Several knockout rodent models have been generated for Dravet syndrome [<xref rid="B244-ijms-24-04223" ref-type="bibr">244</xref>,<xref rid="B245-ijms-24-04223" ref-type="bibr">245</xref>], whereas zebrafish homozygous <italic toggle="yes">scn1lab</italic><sup>&#x2212;/&#x2212;</sup> mutants have also been used as an epilepsy model [<xref rid="B246-ijms-24-04223" ref-type="bibr">246</xref>]. Except for &#x3B1; subunit, &#x3B2; subunit (<italic toggle="yes">Scn1b</italic>), type 2 (<italic toggle="yes">Scn2a</italic>), and type 8 (<italic toggle="yes">Scn8a</italic>) have also been used as genetic models for epilepsy in mice. <italic toggle="yes">Scn2a</italic> transgenic mice display spontaneous seizures [<xref rid="B247-ijms-24-04223" ref-type="bibr">247</xref>]. In addition to epilepsy, <italic toggle="yes">Scn2a</italic> has also been implicated in other neurological disorders, including schizophrenia and autism spectrum disorder [<xref rid="B202-ijms-24-04223" ref-type="bibr">202</xref>]. Intriguingly, one <italic toggle="yes">Scn8a</italic> mutation leading to hypoexcitation of cortical circuits results in convulsive seizure resistance, whereas the other <italic toggle="yes">Scn8a</italic> mutation leading to hyperexcitation of thalamocortical circuits causes nonconvulsive absence epilepsy [<xref rid="B248-ijms-24-04223" ref-type="bibr">248</xref>]. The members of the KCNQ family, especially <italic toggle="yes">KCNQ2</italic> and <italic toggle="yes">KCNQ3</italic>, encode voltage-gated potassium channels (VGKC), which are associated with epilepsy, such as benign familial neonatal seizures (BFNS) [<xref rid="B249-ijms-24-04223" ref-type="bibr">249</xref>]. In zebrafish, <italic toggle="yes">kcnq2</italic>, <italic toggle="yes">kcnq3</italic>, and <italic toggle="yes">kcnq5</italic> are expressed in early development, and inhibitors of K<sub>v</sub>7 channels evoke convulsive behaviors in larvae from 3 dpf (days postfertilization) to 7 dpf [<xref rid="B236-ijms-24-04223" ref-type="bibr">236</xref>]. Homozygous <italic toggle="yes">Kcnq2</italic><sup>&#x2212;/&#x2212;</sup> and <italic toggle="yes">Kcnq3</italic><sup>&#x2212;/&#x2212;</sup> mice also exhibit severe spontaneous generalized seizures concurrent with a disturbed M-current [<xref rid="B205-ijms-24-04223" ref-type="bibr">205</xref>]. Moreover, <italic toggle="yes">Kcnj10</italic> (potassium inwardly rectifying channel subfamily J10), expressed in glial cells, is an important causative gene for EAST (epilepsy, ataxia, sensorineural deafness, tubulopathy) syndrome [<xref rid="B250-ijms-24-04223" ref-type="bibr">250</xref>]. In human patients, <italic toggle="yes">KCNJ10</italic> missense or nonsense mutations lead to electrolyte imbalance, seizures, and deafness [<xref rid="B251-ijms-24-04223" ref-type="bibr">251</xref>], which are recapitulated in <italic toggle="yes">Kcnj10</italic><sup>&#x2212;/&#x2212;</sup> knockout mice [<xref rid="B194-ijms-24-04223" ref-type="bibr">194</xref>]. In zebrafish, knocking down orthologs <italic toggle="yes">kcnj10a</italic> and <italic toggle="yes">kcnj10b</italic> leads to locomotor defects [<xref rid="B235-ijms-24-04223" ref-type="bibr">235</xref>]. Furthermore, models for GABA-receptor-related genes also have been generated [<xref rid="B252-ijms-24-04223" ref-type="bibr">252</xref>]. <italic toggle="yes">Gabra1</italic><sup>&#x2212;/&#x2212;</sup> knockout mice exhibit brain dysfunction, such as anxiety and seizures, and <italic toggle="yes">gabra1</italic><sup>&#x2212;/&#x2212;</sup> zebrafish show generalized seizures in the larval stages [<xref rid="B233-ijms-24-04223" ref-type="bibr">233</xref>]. Zebrafish mutants for <italic toggle="yes">gabrg2</italic> [<xref rid="B212-ijms-24-04223" ref-type="bibr">212</xref>,<xref rid="B234-ijms-24-04223" ref-type="bibr">234</xref>] and <italic toggle="yes">gabrb3</italic> [<xref rid="B239-ijms-24-04223" ref-type="bibr">239</xref>] have been established for epilepsy research. Other genetic models have been established with gene-editing tools such as CRISPR-Cas9 for numerous zebrafish epilepsy genes, including <italic toggle="yes">arxa, eef1a2, pnpo,</italic> and <italic toggle="yes">strada</italic>, some of which have been used for drug screens [<xref rid="B228-ijms-24-04223" ref-type="bibr">228</xref>,<xref rid="B233-ijms-24-04223" ref-type="bibr">233</xref>,<xref rid="B234-ijms-24-04223" ref-type="bibr">234</xref>,<xref rid="B239-ijms-24-04223" ref-type="bibr">239</xref>] (<xref rid="ijms-24-04223-t003" ref-type="table">Table 3</xref>).</p>
      </sec>
      <sec id="sec7dot3-ijms-24-04223">
        <title>7.3. Circadian Rhythms of Epileptic Animal Models</title>
        <p>These drug-induced and genetic epilepsy models are invaluable for unraveling the specific mechanisms underlying not only epileptic pathogenesis but also how the circadian clock contributes to epilepsy. Pilocarpine-induced temporal lobe epilepsy mice [<xref rid="B184-ijms-24-04223" ref-type="bibr">184</xref>] and electrically induced post-limbic status (PLS) rats [<xref rid="B127-ijms-24-04223" ref-type="bibr">127</xref>] were shown to display robust rhythmicity of seizures. Interestingly, transcriptome analysis of the ventral hypothalamus of pilocarpine-induced temporal lobe epilepsy mice revealed altered rhythmicity of the genes involved in oxidative phosphorylation and aerobic glycolysis [<xref rid="B184-ijms-24-04223" ref-type="bibr">184</xref>], providing novel insights into circadian involvement in epilepsy pathogenesis. Long-term intracranial EEG monitoring with implantable devices (NeuroVista Seizure Advisory System and Summit RC + S) revealed that one human patient and seven epileptic dogs displayed robust rhythmicity of interictal epileptiform spikes (IES), and, intriguingly, thalamic deep brain stimulations (DBS) could alter IES rhythmicity in the human patient and epileptic dogs [<xref rid="B253-ijms-24-04223" ref-type="bibr">253</xref>], indicating that the thalamocortical system is involved in regulating the circadian rhythm of epilepsy. Intriguingly, a comparison of the rhythms of chronic TLE rats evoked by chemical drugs or electrical stimuli showed that approximately 78% (7 out of 9) of these epilepsies peak in the light period when these animals sleep [<xref rid="B254-ijms-24-04223" ref-type="bibr">254</xref>], whereas most human TLE patients peak in the afternoon, i.e., the light and wakefulness period, indicating that the robust and endogenous circadian rhythm of TLE is independent of the diurnality and nocturnality of animals. Monitoring electrical-stimulation-induced epileptic rats with hippocampal electrodes found that seizures peak at 14:05 under constant dark (DD) conditions but around 14:59 under 12&#x2013;12 h light/dark (LD) conditions [<xref rid="B255-ijms-24-04223" ref-type="bibr">255</xref>], indicating that the circadian clock likely contributes to seizures. Epileptic seizures as abnormal stimuli were shown to induce phase shifts of core body temperature (CBT) rhythms [<xref rid="B256-ijms-24-04223" ref-type="bibr">256</xref>]. Furthermore, a comparison of the latency of evoked potentials of the dentate gyrus (DG) of electrically induced epileptic rats found that the latency was significantly reduced in the high-seizure phase (14:00 to 22:00) but not in the low-seizure phase (22:00 to 14:00) [<xref rid="B257-ijms-24-04223" ref-type="bibr">257</xref>], indicating that limbic seizures are likely regulated by circadian excitation and inhibition of the DG in chronic epilepsy. These lines of investigation are much needed for a chronomodulated strategy-based epilepsy chronotherapy.</p>
      </sec>
      <sec id="sec7dot4-ijms-24-04223">
        <title>7.4. Advantages and Challenges of Epileptic Animal Models</title>
        <p>Mice have played an important role in studies on the mechanisms of epilepsy because their anatomical structures and gene expression patterns are highly similar to those of humans [<xref rid="B258-ijms-24-04223" ref-type="bibr">258</xref>,<xref rid="B259-ijms-24-04223" ref-type="bibr">259</xref>]. In particular, the development of long-term EEG recordings allows for monitoring of seizures that are usually difficult to measure, including certain age-related spontaneous seizures, infrequent seizures, and nonconvulsive electrographic seizures [<xref rid="B177-ijms-24-04223" ref-type="bibr">177</xref>].</p>
        <p>However, several limitations of mouse epilepsy models are difficult to circumvent; for instance, some seizure models fail to recapitulate relevant human behaviors [<xref rid="B260-ijms-24-04223" ref-type="bibr">260</xref>], and other genetic models result in fatal seizures [<xref rid="B261-ijms-24-04223" ref-type="bibr">261</xref>,<xref rid="B262-ijms-24-04223" ref-type="bibr">262</xref>]. Mice EEG recordings make long-term seizure monitoring possible, but the procedure also damages the brain due to the insertion of electrodes, and animals are socially isolated during seizure monitoring. Despite these challenges, mice still stand as excellent models for studying epilepsy.</p>
        <p>The zebrafish has figured prominently as a model for epileptic studies in recent years, largely due to its large clutch size, transparent embryos, sophisticated genetic manipulation, and utility for high-throughput drug screens [<xref rid="B263-ijms-24-04223" ref-type="bibr">263</xref>]. In 2005, Baraban et al. reported the PTZ-induced zebrafish epilepsy model and clearly showed clonus-like convulsion of larval zebrafish as a new powerful system for epileptic studies [<xref rid="B228-ijms-24-04223" ref-type="bibr">228</xref>].</p>
        <p>As discussed above, several pharmacological and genetic manipulations have successfully been employed to elicit robust seizure-like behavioral and neurophysiological phenotypes in both larval and adult zebrafish. High-throughput drug screens have been developed using zebrafish larvae [<xref rid="B264-ijms-24-04223" ref-type="bibr">264</xref>], and a unique scoring system has been established to measure the seizures of adult zebrafish [<xref rid="B265-ijms-24-04223" ref-type="bibr">265</xref>]. Light-sheet microscopy and in vivo calcium imaging with genetically encoded indicators allow for directly visualizing almost whole-brain neuronal activities and network connections during epilepsy [<xref rid="B266-ijms-24-04223" ref-type="bibr">266</xref>], and pERK (phosphorylated extracellular signal-regulated kinase) [<xref rid="B267-ijms-24-04223" ref-type="bibr">267</xref>,<xref rid="B268-ijms-24-04223" ref-type="bibr">268</xref>] combined with the Map-Map method as effective biomarkers have been used to characterize neuronal circuits involved in zebrafish epilepsy models. However, the relatively primitive zebrafish behaviors have compromised their predictive power [<xref rid="B269-ijms-24-04223" ref-type="bibr">269</xref>]. Zebrafish larvae are thought to be effective only for modeling early-onset epilepsy because of their simple movement and underdeveloped neural system [<xref rid="B270-ijms-24-04223" ref-type="bibr">270</xref>], and the small size of zebrafish makes it challenging to use them to perform specific epilepsy interventions such as deep brain stimulation [<xref rid="B271-ijms-24-04223" ref-type="bibr">271</xref>]. Nevertheless, as an effective and complementary model, zebrafish epilepsy studies have advanced rapidly [<xref rid="B272-ijms-24-04223" ref-type="bibr">272</xref>].</p>
      </sec>
    </sec>
    <sec id="sec8-ijms-24-04223">
      <title>8. A Chronomodulated Strategy for Epilepsy Therapy</title>
      <sec id="sec8dot1-ijms-24-04223">
        <title>8.1. Circadian Mechanisms Underlying Epileptogenesis</title>
        <p>Although our understanding of the mechanisms underlying epilepsy remains limited, mounting evidence indicates circadian involvement in epilepsy pathogenesis, as numerous types of human epilepsies display robust daily rhythmicity [<xref rid="B111-ijms-24-04223" ref-type="bibr">111</xref>]. Future efforts will aim to identify circadian biomarkers by elucidating molecular genetic mechanisms underlying how the circadian clock regulates the robust rhythmicity of these epilepsies. In doing so, the circadian clock system and possible circadian-clock-regulated epilepsy processes such as the hypothalamus&#x2013;pituitary&#x2013;adrenal (HPA) axis and the hypothalamus&#x2013;pituitary&#x2013;gonadal (HPG) axis should be investigated. The circadian clock regulates the HPA axis [<xref rid="B273-ijms-24-04223" ref-type="bibr">273</xref>,<xref rid="B274-ijms-24-04223" ref-type="bibr">274</xref>] and the HPG axis [<xref rid="B275-ijms-24-04223" ref-type="bibr">275</xref>,<xref rid="B276-ijms-24-04223" ref-type="bibr">276</xref>], which are known to contribute to epilepsy pathogenesis [<xref rid="B277-ijms-24-04223" ref-type="bibr">277</xref>,<xref rid="B278-ijms-24-04223" ref-type="bibr">278</xref>,<xref rid="B279-ijms-24-04223" ref-type="bibr">279</xref>]. In some epilepsies, it would be worthwhile to investigate how the circadian clock acts through the HPA axis or the HPG axis to regulate epilepsy pathogenesis. Furthermore, it would be intriguing to determine whether the core circadian clock genes and circadian-clock-controlled epilepsy genes harbor mutations or whether the normal rhythmic expression patterns of these circadian clock genes and circadian-clock-controlled epilepsy genes are altered in individual patients. This line of investigation should provide insights into the circadian regulation of the dynamics of the pathogenesis of a particular epilepsy, which should provide cues for the time-of-day delivery of AEDs (<xref rid="ijms-24-04223-f005" ref-type="fig">Figure 5</xref>). It is important to investigate the mechanisms underlying why epilepsy displays robust rhythmicity. We have reanalyzed the circadian rhythms of epilepsy-related genes in TLE mice [<xref rid="B184-ijms-24-04223" ref-type="bibr">184</xref>] and observed that the circadian rhythmicity of approximately 50 epileptic driver genes is altered in TLE mice, with some losing their rhythmicity, some gaining rhythmicity, and some maintaining rhythmicity [<xref rid="B280-ijms-24-04223" ref-type="bibr">280</xref>]. For instance, <italic toggle="yes">APEH</italic> (acylaminoacyl-peptide hydrolase) was shown to be associated with valproic acid metabolism in Chinese epileptic patients [<xref rid="B281-ijms-24-04223" ref-type="bibr">281</xref>], and its expression amplitude increased with the lengthened period in TLE mice. The specific alteration of the rhythmicity of circadian clock genes and epilepsy genes in epilepsy patients and animal models must be emphasized when developing a chronomodulated chronotherapy.</p>
      </sec>
      <sec id="sec8dot2-ijms-24-04223">
        <title>8.2. Pharmacokinetic and Pharmacodynamic Studies of AEDs</title>
        <p>The circadian clock has been known to contribute to pharmacokinetics and pharmacodynamics [<xref rid="B282-ijms-24-04223" ref-type="bibr">282</xref>]. Chronopharmacokinetics investigates how the circadian clock regulates drug absorption, distribution, metabolism, and excretion (ADME), each of which plays a critical role in regulating drug levels in the body [<xref rid="B283-ijms-24-04223" ref-type="bibr">283</xref>,<xref rid="B284-ijms-24-04223" ref-type="bibr">284</xref>]. In particular, peripheral molecular clocks in several vital organs, such as the intestine, liver, and drug target tissues, play a direct role in regulating blood drug levels. The absorption of oral drugs depends on the intestinal tract&#x2019;s physiological parameters [<xref rid="B285-ijms-24-04223" ref-type="bibr">285</xref>]. Considerable evidence has shown the importance of circadian clocks in intestinal physiology [<xref rid="B286-ijms-24-04223" ref-type="bibr">286</xref>]. Recently, a study reported intestinal dysbiosis associated with a particular form of epilepsy and short-bowel syndrome in an epilepsy patient who was successfully treated with valproic acid (VPA) and levetiracetam (LEV) [<xref rid="B287-ijms-24-04223" ref-type="bibr">287</xref>]. Further, intractable epilepsy in children is comorbid with intestinal bacterial dysbiosis [<xref rid="B288-ijms-24-04223" ref-type="bibr">288</xref>]. In addition to the lipophilicity of drugs, the distribution of drugs is also determined by plasma protein characteristics and the transport capabilities of membrane channels [<xref rid="B282-ijms-24-04223" ref-type="bibr">282</xref>]. Daily variations of the free fraction of valproic acid (VPA) are affected by the collective actions of albumin concentration, free fatty acid (FFA) levels, and valproate concentration [<xref rid="B289-ijms-24-04223" ref-type="bibr">289</xref>], and both free and total plasma levels of carbamazepine (CBZ) exhibit diurnal fluctuations, which should be monitored to help adjust the dosing schedule to minimize its intermittent adverse effects [<xref rid="B290-ijms-24-04223" ref-type="bibr">290</xref>]. Numerous transporters regulated by the circadian clock are critical for drug distribution [<xref rid="B291-ijms-24-04223" ref-type="bibr">291</xref>,<xref rid="B292-ijms-24-04223" ref-type="bibr">292</xref>]. Metabolism and excretion are affected by liver and kidney functions, respectively. Drug efficacy duration depends on the metabolizing speed regulated by the liver clock [<xref rid="B293-ijms-24-04223" ref-type="bibr">293</xref>]. Both aerobic glycolysis and oxidative phosphorylation are altered in TLE mice [<xref rid="B184-ijms-24-04223" ref-type="bibr">184</xref>], indicating that AED metabolism is also altered in epilepsy. Finally, the circadian clock also regulates the expression of renal epithelial sodium transporters, directly affecting drug excretion in mice [<xref rid="B294-ijms-24-04223" ref-type="bibr">294</xref>,<xref rid="B295-ijms-24-04223" ref-type="bibr">295</xref>].</p>
        <p>Furthermore, chronopharmacodynamics focuses on how the circadian clock regulates the factors that affect drug efficacy [<xref rid="B282-ijms-24-04223" ref-type="bibr">282</xref>]. The circadian clock acts through the genes encoding drug targets, transporters, and enzymes, as well as those involved in intracellular signaling pathways, to exert effects on drug efficacy [<xref rid="B296-ijms-24-04223" ref-type="bibr">296</xref>]. Together, chronopharmacokinetic and chronopharmacodynamic studies of an AED should help develop a chronomodulated schedule for time-of-day-specific drug delivery to maximize its efficacy and minimize its toxicities/side effects (<xref rid="ijms-24-04223-f005" ref-type="fig">Figure 5</xref>).</p>
      </sec>
      <sec id="sec8dot3-ijms-24-04223">
        <title>8.3. Epileptic Chronotherapy</title>
        <p>In a study with a small cohort of 17 children with nocturnal or early-morning seizures, instead of conventional administration of equal doses of AEDs in the morning and evening each day, two times the morning AED dose was delivered in the evening with the equivalent total dosage. After the 5-month differential dosing treatment, 64.7% (11/17) of patients became seizure-free, and 88.2% (15/17) experienced a &#x2265;50% reduction in seizures [<xref rid="B24-ijms-24-04223" ref-type="bibr">24</xref>]. AED therapy with CBZ treatment was shown to significantly reduce urinary melatonin metabolite levels of epileptic patients during 06:00&#x2013;14:00 and 22:00&#x2013;06:00 [<xref rid="B126-ijms-24-04223" ref-type="bibr">126</xref>]. Further, a 5&#x2013;10 mg evening melatonin delivery can effectively reduce the frequency of epileptic attacks [<xref rid="B297-ijms-24-04223" ref-type="bibr">297</xref>]. These studies have demonstrated clear efficacies of time-of-day-specific dosing of AEDs [<xref rid="B284-ijms-24-04223" ref-type="bibr">284</xref>,<xref rid="B298-ijms-24-04223" ref-type="bibr">298</xref>]. Indeed, the robust rhythmicity of epilepsy/seizures allows for timing the dosing of higher levels of AEDs to be around the time when seizures peak to control seizures effectively. Chronomodulation-based chronotherapy aims at enhancing efficacy and reducing side effects through the proper timing and dosing of AEDs [<xref rid="B298-ijms-24-04223" ref-type="bibr">298</xref>,<xref rid="B299-ijms-24-04223" ref-type="bibr">299</xref>,<xref rid="B300-ijms-24-04223" ref-type="bibr">300</xref>,<xref rid="B301-ijms-24-04223" ref-type="bibr">301</xref>] (<xref rid="ijms-24-04223-f005" ref-type="fig">Figure 5</xref>). In addition, as numerous factors are involved, mathematical/computational modeling is also needed to help develop an optimal chronotherapy plan for a specific epilepsy (<xref rid="ijms-24-04223-f005" ref-type="fig">Figure 5</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="sec9-ijms-24-04223">
      <title>9. Discussion</title>
      <p>We interrogated 2 major disease gene databases, PHGKB and OMIM, as well as relevant published studies, compiled 661 epilepsy-related genes (<xref rid="app1-ijms-24-04223" ref-type="app">Supplementary Table S1</xref>), and classified 192 as epilepsy causative/driver genes (<xref rid="ijms-24-04223-t001" ref-type="table">Table 1</xref>). These epilepsy driver genes included those involved in GABAergic, cholinergic, glutamatergic, and dopaminergic synapses; mTOR signaling, MAPK signaling, and numerous metabolic pathways; and lysosomes, as well as those encoding various ligand-gated and voltage-gated ion channels and transcription factors (<xref rid="ijms-24-04223-f001" ref-type="fig">Figure 1</xref>B, <xref rid="ijms-24-04223-t001" ref-type="table">Table 1</xref>), indicating the complex, polygenic, and heterogeneous nature of epilepsy. A great majority of these 192 driver genes were identified with the ever-increasing power of DNA/RNA sequencing technologies [<xref rid="B45-ijms-24-04223" ref-type="bibr">45</xref>] but have yet to be investigated in animal models. A future endeavor will be to generate mouse and/or zebrafish models for these epilepsy driver genes, particularly employing CRISPR-Cas9-mediated base-editing tools to generate mutated animals that precisely model relevant human variants [<xref rid="B302-ijms-24-04223" ref-type="bibr">302</xref>]. The animal models of these epilepsy driver genes will help elucidate their roles in epileptic pathogenesis and provide novel targets for AED development. In the latter case, zebrafish models should be employed to conduct large-scale high-throughput epileptic drug screens [<xref rid="B269-ijms-24-04223" ref-type="bibr">269</xref>]. In addition, whether the remaining 469 passenger and undetermined genes contribute to epilepsy also needs to be genetically ascertained using animal models in the future. However, even though OMIM and PHGKB are widely accepted disease databases, we may have missed some epileptic genes that were not yet collected in the two disease databases. This list of 661 epilepsy-related genes will need to be revised and updated because some passenger or undetermined genes may have new experimental verification. The subjective classification may result in an inaccurate grouping. In addition, limited references likely result in data omission for the pharmacological and genetic animal models. Nevertheless, we have made efforts to avoid these situations.</p>
      <p>Many types of human epilepsies display robust rhythmicity (<xref rid="ijms-24-04223-t002" ref-type="table">Table 2</xref>) [<xref rid="B20-ijms-24-04223" ref-type="bibr">20</xref>], which is also observed in some epileptic animal models [<xref rid="B127-ijms-24-04223" ref-type="bibr">127</xref>,<xref rid="B184-ijms-24-04223" ref-type="bibr">184</xref>,<xref rid="B253-ijms-24-04223" ref-type="bibr">253</xref>]. Epileptic rhythmicity supports the notion of circadian involvement in epileptogenesis and provides a unique opportunity for developing a chronomodulated strategy-based epileptic chronotherapy. We postulate three lines of experiments for developing epileptic chronotherapy (<xref rid="ijms-24-04223-f004" ref-type="fig">Figure 4</xref>). First, to investigate circadian mechanisms underlying time-of-day-specific dynamics of rhythmic epilepsies, particularly to determine how the peak occurrences of epilepsies are regulated by the circadian clock genes and/or by the circadian-clock-controlled epileptic genes. The findings of this line of experiments are useful for developing new AEDs per se and for helping to determine time-of-day-specific timing for dosing AEDs. Second, to investigate the chronopharmacokinetics of specific AEDs, i.e., to determine how the circadian clock regulates the ADME of the AEDs. Third, to investigate the chronopharmacodynamics of specific AEDs, i.e., to determine how the circadian clock regulates the factors affecting the efficacy and toxicity of the AEDs. The findings from chronopharmacokinetic and chronopharmacodynamic studies, combined with the circadian investigation of rhythmic epilepsies, should help select time-of-day-specific timing for the AED delivery to maximize its efficacy but minimize its toxicity [<xref rid="B298-ijms-24-04223" ref-type="bibr">298</xref>,<xref rid="B299-ijms-24-04223" ref-type="bibr">299</xref>,<xref rid="B300-ijms-24-04223" ref-type="bibr">300</xref>,<xref rid="B301-ijms-24-04223" ref-type="bibr">301</xref>] (<xref rid="ijms-24-04223-f005" ref-type="fig">Figure 5</xref>).</p>
      <p>The sleep&#x2013;wake cycle is the most overt circadian rhythm [<xref rid="B303-ijms-24-04223" ref-type="bibr">303</xref>] and also affects epilepsy [<xref rid="B304-ijms-24-04223" ref-type="bibr">304</xref>]. The sleep status of epileptic patients cannot be ignored. Sleep disorders are commonly comorbid with epilepsy and should be separately diagnosed and treated, if verified, as a part of the epilepsy treatment. Sleep problems can wreak havoc on epilepsy treatment, but ensuring that patients have good-quality sleep helps contain epilepsy.</p>
      <p>Even though sophisticated medical management with numerous AEDs has been well carried out in clinics, more than 30% of epilepsy patients cannot be cured. Unfortunately, they must live with unpredictable seizures, pains, and fears [<xref rid="B305-ijms-24-04223" ref-type="bibr">305</xref>]. With approximately 1% of the population worldwide suffering from epilepsies [<xref rid="B1-ijms-24-04223" ref-type="bibr">1</xref>], the enormous number of drug-resistant epilepsy (DRE) patients makes it necessary and urgent to develop effective therapeutics. Targeting the circadian clock and circadian-clock-regulated epileptic processes will shed light on novel aspects of epilepsy pathogenesis, provide novel targets for AED development, and promise to develop effective chronomodulated strategy-based chronotherapy for the large proportion of rhythmic epilepsy patients.</p>
    </sec>
    <sec sec-type="methods" id="sec10-ijms-24-04223">
      <title>10. Methods</title>
      <p>Epilepsy-related genes in PHGKB [<xref rid="B306-ijms-24-04223" ref-type="bibr">306</xref>] and OMIM were searched for with the keyword &#x201C;epilepsy and genes&#x201D; and with the keyword &#x201C;epilepsy&#x201D; in 2022, respectively. In addition to the papers listed on PHGKB and OMIM, relevant papers in PubMed of NCBI were also searched for with the keyword &#x201C;epilepsy and gene name.&#x201D; If one gene had fewer than three references, all were included. Only the latest articles were included for those genes with more than three references. A total of 543 articles were cited. Those genes without a reference are still shown in <xref rid="app1-ijms-24-04223" ref-type="app">Supplementary Table S1</xref>, marked with an asterisk. Two authors selected papers independently, and only English papers were selected. According to the conclusions of these relevant articles, epilepsy-related genes were classified into driver genes, passenger genes, or undetermined genes, respectively. Because this is a narrative review, no sensitivity analysis was performed. The KEGG enrichment analysis was conducted with the KOBAS database (<uri xlink:href="http://kobas.cbi.pku.edu.cn/kobas3/">http://kobas.cbi.pku.edu.cn/kobas3/</uri>, accessed on 8 August 2022) [<xref rid="B307-ijms-24-04223" ref-type="bibr">307</xref>], and a Q-value less than 0.05 was selected; the top 20 ranked KEGG pathways of the 192 driver genes are shown in <xref rid="app1-ijms-24-04223" ref-type="app">Supplementary Table S3</xref>. GO enrichment analysis was performed with ClueGO in Cytoscape, and those with a kappa score higher than 0.4 were selected.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>We wish to thank the members of the Han Wang laboratory and Manxiu Ma for their helpful discussions on the early versions of the manuscript.</p>
    </ack>
    <fn-group>
      <fn>
        <p><bold>Disclaimer/Publisher&#x2019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p>
      </fn>
    </fn-group>
    <app-group>
      <app id="app1-ijms-24-04223">
        <title>Supplementary Materials</title>
        <p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/ijms24044223/s1">https://www.mdpi.com/article/10.3390/ijms24044223/s1</uri>.</p>
        <supplementary-material id="ijms-24-04223-s001" position="float" content-type="local-data">
          <media xlink:href="ijms-24-04223-s001.zip">
            <caption>
              <p>Click here for additional data file.</p>
            </caption>
          </media>
        </supplementary-material>
      </app>
    </app-group>
    <notes>
      <title>Author Contributions</title>
      <p>H.W. and S.S.: the conceptualization and design of this study. S.S.: the investigation and methodology of this study. H.W. and S.S.: the formal analysis. H.W.: the funding acquisition and project administration of this study. S.S.: writing&#x2014;original draft. H.W. and S.S.: writing&#x2014;reviewing and editing the manuscript. All authors have read and agreed to the published version of the manuscript.</p>
    </notes>
    <notes>
      <title>Institutional Review Board Statement</title>
      <p>Not applicable.</p>
    </notes>
    <notes notes-type="COI-statement">
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-ijms-24-04223">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Leonardi</surname><given-names>M.</given-names></name>
<name><surname>Ustun</surname><given-names>T.B.</given-names></name>
</person-group>
          <article-title>The global burden of epilepsy</article-title>
          <source>Epilepsia</source>
          <year>2002</year>
          <volume>43</volume>
          <fpage>21</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1528-1157.43.s.6.11.x</pub-id>
          <pub-id pub-id-type="pmid">12190974</pub-id>
        </element-citation>
      </ref>
      <ref id="B2-ijms-24-04223">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Kwan</surname><given-names>P.</given-names></name>
<name><surname>Brodie</surname><given-names>M.J.</given-names></name>
</person-group>
          <article-title>Effectiveness of First Antiepileptic Drug</article-title>
          <source>Epilepsia</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>1255</fpage>
          <lpage>1260</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1528-1157.2001.04501.x</pub-id>
          <pub-id pub-id-type="pmid">11737159</pub-id>
        </element-citation>
      </ref>
      <ref id="B3-ijms-24-04223">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Schmidt</surname><given-names>D.</given-names></name>
<name><surname>L&#xF6;scher</surname><given-names>W.</given-names></name>
</person-group>
          <article-title>Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical Mechanisms</article-title>
          <source>Epilepsia</source>
          <year>2005</year>
          <volume>46</volume>
          <fpage>858</fpage>
          <lpage>877</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2005.54904.x</pub-id>
          <pub-id pub-id-type="pmid">15946327</pub-id>
        </element-citation>
      </ref>
      <ref id="B4-ijms-24-04223">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Semah</surname><given-names>F.</given-names></name>
<name><surname>Picot</surname><given-names>M.C.</given-names></name>
<name><surname>Adam</surname><given-names>C.</given-names></name>
<name><surname>Broglin</surname><given-names>D.</given-names></name>
<name><surname>Arzimanoglou</surname><given-names>A.</given-names></name>
<name><surname>Bazin</surname><given-names>B.</given-names></name>
<name><surname>Cavalcanti</surname><given-names>D.</given-names></name>
<name><surname>Baulac</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Is the underlying cause of epilepsy a major prognostic factor for recurrence?</article-title>
          <source>Neurology</source>
          <year>1998</year>
          <volume>51</volume>
          <fpage>1256</fpage>
          <lpage>1262</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.51.5.1256</pub-id>
          <pub-id pub-id-type="pmid">9818842</pub-id>
        </element-citation>
      </ref>
      <ref id="B5-ijms-24-04223">
        <label>5.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Vogel</surname><given-names>F.</given-names></name>
</person-group>
          <source>Moderne Probleme der Humangenetik</source>
          <publisher-name>Springer</publisher-name>
          <publisher-loc>Berlin/Heidelberg, Germany</publisher-loc>
          <year>1959</year>
          <fpage>52</fpage>
          <lpage>125</lpage>
        </element-citation>
      </ref>
      <ref id="B6-ijms-24-04223">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Tate</surname><given-names>S.K.</given-names></name>
<name><surname>Sisodiya</surname><given-names>S.M.</given-names></name>
</person-group>
          <article-title>Multidrug resistance in epilepsy: A pharmacogenomic update</article-title>
          <source>Expert Opin. Pharmacother.</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>1441</fpage>
          <lpage>1449</lpage>
          <pub-id pub-id-type="doi">10.1517/14656566.8.10.1441</pub-id>
          <pub-id pub-id-type="pmid">17661727</pub-id>
        </element-citation>
      </ref>
      <ref id="B7-ijms-24-04223">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ott</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Association of genetic loci: Replication or not, that is the question</article-title>
          <source>Neurology</source>
          <year>2004</year>
          <volume>63</volume>
          <fpage>955</fpage>
          <lpage>958</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.63.6.955</pub-id>
          <pub-id pub-id-type="pmid">15452283</pub-id>
        </element-citation>
      </ref>
      <ref id="B8-ijms-24-04223">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>L&#xF6;scher</surname><given-names>W.</given-names></name>
<name><surname>Klotz</surname><given-names>U.</given-names></name>
<name><surname>Zimprich</surname><given-names>F.</given-names></name>
<name><surname>Schmidt</surname><given-names>D.</given-names></name>
</person-group>
          <article-title>The clinical impact of pharmacogenetics on the treatment of epilepsy</article-title>
          <source>Epilepsia</source>
          <year>2009</year>
          <volume>50</volume>
          <fpage>1</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01716.x</pub-id>
        </element-citation>
      </ref>
      <ref id="B9-ijms-24-04223">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Chouchi</surname><given-names>M.</given-names></name>
<name><surname>Klaa</surname><given-names>H.</given-names></name>
<name><surname>Ben-Youssef Turki</surname><given-names>I.</given-names></name>
<name><surname>Hila</surname><given-names>L.</given-names></name>
</person-group>
          <article-title>ABCB1 Polymorphisms and Drug-Resistant Epilepsy in a Tunisian Population</article-title>
          <source>Dis. Markers</source>
          <year>2019</year>
          <volume>2019</volume>
          <fpage>1343650</fpage>
          <pub-id pub-id-type="doi">10.1155/2019/1343650</pub-id>
          <pub-id pub-id-type="pmid">31871496</pub-id>
        </element-citation>
      </ref>
      <ref id="B10-ijms-24-04223">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ihtisham</surname><given-names>K.</given-names></name>
<name><surname>Ramanujam</surname><given-names>B.</given-names></name>
<name><surname>Srivastava</surname><given-names>S.</given-names></name>
<name><surname>Mehra</surname><given-names>N.K.</given-names></name>
<name><surname>Kaur</surname><given-names>G.</given-names></name>
<name><surname>Khanna</surname><given-names>N.</given-names></name>
<name><surname>Jain</surname><given-names>S.</given-names></name>
<name><surname>Kumar</surname><given-names>S.</given-names></name>
<name><surname>Kaul</surname><given-names>B.</given-names></name>
<name><surname>Samudrala</surname><given-names>R.</given-names></name>
<etal/>
</person-group>
          <article-title>Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population</article-title>
          <source>Seizure</source>
          <year>2019</year>
          <volume>66</volume>
          <fpage>99</fpage>
          <lpage>103</lpage>
          <pub-id pub-id-type="doi">10.1016/j.seizure.2019.02.011</pub-id>
          <pub-id pub-id-type="pmid">30826555</pub-id>
        </element-citation>
      </ref>
      <ref id="B11-ijms-24-04223">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Langdon-Down</surname><given-names>M.</given-names></name>
<name><surname>Brain</surname><given-names>W.R.</given-names></name>
</person-group>
          <article-title>Time of day in relation to convulsions in epilepsy</article-title>
          <source>Lancet</source>
          <year>1929</year>
          <volume>213</volume>
          <fpage>1029</fpage>
          <lpage>1032</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(00)79288-9</pub-id>
        </element-citation>
      </ref>
      <ref id="B12-ijms-24-04223">
        <label>12.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Gowers</surname><given-names>W.R.</given-names></name>
</person-group>
          <source>Epilepsy and Other Chronic Convulsive Diseases: Their Causes, Symptoms &amp; Treatment</source>
          <publisher-name>William Wood &amp; Company</publisher-name>
          <publisher-loc>West Chester, PA, USA</publisher-loc>
          <year>1885</year>
        </element-citation>
      </ref>
      <ref id="B13-ijms-24-04223">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Fisher</surname><given-names>R.S.</given-names></name>
<name><surname>Boas</surname><given-names>W.V.E.</given-names></name>
<name><surname>Blume</surname><given-names>W.</given-names></name>
<name><surname>Elger</surname><given-names>C.</given-names></name>
<name><surname>Genton</surname><given-names>P.</given-names></name>
<name><surname>Lee</surname><given-names>P.</given-names></name>
<name><surname>Engel</surname><given-names>J.</given-names><suffix>Jr.</suffix></name>
</person-group>
          <article-title>Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)</article-title>
          <source>Epilepsia</source>
          <year>2005</year>
          <volume>46</volume>
          <fpage>470</fpage>
          <lpage>472</lpage>
          <pub-id pub-id-type="doi">10.1111/j.0013-9580.2005.66104.x</pub-id>
          <pub-id pub-id-type="pmid">15816939</pub-id>
        </element-citation>
      </ref>
      <ref id="B14-ijms-24-04223">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Horne</surname><given-names>J.A.</given-names></name>
<name><surname>&#xD6;stberg</surname><given-names>O.</given-names></name>
</person-group>
          <article-title>A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms</article-title>
          <source>Int. J. Chronobiol.</source>
          <year>1976</year>
          <volume>4</volume>
          <fpage>97</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">1027738</pub-id>
        </element-citation>
      </ref>
      <ref id="B15-ijms-24-04223">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Quigg</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Circadian rhythms: Interactions with seizures and epilepsy</article-title>
          <source>Epilepsy Res.</source>
          <year>2000</year>
          <volume>42</volume>
          <fpage>43</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.1016/S0920-1211(00)00157-1</pub-id>
          <pub-id pub-id-type="pmid">10996505</pub-id>
        </element-citation>
      </ref>
      <ref id="B16-ijms-24-04223">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Pavlova</surname><given-names>M.K.</given-names></name>
<name><surname>Shea</surname><given-names>S.A.</given-names></name>
<name><surname>Scheer</surname><given-names>F.A.</given-names></name>
<name><surname>Bromfield</surname><given-names>E.B.</given-names></name>
</person-group>
          <article-title>Is there a circadian variation of epileptiform abnormalities in idiopathic generalized epilepsy?</article-title>
          <source>Epilepsy Behav.</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>461</fpage>
          <lpage>467</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yebeh.2009.08.022</pub-id>
          <pub-id pub-id-type="pmid">19786369</pub-id>
        </element-citation>
      </ref>
      <ref id="B17-ijms-24-04223">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Hofstra</surname><given-names>W.A.</given-names></name>
</person-group>
          <article-title>The circadian rhythm and its interaction with human epilepsy: A review of literature</article-title>
          <source>Sleep Med. Rev.</source>
          <year>2009</year>
          <volume>13</volume>
          <fpage>413</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="doi">10.1016/j.smrv.2009.01.002</pub-id>
          <pub-id pub-id-type="pmid">19398353</pub-id>
        </element-citation>
      </ref>
      <ref id="B18-ijms-24-04223">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Pavlova</surname><given-names>M.K.</given-names></name>
<name><surname>Shea</surname><given-names>S.A.</given-names></name>
<name><surname>Bromfield</surname><given-names>E.B.</given-names></name>
</person-group>
          <article-title>Day/night patterns of focal seizures</article-title>
          <source>Epilepsy Behav.</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>44</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yebeh.2003.10.013</pub-id>
          <pub-id pub-id-type="pmid">14751206</pub-id>
        </element-citation>
      </ref>
      <ref id="B19-ijms-24-04223">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Pung</surname><given-names>T.</given-names></name>
<name><surname>Schmitz</surname><given-names>B.</given-names></name>
</person-group>
          <article-title>Circadian rhythm and personality profile in juvenile myoclonic epilepsy</article-title>
          <source>Epilepsia</source>
          <year>2006</year>
          <volume>47</volume>
          <fpage>111</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2006.00707.x</pub-id>
          <pub-id pub-id-type="pmid">17105479</pub-id>
        </element-citation>
      </ref>
      <ref id="B20-ijms-24-04223">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Durazzo</surname><given-names>T.</given-names></name>
<name><surname>Spencer</surname><given-names>S.</given-names></name>
<name><surname>Duckrow</surname><given-names>R.</given-names></name>
<name><surname>Novotny</surname><given-names>E.</given-names></name>
<name><surname>Spencer</surname><given-names>D.</given-names></name>
<name><surname>Zaveri</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Temporal distributions of seizure occurrence from various epileptogenic regions</article-title>
          <source>Neurology</source>
          <year>2008</year>
          <volume>70</volume>
          <fpage>1265</fpage>
          <lpage>1271</lpage>
          <pub-id pub-id-type="doi">10.1212/01.wnl.0000308938.84918.3f</pub-id>
          <pub-id pub-id-type="pmid">18391158</pub-id>
        </element-citation>
      </ref>
      <ref id="B21-ijms-24-04223">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lemmer</surname><given-names>B.</given-names></name>
<name><surname>Labrecque</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>Chronopharmacology and chronotherapeutics: Definitions and concepts</article-title>
          <source>Chronobiol. Int.</source>
          <year>1987</year>
          <volume>4</volume>
          <fpage>319</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="doi">10.3109/07420528709083522</pub-id>
          <pub-id pub-id-type="pmid">3315263</pub-id>
        </element-citation>
      </ref>
      <ref id="B22-ijms-24-04223">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Manganaro</surname><given-names>S.</given-names></name>
<name><surname>Loddenkemper</surname><given-names>T.</given-names></name>
<name><surname>Rotenberg</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>The Need for Antiepileptic Drug Chronotherapy to Treat Selected Childhood Epilepsy Syndromes and Avert the Harmful Consequences of Drug Resistance</article-title>
          <source>J. Cent. Nerv. Syst. Dis.</source>
          <year>2017</year>
          <volume>9</volume>
          <fpage>1179573516685883</fpage>
          <pub-id pub-id-type="doi">10.1177/1179573516685883</pub-id>
          <pub-id pub-id-type="pmid">29308021</pub-id>
        </element-citation>
      </ref>
      <ref id="B23-ijms-24-04223">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Loddenkemper</surname><given-names>T.</given-names></name>
<name><surname>Vendrame</surname><given-names>M.</given-names></name>
<name><surname>Zarowski</surname><given-names>M.</given-names></name>
<name><surname>Gregas</surname><given-names>M.</given-names></name>
<name><surname>Alexopoulos</surname><given-names>A.V.</given-names></name>
<name><surname>Wyllie</surname><given-names>E.</given-names></name>
<name><surname>Kothare</surname><given-names>S.V.</given-names></name>
</person-group>
          <article-title>Circadian patterns of pediatric seizures</article-title>
          <source>Neurology</source>
          <year>2011</year>
          <volume>76</volume>
          <fpage>145</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0b013e318206ca46</pub-id>
          <pub-id pub-id-type="pmid">21220719</pub-id>
        </element-citation>
      </ref>
      <ref id="B24-ijms-24-04223">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Guilhoto</surname><given-names>L.M.</given-names></name>
<name><surname>Loddenkemper</surname><given-names>T.</given-names></name>
<name><surname>Vendrame</surname><given-names>M.</given-names></name>
<name><surname>Bergin</surname><given-names>A.</given-names></name>
<name><surname>Bourgeois</surname><given-names>B.F.</given-names></name>
<name><surname>Kothare</surname><given-names>S.V.</given-names></name>
</person-group>
          <article-title>Higher evening antiepileptic drug dose for nocturnal and early-morning seizures</article-title>
          <source>Epilepsy Behav.</source>
          <year>2011</year>
          <volume>20</volume>
          <fpage>334</fpage>
          <lpage>337</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yebeh.2010.11.017</pub-id>
          <pub-id pub-id-type="pmid">21195032</pub-id>
        </element-citation>
      </ref>
      <ref id="B25-ijms-24-04223">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Kalilani</surname><given-names>L.</given-names></name>
<name><surname>Sun</surname><given-names>X.</given-names></name>
<name><surname>Pelgrims</surname><given-names>B.</given-names></name>
<name><surname>Noack-Rink</surname><given-names>M.</given-names></name>
<name><surname>Villanueva</surname><given-names>V.</given-names></name>
</person-group>
          <article-title>The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis</article-title>
          <source>Epilepsia</source>
          <year>2018</year>
          <volume>59</volume>
          <fpage>2179</fpage>
          <lpage>2193</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.14596</pub-id>
          <pub-id pub-id-type="pmid">30426482</pub-id>
        </element-citation>
      </ref>
      <ref id="B26-ijms-24-04223">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Kwan</surname><given-names>P.</given-names></name>
<name><surname>Brodie</surname><given-names>M.J.</given-names></name>
</person-group>
          <article-title>Early identification of refractory epilepsy</article-title>
          <source>N. Engl. J. Med.</source>
          <year>2000</year>
          <volume>342</volume>
          <fpage>314</fpage>
          <lpage>319</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM200002033420503</pub-id>
          <pub-id pub-id-type="pmid">10660394</pub-id>
        </element-citation>
      </ref>
      <ref id="B27-ijms-24-04223">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sillanp&#xE4;&#xE4;</surname><given-names>M.</given-names></name>
<name><surname>Schmidt</surname><given-names>D.</given-names></name>
</person-group>
          <article-title>Natural history of treated childhood-onset epilepsy: Prospective, long-term population-based study</article-title>
          <source>Brain</source>
          <year>2006</year>
          <volume>129</volume>
          <fpage>617</fpage>
          <lpage>624</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awh726</pub-id>
          <pub-id pub-id-type="pmid">16401617</pub-id>
        </element-citation>
      </ref>
      <ref id="B28-ijms-24-04223">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wolking</surname><given-names>S.</given-names></name>
<name><surname>Moreau</surname><given-names>C.</given-names></name>
<name><surname>McCormack</surname><given-names>M.</given-names></name>
<name><surname>Krause</surname><given-names>R.</given-names></name>
<name><surname>Krenn</surname><given-names>M.</given-names></name>
<name><surname>Berkovic</surname><given-names>S.</given-names></name>
<name><surname>Cavalleri</surname><given-names>G.L.</given-names></name>
<name><surname>Delanty</surname><given-names>N.</given-names></name>
<name><surname>Depondt</surname><given-names>C.</given-names></name>
<name><surname>Johnson</surname><given-names>M.R.</given-names></name>
<etal/>
</person-group>
          <article-title>Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsy</article-title>
          <source>Ann. Clin. Transl. Neurol.</source>
          <year>2021</year>
          <volume>8</volume>
          <fpage>1376</fpage>
          <lpage>1387</lpage>
          <pub-id pub-id-type="doi">10.1002/acn3.51374</pub-id>
          <pub-id pub-id-type="pmid">34018700</pub-id>
        </element-citation>
      </ref>
      <ref id="B29-ijms-24-04223">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Cui</surname><given-names>L.</given-names></name>
<name><surname>Tao</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Xu</surname><given-names>Z.</given-names></name>
<name><surname>Zhou</surname><given-names>H.</given-names></name>
<name><surname>Cai</surname><given-names>Y.</given-names></name>
<name><surname>Yao</surname><given-names>L.</given-names></name>
<name><surname>Chen</surname><given-names>B.</given-names></name>
<name><surname>Liang</surname><given-names>W.</given-names></name>
<etal/>
</person-group>
          <article-title>A functional polymorphism of the microRNA-146a gene is associated with susceptibility to drug-resistant epilepsy and seizures frequency</article-title>
          <source>Seizure</source>
          <year>2015</year>
          <volume>27</volume>
          <fpage>60</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1016/j.seizure.2015.02.032</pub-id>
          <pub-id pub-id-type="pmid">25891929</pub-id>
        </element-citation>
      </ref>
      <ref id="B30-ijms-24-04223">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Balestrini</surname><given-names>S.</given-names></name>
<name><surname>Sisodiya</surname><given-names>S.M.</given-names></name>
</person-group>
          <article-title>Pharmacogenomics in epilepsy</article-title>
          <source>Neurosci. Lett.</source>
          <year>2018</year>
          <volume>667</volume>
          <fpage>27</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neulet.2017.01.014</pub-id>
          <pub-id pub-id-type="pmid">28082152</pub-id>
        </element-citation>
      </ref>
      <ref id="B31-ijms-24-04223">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Bo&#x17E;ina</surname><given-names>N.</given-names></name>
<name><surname>Spori&#x161;</surname><given-names>I.</given-names></name>
<name><surname>Bo&#x17E;ina</surname><given-names>T.</given-names></name>
<name><surname>Klarica-Domjanovi&#x107;</surname><given-names>I.</given-names></name>
<name><surname>Tvrdei&#x107;</surname><given-names>A.</given-names></name>
<name><surname>Spori&#x161;</surname><given-names>D.</given-names></name>
</person-group>
          <article-title>Pharmacogenetics and the treatment of epilepsy: What do we know?</article-title>
          <source>Pharmacogenomics</source>
          <year>2019</year>
          <volume>20</volume>
          <fpage>1093</fpage>
          <lpage>1101</lpage>
          <pub-id pub-id-type="doi">10.2217/pgs-2019-0085</pub-id>
          <pub-id pub-id-type="pmid">31588875</pub-id>
        </element-citation>
      </ref>
      <ref id="B32-ijms-24-04223">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Vadlamudi</surname><given-names>L.</given-names></name>
<name><surname>Milne</surname><given-names>R.L.</given-names></name>
<name><surname>Lawrence</surname><given-names>K.</given-names></name>
<name><surname>Heron</surname><given-names>S.E.</given-names></name>
<name><surname>Eckhaus</surname><given-names>J.</given-names></name>
<name><surname>Keay</surname><given-names>D.</given-names></name>
<name><surname>Connellan</surname><given-names>M.</given-names></name>
<name><surname>Torn-Broers</surname><given-names>Y.</given-names></name>
<name><surname>Howell</surname><given-names>R.A.</given-names></name>
<name><surname>Mulley</surname><given-names>J.C.</given-names></name>
<etal/>
</person-group>
          <article-title>Genetics of epilepsy: The testimony of twins in the molecular era</article-title>
          <source>Neurology</source>
          <year>2014</year>
          <volume>83</volume>
          <fpage>1042</fpage>
          <lpage>1048</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0000000000000790</pub-id>
          <pub-id pub-id-type="pmid">25107880</pub-id>
        </element-citation>
      </ref>
      <ref id="B33-ijms-24-04223">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Berkovic</surname><given-names>S.F.</given-names></name>
<name><surname>Howell</surname><given-names>R.A.</given-names></name>
<name><surname>Hay</surname><given-names>D.A.</given-names></name>
<name><surname>Hopper</surname><given-names>J.L.</given-names></name>
</person-group>
          <article-title>Epilepsies in twins: Genetics of the major epilepsy syndromes</article-title>
          <source>Ann. Neurol.</source>
          <year>1998</year>
          <volume>43</volume>
          <fpage>435</fpage>
          <lpage>445</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.410430405</pub-id>
          <pub-id pub-id-type="pmid">9546323</pub-id>
        </element-citation>
      </ref>
      <ref id="B34-ijms-24-04223">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Steinlein</surname><given-names>O.K.</given-names></name>
<name><surname>Mulley</surname><given-names>J.C.</given-names></name>
<name><surname>Propping</surname><given-names>P.</given-names></name>
<name><surname>Wallace</surname><given-names>R.H.</given-names></name>
<name><surname>Phillips</surname><given-names>H.A.</given-names></name>
<name><surname>Sutherland</surname><given-names>G.R.</given-names></name>
<name><surname>Scheffer</surname><given-names>I.E.</given-names></name>
<name><surname>Berkovic</surname><given-names>S.F.</given-names></name>
</person-group>
          <article-title>A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy</article-title>
          <source>Nat. Genet.</source>
          <year>1995</year>
          <volume>11</volume>
          <fpage>201</fpage>
          <lpage>203</lpage>
          <pub-id pub-id-type="doi">10.1038/ng1095-201</pub-id>
          <pub-id pub-id-type="pmid">7550350</pub-id>
        </element-citation>
      </ref>
      <ref id="B35-ijms-24-04223">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Anand</surname><given-names>R.</given-names></name>
<name><surname>Lindstrom</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans</article-title>
          <source>Genomics</source>
          <year>1992</year>
          <volume>13</volume>
          <fpage>962</fpage>
          <lpage>967</lpage>
          <pub-id pub-id-type="doi">10.1016/0888-7543(92)90008-G</pub-id>
          <pub-id pub-id-type="pmid">1505988</pub-id>
        </element-citation>
      </ref>
      <ref id="B36-ijms-24-04223">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Conti</surname><given-names>V.</given-names></name>
<name><surname>Aracri</surname><given-names>P.</given-names></name>
<name><surname>Chiti</surname><given-names>L.</given-names></name>
<name><surname>Brusco</surname><given-names>S.</given-names></name>
<name><surname>Mari</surname><given-names>F.</given-names></name>
<name><surname>Marini</surname><given-names>C.</given-names></name>
<name><surname>Albanese</surname><given-names>M.</given-names></name>
<name><surname>Marchi</surname><given-names>A.</given-names></name>
<name><surname>Liguori</surname><given-names>C.</given-names></name>
<name><surname>Placidi</surname><given-names>F.</given-names></name>
<etal/>
</person-group>
          <article-title>Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function</article-title>
          <source>Neurology</source>
          <year>2015</year>
          <volume>84</volume>
          <fpage>1520</fpage>
          <lpage>1528</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0000000000001471</pub-id>
          <pub-id pub-id-type="pmid">25770198</pub-id>
        </element-citation>
      </ref>
      <ref id="B37-ijms-24-04223">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ellis</surname><given-names>C.A.</given-names></name>
<name><surname>Petrovski</surname><given-names>S.</given-names></name>
<name><surname>Berkovic</surname><given-names>S.F.</given-names></name>
</person-group>
          <article-title>Epilepsy genetics: Clinical impacts and biological insights</article-title>
          <source>Lancet Neurol.</source>
          <year>2020</year>
          <volume>19</volume>
          <fpage>93</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="doi">10.1016/S1474-4422(19)30269-8</pub-id>
          <pub-id pub-id-type="pmid">31494011</pub-id>
        </element-citation>
      </ref>
      <ref id="B38-ijms-24-04223">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Dunn</surname><given-names>P.</given-names></name>
<name><surname>Albury</surname><given-names>C.L.</given-names></name>
<name><surname>Maksemous</surname><given-names>N.</given-names></name>
<name><surname>Benton</surname><given-names>M.C.</given-names></name>
<name><surname>Sutherland</surname><given-names>H.G.</given-names></name>
<name><surname>Smith</surname><given-names>R.A.</given-names></name>
<name><surname>Haupt</surname><given-names>L.M.</given-names></name>
<name><surname>Griffiths</surname><given-names>L.R.</given-names></name>
</person-group>
          <article-title>Next Generation Sequencing Methods for Diagnosis of Epilepsy Syndromes</article-title>
          <source>Front. Genet.</source>
          <year>2018</year>
          <volume>9</volume>
          <fpage>20</fpage>
          <pub-id pub-id-type="doi">10.3389/fgene.2018.00020</pub-id>
          <pub-id pub-id-type="pmid">29467791</pub-id>
        </element-citation>
      </ref>
      <ref id="B39-ijms-24-04223">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<collab>Epilepsy Genetics Initiative</collab>
</person-group>
          <article-title>The Epilepsy Genetics Initiative: Systematic reanalysis of diagnostic exomes increases yield</article-title>
          <source>Epilepsia</source>
          <year>2019</year>
          <volume>60</volume>
          <fpage>797</fpage>
          <lpage>806</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.14698</pub-id>
          <pub-id pub-id-type="pmid">30951195</pub-id>
        </element-citation>
      </ref>
      <ref id="B40-ijms-24-04223">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Mei</surname><given-names>D.</given-names></name>
<name><surname>Cetica</surname><given-names>V.</given-names></name>
<name><surname>Marini</surname><given-names>C.</given-names></name>
<name><surname>Guerrini</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies</article-title>
          <source>Epilepsia</source>
          <year>2019</year>
          <volume>60</volume>
          <issue>(Suppl. 3)</issue>
          <fpage>S2</fpage>
          <lpage>S7</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.16054</pub-id>
          <pub-id pub-id-type="pmid">31904125</pub-id>
        </element-citation>
      </ref>
      <ref id="B41-ijms-24-04223">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Costain</surname><given-names>G.</given-names></name>
<name><surname>Cordeiro</surname><given-names>D.</given-names></name>
<name><surname>Matviychuk</surname><given-names>D.</given-names></name>
<name><surname>Mercimek-Andrews</surname><given-names>S.</given-names></name>
</person-group>
          <article-title>Clinical Application of Targeted Next-Generation Sequencing Panels and Whole Exome Sequencing in Childhood Epilepsy</article-title>
          <source>Neuroscience</source>
          <year>2019</year>
          <volume>418</volume>
          <fpage>291</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuroscience.2019.08.016</pub-id>
          <pub-id pub-id-type="pmid">31487502</pub-id>
        </element-citation>
      </ref>
      <ref id="B42-ijms-24-04223">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Heinzen</surname><given-names>E.L.</given-names></name>
<name><surname>Yoon</surname><given-names>W.</given-names></name>
<name><surname>Tate</surname><given-names>S.K.</given-names></name>
<name><surname>Sen</surname><given-names>A.</given-names></name>
<name><surname>Wood</surname><given-names>N.W.</given-names></name>
<name><surname>Sisodiya</surname><given-names>S.M.</given-names></name>
<name><surname>Goldstein</surname><given-names>D.B.</given-names></name>
</person-group>
          <article-title>Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A</article-title>
          <source>Am. J. Hum. Genet.</source>
          <year>2007</year>
          <volume>80</volume>
          <fpage>876</fpage>
          <lpage>883</lpage>
          <pub-id pub-id-type="doi">10.1086/516650</pub-id>
          <pub-id pub-id-type="pmid">17436242</pub-id>
        </element-citation>
      </ref>
      <ref id="B43-ijms-24-04223">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Fricke-Galindo</surname><given-names>I.</given-names></name>
<name><surname>Jung-Cook</surname><given-names>H.</given-names></name>
<name><surname>Llerena</surname><given-names>A.</given-names></name>
<name><surname>L&#xF3;pez-L&#xF3;pez</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Pharmacogenetics of adverse reactions to antiepileptic drugs</article-title>
          <source>Neurologia</source>
          <year>2018</year>
          <volume>33</volume>
          <fpage>165</fpage>
          <lpage>176</lpage>
          <pub-id pub-id-type="doi">10.1016/j.nrl.2015.03.005</pub-id>
          <pub-id pub-id-type="pmid">25976948</pub-id>
        </element-citation>
      </ref>
      <ref id="B44-ijms-24-04223">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zaccara</surname><given-names>G.</given-names></name>
<name><surname>Franciotta</surname><given-names>D.</given-names></name>
<name><surname>Perucca</surname><given-names>E.</given-names></name>
</person-group>
          <article-title>Idiosyncratic Adverse Reactions to Antiepileptic Drugs</article-title>
          <source>Epilepsia</source>
          <year>2007</year>
          <volume>48</volume>
          <fpage>1223</fpage>
          <lpage>1244</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.01041.x</pub-id>
          <pub-id pub-id-type="pmid">17386054</pub-id>
        </element-citation>
      </ref>
      <ref id="B45-ijms-24-04223">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Perucca</surname><given-names>P.</given-names></name>
<name><surname>Bahlo</surname><given-names>M.</given-names></name>
<name><surname>Berkovic</surname><given-names>S.F.</given-names></name>
</person-group>
          <article-title>The Genetics of Epilepsy</article-title>
          <source>Annu. Rev. Genom. Hum. Genet.</source>
          <year>2020</year>
          <volume>21</volume>
          <fpage>205</fpage>
          <lpage>230</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev-genom-120219-074937</pub-id>
          <pub-id pub-id-type="pmid">32339036</pub-id>
        </element-citation>
      </ref>
      <ref id="B46-ijms-24-04223">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Lin</surname><given-names>Z.J.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>Xu</surname><given-names>H.Q.</given-names></name>
<name><surname>Shi</surname><given-names>Y.W.</given-names></name>
<name><surname>Yi</surname><given-names>Y.H.</given-names></name>
<name><surname>He</surname><given-names>N.</given-names></name>
<name><surname>Liao</surname><given-names>W.P.</given-names></name>
</person-group>
          <article-title>Epilepsy-associated genes</article-title>
          <source>Seizure</source>
          <year>2017</year>
          <volume>44</volume>
          <fpage>11</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1016/j.seizure.2016.11.030</pub-id>
          <pub-id pub-id-type="pmid">28007376</pub-id>
        </element-citation>
      </ref>
      <ref id="B47-ijms-24-04223">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Peng</surname><given-names>M.</given-names></name>
<name><surname>Yin</surname><given-names>N.</given-names></name>
<name><surname>Li</surname><given-names>M.O.</given-names></name>
</person-group>
          <article-title>SZT2 dictates GATOR control of mTORC1 signalling</article-title>
          <source>Nature</source>
          <year>2017</year>
          <volume>543</volume>
          <fpage>433</fpage>
          <lpage>437</lpage>
          <pub-id pub-id-type="doi">10.1038/nature21378</pub-id>
          <pub-id pub-id-type="pmid">28199315</pub-id>
        </element-citation>
      </ref>
      <ref id="B48-ijms-24-04223">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Naseer</surname><given-names>M.I.</given-names></name>
<name><surname>Alwasiyah</surname><given-names>M.K.</given-names></name>
<name><surname>Abdulkareem</surname><given-names>A.A.</given-names></name>
<name><surname>Bajammal</surname><given-names>R.A.</given-names></name>
<name><surname>Trujillo</surname><given-names>C.</given-names></name>
<name><surname>Abu-Elmagd</surname><given-names>M.</given-names></name>
<name><surname>Jafri</surname><given-names>M.A.</given-names></name>
<name><surname>Chaudhary</surname><given-names>A.G.</given-names></name>
<name><surname>Al-Qahtani</surname><given-names>M.H.</given-names></name>
</person-group>
          <article-title>A novel homozygous mutation in SZT2 gene in Saudi family with developmental delay, macrocephaly and epilepsy</article-title>
          <source>Genes Genom.</source>
          <year>2018</year>
          <volume>40</volume>
          <fpage>1149</fpage>
          <lpage>1155</lpage>
          <pub-id pub-id-type="doi">10.1007/s13258-018-0673-5</pub-id>
        </element-citation>
      </ref>
      <ref id="B49-ijms-24-04223">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Feng</surname><given-names>H.</given-names></name>
<name><surname>Sj&#xF6;gren</surname><given-names>B.</given-names></name>
<name><surname>Karaj</surname><given-names>B.</given-names></name>
<name><surname>Shaw</surname><given-names>V.</given-names></name>
<name><surname>Gezer</surname><given-names>A.</given-names></name>
<name><surname>Neubig</surname><given-names>R.R.</given-names></name>
</person-group>
          <article-title>Movement disorder in GNAO1 encephalopathy associated with gain-of-function mutations</article-title>
          <source>Neurology</source>
          <year>2017</year>
          <volume>89</volume>
          <fpage>762</fpage>
          <lpage>770</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0000000000004262</pub-id>
          <pub-id pub-id-type="pmid">28747448</pub-id>
        </element-citation>
      </ref>
      <ref id="B50-ijms-24-04223">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Mazzola</surname><given-names>L.</given-names></name>
<name><surname>Oliver</surname><given-names>K.L.</given-names></name>
<name><surname>Labalme</surname><given-names>A.</given-names></name>
<name><surname>Baykan</surname><given-names>B.</given-names></name>
<name><surname>Muona</surname><given-names>M.</given-names></name>
<name><surname>Joensuu</surname><given-names>T.H.</given-names></name>
<name><surname>Courage</surname><given-names>C.</given-names></name>
<name><surname>Chatron</surname><given-names>N.</given-names></name>
<name><surname>Borsani</surname><given-names>G.</given-names></name>
<name><surname>Alix</surname><given-names>E.</given-names></name>
<etal/>
</person-group>
          <article-title>Progressive Myoclonus Epilepsy Caused by a Homozygous Splicing Variant of SLC7A6OS</article-title>
          <source>Ann. Neurol.</source>
          <year>2021</year>
          <volume>89</volume>
          <fpage>402</fpage>
          <lpage>407</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.25941</pub-id>
          <pub-id pub-id-type="pmid">33085104</pub-id>
        </element-citation>
      </ref>
      <ref id="B51-ijms-24-04223">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Jonker</surname><given-names>J.W.</given-names></name>
<name><surname>Schinkel</surname><given-names>A.H.</given-names></name>
</person-group>
          <article-title>Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3)</article-title>
          <source>J. Pharmacol. Exp. Ther.</source>
          <year>2004</year>
          <volume>308</volume>
          <fpage>2</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.103.053298</pub-id>
          <pub-id pub-id-type="pmid">14576340</pub-id>
        </element-citation>
      </ref>
      <ref id="B52-ijms-24-04223">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ortega-V&#xE1;zquez</surname><given-names>A.</given-names></name>
<name><surname>Fricke-Galindo</surname><given-names>I.</given-names></name>
<name><surname>Dorado</surname><given-names>P.</given-names></name>
<name><surname>Jung-Cook</surname><given-names>H.</given-names></name>
<name><surname>Mart&#xED;nez-Ju&#xE1;rez</surname><given-names>I.E.</given-names></name>
<name><surname>Monroy-Jaramillo</surname><given-names>N.</given-names></name>
<name><surname>Rojas-Tom&#xE9;</surname><given-names>I.S.</given-names></name>
<name><surname>Pe&#xF1;as-Lled&#xF3;</surname><given-names>E.</given-names></name>
<name><surname>Llerena</surname><given-names>A.</given-names></name>
<name><surname>L&#xF3;pez-L&#xF3;pez</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy</article-title>
          <source>Pharm. J.</source>
          <year>2020</year>
          <volume>20</volume>
          <fpage>845</fpage>
          <lpage>856</lpage>
          <pub-id pub-id-type="doi">10.1038/s41397-020-0173-2</pub-id>
        </element-citation>
      </ref>
      <ref id="B53-ijms-24-04223">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>De Fusco</surname><given-names>M.</given-names></name>
<name><surname>Becchetti</surname><given-names>A.</given-names></name>
<name><surname>Patrignani</surname><given-names>A.</given-names></name>
<name><surname>Annesi</surname><given-names>G.</given-names></name>
<name><surname>Gambardella</surname><given-names>A.</given-names></name>
<name><surname>Quattrone</surname><given-names>A.</given-names></name>
<name><surname>Ballabio</surname><given-names>A.</given-names></name>
<name><surname>Wanke</surname><given-names>E.</given-names></name>
<name><surname>Casari</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy</article-title>
          <source>Nat. Genet.</source>
          <year>2000</year>
          <volume>26</volume>
          <fpage>275</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="doi">10.1038/81566</pub-id>
          <pub-id pub-id-type="pmid">11062464</pub-id>
        </element-citation>
      </ref>
      <ref id="B54-ijms-24-04223">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Phillips</surname><given-names>H.A.</given-names></name>
<name><surname>Favre</surname><given-names>I.</given-names></name>
<name><surname>Kirkpatrick</surname><given-names>M.</given-names></name>
<name><surname>Zuberi</surname><given-names>S.M.</given-names></name>
<name><surname>Goudie</surname><given-names>D.</given-names></name>
<name><surname>Heron</surname><given-names>S.E.</given-names></name>
<name><surname>Scheffer</surname><given-names>I.E.</given-names></name>
<name><surname>Sutherland</surname><given-names>G.R.</given-names></name>
<name><surname>Berkovic</surname><given-names>S.F.</given-names></name>
<name><surname>Bertrand</surname><given-names>D.</given-names></name>
<etal/>
</person-group>
          <article-title>CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy</article-title>
          <source>Am. J. Hum. Genet.</source>
          <year>2001</year>
          <volume>68</volume>
          <fpage>225</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="doi">10.1086/316946</pub-id>
          <pub-id pub-id-type="pmid">11104662</pub-id>
        </element-citation>
      </ref>
      <ref id="B55-ijms-24-04223">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Aridon</surname><given-names>P.</given-names></name>
<name><surname>Marini</surname><given-names>C.</given-names></name>
<name><surname>Di Resta</surname><given-names>C.</given-names></name>
<name><surname>Brilli</surname><given-names>E.</given-names></name>
<name><surname>De Fusco</surname><given-names>M.</given-names></name>
<name><surname>Politi</surname><given-names>F.</given-names></name>
<name><surname>Parrini</surname><given-names>E.</given-names></name>
<name><surname>Manfredi</surname><given-names>I.</given-names></name>
<name><surname>Pisano</surname><given-names>T.</given-names></name>
<name><surname>Pruna</surname><given-names>D.</given-names></name>
<etal/>
</person-group>
          <article-title>Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear</article-title>
          <source>Am. J. Hum. Genet.</source>
          <year>2006</year>
          <volume>79</volume>
          <fpage>342</fpage>
          <lpage>350</lpage>
          <pub-id pub-id-type="doi">10.1086/506459</pub-id>
          <pub-id pub-id-type="pmid">16826524</pub-id>
        </element-citation>
      </ref>
      <ref id="B56-ijms-24-04223">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Steinlein</surname><given-names>O.K.</given-names></name>
</person-group>
          <article-title>Genetics and epilepsy</article-title>
          <source>Dialogues Clin. Neurosci.</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>29</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="doi">10.31887/DCNS.2008.10.1/oksteinlein</pub-id>
          <pub-id pub-id-type="pmid">18472482</pub-id>
        </element-citation>
      </ref>
      <ref id="B57-ijms-24-04223">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Quik</surname><given-names>M.</given-names></name>
<name><surname>Polonskaya</surname><given-names>Y.</given-names></name>
<name><surname>Gillespie</surname><given-names>A.</given-names></name>
<name><surname>Jakowec</surname><given-names>M.</given-names></name>
<name><surname>Lloyd</surname><given-names>G.K.</given-names></name>
<name><surname>Langston</surname><given-names>J.W.</given-names></name>
</person-group>
          <article-title>Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization</article-title>
          <source>J. Comp. Neurol.</source>
          <year>2000</year>
          <volume>425</volume>
          <fpage>58</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="doi">10.1002/1096-9861(20000911)425:1&lt;58::AID-CNE6&gt;3.0.CO;2-X</pub-id>
          <pub-id pub-id-type="pmid">10940942</pub-id>
        </element-citation>
      </ref>
      <ref id="B58-ijms-24-04223">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zoli</surname><given-names>M.</given-names></name>
<name><surname>Pistillo</surname><given-names>F.</given-names></name>
<name><surname>Gotti</surname><given-names>C.</given-names></name>
</person-group>
          <article-title>Diversity of native nicotinic receptor subtypes in mammalian brain</article-title>
          <source>Neuropharmacology</source>
          <year>2015</year>
          <volume>96</volume>
          <fpage>302</fpage>
          <lpage>311</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.11.003</pub-id>
          <pub-id pub-id-type="pmid">25460185</pub-id>
        </element-citation>
      </ref>
      <ref id="B59-ijms-24-04223">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Hilscher</surname><given-names>M.M.</given-names></name>
<name><surname>Le&#xE3;o</surname><given-names>R.N.</given-names></name>
<name><surname>Edwards</surname><given-names>S.J.</given-names></name>
<name><surname>Le&#xE3;o</surname><given-names>K.E.</given-names></name>
<name><surname>Kullander</surname><given-names>K.</given-names></name>
</person-group>
          <article-title>Chrna2-Martinotti Cells Synchronize Layer 5 Type A Pyramidal Cells via Rebound Excitation</article-title>
          <source>PLoS Biol.</source>
          <year>2017</year>
          <volume>15</volume>
          <elocation-id>e2001392</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pbio.2001392</pub-id>
          <pub-id pub-id-type="pmid">28182735</pub-id>
        </element-citation>
      </ref>
      <ref id="B60-ijms-24-04223">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Son</surname><given-names>J.H.</given-names></name>
<name><surname>Winzer-Serhan</surname><given-names>U.H.</given-names></name>
</person-group>
          <article-title>Postnatal expression of alpha2 nicotinic acetylcholine receptor subunit mRNA in developing cortex and hippocampus</article-title>
          <source>J. Chem. Neuroanat.</source>
          <year>2006</year>
          <volume>32</volume>
          <fpage>179</fpage>
          <lpage>190</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jchemneu.2006.09.001</pub-id>
          <pub-id pub-id-type="pmid">17046198</pub-id>
        </element-citation>
      </ref>
      <ref id="B61-ijms-24-04223">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Becchetti</surname><given-names>A.</given-names></name>
<name><surname>Grandi</surname><given-names>L.C.</given-names></name>
<name><surname>Colombo</surname><given-names>G.</given-names></name>
<name><surname>Meneghini</surname><given-names>S.</given-names></name>
<name><surname>Amadeo</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Nicotinic Receptors in Sleep-Related Hypermotor Epilepsy: Pathophysiology and Pharmacology</article-title>
          <source>Brain Sci.</source>
          <year>2020</year>
          <volume>10</volume>
          <elocation-id>907</elocation-id>
          <pub-id pub-id-type="doi">10.3390/brainsci10120907</pub-id>
          <pub-id pub-id-type="pmid">33255633</pub-id>
        </element-citation>
      </ref>
      <ref id="B62-ijms-24-04223">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Olsen</surname><given-names>R.W.</given-names></name>
<name><surname>Avoli</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>GABA and epileptogenesis</article-title>
          <source>Epilepsia</source>
          <year>1997</year>
          <volume>38</volume>
          <fpage>399</fpage>
          <lpage>407</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1157.1997.tb01728.x</pub-id>
          <pub-id pub-id-type="pmid">9118844</pub-id>
        </element-citation>
      </ref>
      <ref id="B63-ijms-24-04223">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Riban</surname><given-names>V.</given-names></name>
<name><surname>Fitzsimons</surname><given-names>H.L.</given-names></name>
<name><surname>During</surname><given-names>M.J.</given-names></name>
</person-group>
          <article-title>Gene therapy in epilepsy</article-title>
          <source>Epilepsia</source>
          <year>2009</year>
          <volume>50</volume>
          <fpage>24</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01743.x</pub-id>
        </element-citation>
      </ref>
      <ref id="B64-ijms-24-04223">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gernert</surname><given-names>M.</given-names></name>
<name><surname>Thompson</surname><given-names>K.W.</given-names></name>
<name><surname>L&#xF6;scher</surname><given-names>W.</given-names></name>
<name><surname>Tobin</surname><given-names>A.J.</given-names></name>
</person-group>
          <article-title>Genetically engineered GABA-producing cells demonstrate anticonvulsant effects and long-term transgene expression when transplanted into the central piriform cortex of rats</article-title>
          <source>Exp. Neurol.</source>
          <year>2002</year>
          <volume>176</volume>
          <fpage>183</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="doi">10.1006/exnr.2002.7914</pub-id>
          <pub-id pub-id-type="pmid">12093095</pub-id>
        </element-citation>
      </ref>
      <ref id="B65-ijms-24-04223">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Asada</surname><given-names>H.</given-names></name>
<name><surname>Kawamura</surname><given-names>Y.</given-names></name>
<name><surname>Maruyama</surname><given-names>K.</given-names></name>
<name><surname>Kume</surname><given-names>H.</given-names></name>
<name><surname>Ding</surname><given-names>R.G.</given-names></name>
<name><surname>Kanbara</surname><given-names>N.</given-names></name>
<name><surname>Kuzume</surname><given-names>H.</given-names></name>
<name><surname>Sanbo</surname><given-names>M.</given-names></name>
<name><surname>Yagi</surname><given-names>T.</given-names></name>
<name><surname>Obata</surname><given-names>K.</given-names></name>
</person-group>
          <article-title>Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>1997</year>
          <volume>94</volume>
          <fpage>6496</fpage>
          <lpage>6499</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.94.12.6496</pub-id>
          <pub-id pub-id-type="pmid">9177246</pub-id>
        </element-citation>
      </ref>
      <ref id="B66-ijms-24-04223">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Kaufman</surname><given-names>D.L.</given-names></name>
<name><surname>Houser</surname><given-names>C.R.</given-names></name>
<name><surname>Tobin</surname><given-names>A.J.</given-names></name>
</person-group>
          <article-title>Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions</article-title>
          <source>J. Neurochem.</source>
          <year>1991</year>
          <volume>56</volume>
          <fpage>720</fpage>
          <lpage>723</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1471-4159.1991.tb08211.x</pub-id>
          <pub-id pub-id-type="pmid">1988566</pub-id>
        </element-citation>
      </ref>
      <ref id="B67-ijms-24-04223">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lynex</surname><given-names>C.N.</given-names></name>
<name><surname>Carr</surname><given-names>I.M.</given-names></name>
<name><surname>Leek</surname><given-names>J.P.</given-names></name>
<name><surname>Achuthan</surname><given-names>R.</given-names></name>
<name><surname>Mitchell</surname><given-names>S.</given-names></name>
<name><surname>Maher</surname><given-names>E.R.</given-names></name>
<name><surname>Woods</surname><given-names>C.G.</given-names></name>
<name><surname>Bonthon</surname><given-names>D.T.</given-names></name>
<name><surname>Markham</surname><given-names>A.F.</given-names></name>
</person-group>
          <article-title>Homozygosity for a missense mutation in the 67 kDa isoform of glutamate decarboxylase in a family with autosomal recessive spastic cerebral palsy: Parallels with Stiff-Person Syndrome and other movement disorders</article-title>
          <source>BMC Neurol.</source>
          <year>2004</year>
          <volume>4</volume>
          <elocation-id>20</elocation-id>
          <pub-id pub-id-type="doi">10.1186/1471-2377-4-20</pub-id>
          <pub-id pub-id-type="pmid">15571623</pub-id>
        </element-citation>
      </ref>
      <ref id="B68-ijms-24-04223">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ruzicka</surname><given-names>W.B.</given-names></name>
<name><surname>Subburaju</surname><given-names>S.</given-names></name>
<name><surname>Benes</surname><given-names>F.M.</given-names></name>
</person-group>
          <article-title>Circuit- and Diagnosis-Specific DNA Methylation Changes at &#x3B3;-Aminobutyric Acid-Related Genes in Postmortem Human Hippocampus in Schizophrenia and Bipolar Disorder</article-title>
          <source>JAMA Psychiatry</source>
          <year>2015</year>
          <volume>72</volume>
          <fpage>541</fpage>
          <lpage>551</lpage>
          <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2015.49</pub-id>
          <pub-id pub-id-type="pmid">25738424</pub-id>
        </element-citation>
      </ref>
      <ref id="B69-ijms-24-04223">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Neuray</surname><given-names>C.</given-names></name>
<name><surname>Maroofian</surname><given-names>R.</given-names></name>
<name><surname>Scala</surname><given-names>M.</given-names></name>
<name><surname>Sultan</surname><given-names>T.</given-names></name>
<name><surname>Pai</surname><given-names>G.S.</given-names></name>
<name><surname>Mojarrad</surname><given-names>M.</given-names></name>
<name><surname>Khashab</surname><given-names>H.E.</given-names></name>
<name><surname>Deholl</surname><given-names>L.</given-names></name>
<name><surname>Yue</surname><given-names>W.</given-names></name>
<name><surname>Alsaif</surname><given-names>H.S.</given-names></name>
<etal/>
</person-group>
          <article-title>Early-infantile onset epilepsy and developmental delay caused by bi-allelic GAD1 variants</article-title>
          <source>Brain</source>
          <year>2020</year>
          <volume>143</volume>
          <fpage>2388</fpage>
          <lpage>2397</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awaa178</pub-id>
          <pub-id pub-id-type="pmid">32705143</pub-id>
        </element-citation>
      </ref>
      <ref id="B70-ijms-24-04223">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Zhan</surname><given-names>L.</given-names></name>
<name><surname>Zeng</surname><given-names>W.</given-names></name>
<name><surname>Li</surname><given-names>K.</given-names></name>
<name><surname>Sun</surname><given-names>W.</given-names></name>
<name><surname>Xu</surname><given-names>Z.C.</given-names></name>
<name><surname>Xu</surname><given-names>E.</given-names></name>
</person-group>
          <article-title>Downregulation of hippocampal GABA after hypoxia-induced seizures in neonatal rats</article-title>
          <source>Neurochem. Res.</source>
          <year>2011</year>
          <volume>36</volume>
          <fpage>2409</fpage>
          <lpage>2416</lpage>
          <pub-id pub-id-type="doi">10.1007/s11064-011-0565-4</pub-id>
          <pub-id pub-id-type="pmid">21833845</pub-id>
        </element-citation>
      </ref>
      <ref id="B71-ijms-24-04223">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Jacob</surname><given-names>T.C.</given-names></name>
<name><surname>Moss</surname><given-names>S.J.</given-names></name>
<name><surname>Jurd</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition</article-title>
          <source>Nat. Reviews. Neurosci.</source>
          <year>2008</year>
          <volume>9</volume>
          <fpage>331</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="doi">10.1038/nrn2370</pub-id>
        </element-citation>
      </ref>
      <ref id="B72-ijms-24-04223">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sieghart</surname><given-names>W.</given-names></name>
<name><surname>Sperk</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>Subunit composition, distribution and function of GABA(A) receptor subtypes</article-title>
          <source>Curr. Top. Med. Chem.</source>
          <year>2002</year>
          <volume>2</volume>
          <fpage>795</fpage>
          <lpage>816</lpage>
          <pub-id pub-id-type="doi">10.2174/1568026023393507</pub-id>
          <pub-id pub-id-type="pmid">12171572</pub-id>
        </element-citation>
      </ref>
      <ref id="B73-ijms-24-04223">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Cossette</surname><given-names>P.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>Brisebois</surname><given-names>K.</given-names></name>
<name><surname>Dong</surname><given-names>H.</given-names></name>
<name><surname>Lortie</surname><given-names>A.</given-names></name>
<name><surname>Vanasse</surname><given-names>M.</given-names></name>
<name><surname>Saint-Hilaire</surname><given-names>J.M.</given-names></name>
<name><surname>Carmant</surname><given-names>L.</given-names></name>
<name><surname>Verner</surname><given-names>A.</given-names></name>
<name><surname>Lu</surname><given-names>W.Y.</given-names></name>
<etal/>
</person-group>
          <article-title>Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy</article-title>
          <source>Nat. Genet.</source>
          <year>2002</year>
          <volume>31</volume>
          <fpage>184</fpage>
          <lpage>189</lpage>
          <pub-id pub-id-type="doi">10.1038/ng885</pub-id>
          <pub-id pub-id-type="pmid">11992121</pub-id>
        </element-citation>
      </ref>
      <ref id="B74-ijms-24-04223">
        <label>74.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Naylor</surname><given-names>D.E.</given-names></name>
<name><surname>Liu</surname><given-names>H.</given-names></name>
<name><surname>Wasterlain</surname><given-names>C.G.</given-names></name>
</person-group>
          <article-title>Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus</article-title>
          <source>J. Neurosci.</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>7724</fpage>
          <lpage>7733</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4944-04.2005</pub-id>
          <pub-id pub-id-type="pmid">16120773</pub-id>
        </element-citation>
      </ref>
      <ref id="B75-ijms-24-04223">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Terunuma</surname><given-names>M.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
<name><surname>Vithlani</surname><given-names>M.</given-names></name>
<name><surname>Sieghart</surname><given-names>W.</given-names></name>
<name><surname>Kittler</surname><given-names>J.</given-names></name>
<name><surname>Pangalos</surname><given-names>M.</given-names></name>
<name><surname>Haydon</surname><given-names>P.G.</given-names></name>
<name><surname>Coulter</surname><given-names>D.A.</given-names></name>
<name><surname>Moss</surname><given-names>S.J.</given-names></name>
</person-group>
          <article-title>Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus</article-title>
          <source>J. Neurosci.</source>
          <year>2008</year>
          <volume>28</volume>
          <fpage>376</fpage>
          <lpage>384</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4346-07.2008</pub-id>
          <pub-id pub-id-type="pmid">18184780</pub-id>
        </element-citation>
      </ref>
      <ref id="B76-ijms-24-04223">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Bouilleret</surname><given-names>V.</given-names></name>
<name><surname>Loup</surname><given-names>F.</given-names></name>
<name><surname>Kiener</surname><given-names>T.</given-names></name>
<name><surname>Marescaux</surname><given-names>C.</given-names></name>
<name><surname>Fritschy</surname><given-names>J.M.</given-names></name>
</person-group>
          <article-title>Early loss of interneurons and delayed subunit-specific changes in GABA(A)-receptor expression in a mouse model of mesial temporal lobe epilepsy</article-title>
          <source>Hippocampus</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>305</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="doi">10.1002/1098-1063(2000)10:3&lt;305::AID-HIPO11&gt;3.0.CO;2-I</pub-id>
          <pub-id pub-id-type="pmid">10902900</pub-id>
        </element-citation>
      </ref>
      <ref id="B77-ijms-24-04223">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Oyrer</surname><given-names>J.</given-names></name>
<name><surname>Maljevic</surname><given-names>S.</given-names></name>
<name><surname>Scheffer</surname><given-names>I.E.</given-names></name>
<name><surname>Berkovic</surname><given-names>S.F.</given-names></name>
<name><surname>Petrou</surname><given-names>S.</given-names></name>
<name><surname>Reid</surname><given-names>C.A.</given-names></name>
</person-group>
          <article-title>Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies</article-title>
          <source>Pharmacol. Rev.</source>
          <year>2018</year>
          <volume>70</volume>
          <fpage>142</fpage>
          <lpage>173</lpage>
          <pub-id pub-id-type="doi">10.1124/pr.117.014456</pub-id>
          <pub-id pub-id-type="pmid">29263209</pub-id>
        </element-citation>
      </ref>
      <ref id="B78-ijms-24-04223">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Brunklaus</surname><given-names>A.</given-names></name>
<name><surname>Du</surname><given-names>J.</given-names></name>
<name><surname>Steckler</surname><given-names>F.</given-names></name>
<name><surname>Ghanty</surname><given-names>I.I.</given-names></name>
<name><surname>Johannesen</surname><given-names>K.M.</given-names></name>
<name><surname>Fenger</surname><given-names>C.D.</given-names></name>
<name><surname>Schorge</surname><given-names>S.</given-names></name>
<name><surname>Baez-Nieto</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>H.R.</given-names></name>
<name><surname>Allen</surname><given-names>A.</given-names></name>
<etal/>
</person-group>
          <article-title>Biological concepts in human sodium channel epilepsies and their relevance in clinical practice</article-title>
          <source>Epilepsia</source>
          <year>2020</year>
          <volume>61</volume>
          <fpage>387</fpage>
          <lpage>399</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.16438</pub-id>
          <pub-id pub-id-type="pmid">32090326</pub-id>
        </element-citation>
      </ref>
      <ref id="B79-ijms-24-04223">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zuberi</surname><given-names>S.M.</given-names></name>
<name><surname>Brunklaus</surname><given-names>A.</given-names></name>
<name><surname>Birch</surname><given-names>R.</given-names></name>
<name><surname>Reavey</surname><given-names>E.</given-names></name>
<name><surname>Duncan</surname><given-names>J.</given-names></name>
<name><surname>Forbes</surname><given-names>G.H.</given-names></name>
</person-group>
          <article-title>Genotype-phenotype associations in SCN1A-related epilepsies</article-title>
          <source>Neurology</source>
          <year>2011</year>
          <volume>76</volume>
          <fpage>594</fpage>
          <lpage>600</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0b013e31820c309b</pub-id>
          <pub-id pub-id-type="pmid">21248271</pub-id>
        </element-citation>
      </ref>
      <ref id="B80-ijms-24-04223">
        <label>80.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Nabbout</surname><given-names>R.</given-names></name>
<name><surname>Gennaro</surname><given-names>E.</given-names></name>
<name><surname>Dalla Bernardina</surname><given-names>B.</given-names></name>
<name><surname>Dulac</surname><given-names>O.</given-names></name>
<name><surname>Madia</surname><given-names>F.</given-names></name>
<name><surname>Bertini</surname><given-names>E.</given-names></name>
<name><surname>Capovilla</surname><given-names>G.</given-names></name>
<name><surname>Chiron</surname><given-names>C.</given-names></name>
<name><surname>Cristofori</surname><given-names>G.</given-names></name>
<name><surname>Elia</surname><given-names>M.</given-names></name>
<etal/>
</person-group>
          <article-title>Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy</article-title>
          <source>Neurology</source>
          <year>2003</year>
          <volume>60</volume>
          <fpage>1961</fpage>
          <lpage>1967</lpage>
          <pub-id pub-id-type="doi">10.1212/01.WNL.0000069463.41870.2F</pub-id>
          <pub-id pub-id-type="pmid">12821740</pub-id>
        </element-citation>
      </ref>
      <ref id="B81-ijms-24-04223">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Begemann</surname><given-names>A.</given-names></name>
<name><surname>Acu&#xF1;a</surname><given-names>M.A.</given-names></name>
<name><surname>Zweier</surname><given-names>M.</given-names></name>
<name><surname>Vincent</surname><given-names>M.</given-names></name>
<name><surname>Steindl</surname><given-names>K.</given-names></name>
<name><surname>Bachmann-Gagescu</surname><given-names>R.</given-names></name>
<name><surname>Hackenberg</surname><given-names>A.</given-names></name>
<name><surname>Abela</surname><given-names>L.</given-names></name>
<name><surname>Plecko</surname><given-names>B.</given-names></name>
<name><surname>Kroell-Seger</surname><given-names>J.</given-names></name>
<etal/>
</person-group>
          <article-title>Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes</article-title>
          <source>Mol. Med.</source>
          <year>2019</year>
          <volume>25</volume>
          <fpage>6</fpage>
          <pub-id pub-id-type="doi">10.1186/s10020-019-0073-6</pub-id>
          <pub-id pub-id-type="pmid">30813884</pub-id>
        </element-citation>
      </ref>
      <ref id="B82-ijms-24-04223">
        <label>82.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wallace</surname><given-names>R.H.</given-names></name>
<name><surname>Wang</surname><given-names>D.W.</given-names></name>
<name><surname>Singh</surname><given-names>R.</given-names></name>
<name><surname>Scheffer</surname><given-names>I.E.</given-names></name>
<name><surname>George</surname><given-names>A.L.</given-names><suffix>Jr.</suffix></name>
<name><surname>Phillips</surname><given-names>H.A.</given-names></name>
<name><surname>Saar</surname><given-names>K.</given-names></name>
<name><surname>Reis</surname><given-names>A.</given-names></name>
<name><surname>Johnson</surname><given-names>E.W.</given-names></name>
<name><surname>Sutherland</surname><given-names>G.R.</given-names></name>
<etal/>
</person-group>
          <article-title>Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B</article-title>
          <source>Nat. Genet.</source>
          <year>1998</year>
          <volume>19</volume>
          <fpage>366</fpage>
          <lpage>370</lpage>
          <pub-id pub-id-type="doi">10.1038/1252</pub-id>
          <pub-id pub-id-type="pmid">9697698</pub-id>
        </element-citation>
      </ref>
      <ref id="B83-ijms-24-04223">
        <label>83.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wimmer</surname><given-names>V.C.</given-names></name>
<name><surname>Reid</surname><given-names>C.A.</given-names></name>
<name><surname>Mitchell</surname><given-names>S.</given-names></name>
<name><surname>Richards</surname><given-names>K.L.</given-names></name>
<name><surname>Scaf</surname><given-names>B.B.</given-names></name>
<name><surname>Leaw</surname><given-names>B.T.</given-names></name>
<name><surname>Hill</surname><given-names>E.L.</given-names></name>
<name><surname>Royeck</surname><given-names>M.</given-names></name>
<name><surname>Horstmann</surname><given-names>M.T.</given-names></name>
<name><surname>Cromer</surname><given-names>B.A.</given-names></name>
<etal/>
</person-group>
          <article-title>Axon initial segment dysfunction in a mouse model of genetic epilepsy with febrile seizures plus</article-title>
          <source>J. Clin. Investig.</source>
          <year>2010</year>
          <volume>120</volume>
          <fpage>2661</fpage>
          <lpage>2671</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI42219</pub-id>
          <pub-id pub-id-type="pmid">20628201</pub-id>
        </element-citation>
      </ref>
      <ref id="B84-ijms-24-04223">
        <label>84.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Maljevic</surname><given-names>S.</given-names></name>
<name><surname>Lerche</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Potassium channel genes and benign familial neonatal epilepsy</article-title>
          <source>Prog. Brain Res.</source>
          <year>2014</year>
          <volume>213</volume>
          <fpage>17</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="doi">10.1016/b978-0-444-63326-2.00002-8</pub-id>
          <pub-id pub-id-type="pmid">25194482</pub-id>
        </element-citation>
      </ref>
      <ref id="B85-ijms-24-04223">
        <label>85.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wang</surname><given-names>H.S.</given-names></name>
<name><surname>Pan</surname><given-names>Z.</given-names></name>
<name><surname>Shi</surname><given-names>W.</given-names></name>
<name><surname>Brown</surname><given-names>B.S.</given-names></name>
<name><surname>Wymore</surname><given-names>R.S.</given-names></name>
<name><surname>Cohen</surname><given-names>I.S.</given-names></name>
<name><surname>Dixon</surname><given-names>J.E.</given-names></name>
<name><surname>McKinnon</surname><given-names>D.</given-names></name>
</person-group>
          <article-title>KCNQ2 and KCNQ3 potassium channel subunits: Molecular correlates of the M-channel</article-title>
          <source>Science</source>
          <year>1998</year>
          <volume>282</volume>
          <fpage>1890</fpage>
          <lpage>1893</lpage>
          <pub-id pub-id-type="doi">10.1126/science.282.5395.1890</pub-id>
          <pub-id pub-id-type="pmid">9836639</pub-id>
        </element-citation>
      </ref>
      <ref id="B86-ijms-24-04223">
        <label>86.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>H.</given-names></name>
<name><surname>Nagata</surname><given-names>E.</given-names></name>
<name><surname>Kosakai</surname><given-names>A.</given-names></name>
<name><surname>Nakamura</surname><given-names>M.</given-names></name>
<name><surname>Yokoyama</surname><given-names>M.</given-names></name>
<name><surname>Tanaka</surname><given-names>K.</given-names></name>
<name><surname>Sasai</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability</article-title>
          <source>J. Neurochem.</source>
          <year>2000</year>
          <volume>75</volume>
          <fpage>28</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1471-4159.2000.0750028.x</pub-id>
          <pub-id pub-id-type="pmid">10854243</pub-id>
        </element-citation>
      </ref>
      <ref id="B87-ijms-24-04223">
        <label>87.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zamponi</surname><given-names>G.W.</given-names></name>
<name><surname>Lory</surname><given-names>P.</given-names></name>
<name><surname>Perez-Reyes</surname><given-names>E.</given-names></name>
</person-group>
          <article-title>Role of voltage-gated calcium channels in epilepsy</article-title>
          <source>Pflug. Arch. Eur. J. Physiol.</source>
          <year>2010</year>
          <volume>460</volume>
          <fpage>395</fpage>
          <lpage>403</lpage>
          <pub-id pub-id-type="doi">10.1007/s00424-009-0772-x</pub-id>
        </element-citation>
      </ref>
      <ref id="B88-ijms-24-04223">
        <label>88.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>S&#xE1;nchez-Carpintero Abad</surname><given-names>R.</given-names></name>
<name><surname>Sanmart&#xED; Vilaplana</surname><given-names>F.X.</given-names></name>
<name><surname>Serratosa Fern&#xE1;ndez</surname><given-names>J.M.</given-names></name>
</person-group>
          <article-title>Genetic causes of epilepsy</article-title>
          <source>Neurologist</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>S47</fpage>
          <lpage>S51</lpage>
          <pub-id pub-id-type="doi">10.1097/NRL.0b013e31815bb07d</pub-id>
          <pub-id pub-id-type="pmid">18090951</pub-id>
        </element-citation>
      </ref>
      <ref id="B89-ijms-24-04223">
        <label>89.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Citraro</surname><given-names>R.</given-names></name>
<name><surname>Leo</surname><given-names>A.</given-names></name>
<name><surname>Constanti</surname><given-names>A.</given-names></name>
<name><surname>Russo</surname><given-names>E.</given-names></name>
<name><surname>De Sarro</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis</article-title>
          <source>Pharmacol. Res.</source>
          <year>2016</year>
          <volume>107</volume>
          <fpage>333</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="doi">10.1016/j.phrs.2016.03.039</pub-id>
          <pub-id pub-id-type="pmid">27049136</pub-id>
        </element-citation>
      </ref>
      <ref id="B90-ijms-24-04223">
        <label>90.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Hodges</surname><given-names>S.L.</given-names></name>
<name><surname>Lugo</surname><given-names>J.N.</given-names></name>
</person-group>
          <article-title>Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy</article-title>
          <source>Epilepsy Res.</source>
          <year>2020</year>
          <volume>161</volume>
          <fpage>106282</fpage>
          <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2020.106282</pub-id>
          <pub-id pub-id-type="pmid">32036255</pub-id>
        </element-citation>
      </ref>
      <ref id="B91-ijms-24-04223">
        <label>91.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Crino</surname><given-names>P.B.</given-names></name>
</person-group>
          <article-title>mTOR: A pathogenic signaling pathway in developmental brain malformations</article-title>
          <source>Trends Mol. Med.</source>
          <year>2011</year>
          <volume>17</volume>
          <fpage>734</fpage>
          <lpage>742</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molmed.2011.07.008</pub-id>
          <pub-id pub-id-type="pmid">21890410</pub-id>
        </element-citation>
      </ref>
      <ref id="B92-ijms-24-04223">
        <label>92.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Baulac</surname><given-names>S.</given-names></name>
<name><surname>Ishida</surname><given-names>S.</given-names></name>
<name><surname>Marsan</surname><given-names>E.</given-names></name>
<name><surname>Miquel</surname><given-names>C.</given-names></name>
<name><surname>Biraben</surname><given-names>A.</given-names></name>
<name><surname>Nguyen</surname><given-names>D.K.</given-names></name>
<name><surname>Nordli</surname><given-names>D.</given-names></name>
<name><surname>Cossette</surname><given-names>P.</given-names></name>
<name><surname>Nguyen</surname><given-names>S.</given-names></name>
<name><surname>Lambrecq</surname><given-names>V.</given-names></name>
<etal/>
</person-group>
          <article-title>Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations</article-title>
          <source>Ann. Neurol.</source>
          <year>2015</year>
          <volume>77</volume>
          <fpage>675</fpage>
          <lpage>683</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.24368</pub-id>
          <pub-id pub-id-type="pmid">25623524</pub-id>
        </element-citation>
      </ref>
      <ref id="B93-ijms-24-04223">
        <label>93.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sim</surname><given-names>J.C.</given-names></name>
<name><surname>Scerri</surname><given-names>T.</given-names></name>
<name><surname>Fanjul-Fern&#xE1;ndez</surname><given-names>M.</given-names></name>
<name><surname>Riseley</surname><given-names>J.R.</given-names></name>
<name><surname>Gillies</surname><given-names>G.</given-names></name>
<name><surname>Pope</surname><given-names>K.</given-names></name>
<name><surname>van Roozendaal</surname><given-names>H.</given-names></name>
<name><surname>Heng</surname><given-names>J.I.</given-names></name>
<name><surname>Mandelstam</surname><given-names>S.A.</given-names></name>
<name><surname>McGillivray</surname><given-names>G.</given-names></name>
<etal/>
</person-group>
          <article-title>Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3</article-title>
          <source>Ann. Neurol.</source>
          <year>2016</year>
          <volume>79</volume>
          <fpage>132</fpage>
          <lpage>137</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.24502</pub-id>
          <pub-id pub-id-type="pmid">26285051</pub-id>
        </element-citation>
      </ref>
      <ref id="B94-ijms-24-04223">
        <label>94.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Baldassari</surname><given-names>S.</given-names></name>
<name><surname>Picard</surname><given-names>F.</given-names></name>
<name><surname>Verbeek</surname><given-names>N.E.</given-names></name>
<name><surname>Van Kempen</surname><given-names>M.</given-names></name>
<name><surname>Brilstra</surname><given-names>E.H.</given-names></name>
<name><surname>Lesca</surname><given-names>G.</given-names></name>
<name><surname>Conti</surname><given-names>V.</given-names></name>
<name><surname>Guerrini</surname><given-names>R.</given-names></name>
<name><surname>Bisulli</surname><given-names>F.</given-names></name>
<name><surname>Licchetta</surname><given-names>L.</given-names></name>
<etal/>
</person-group>
          <article-title>The landscape of epilepsy-related GATOR1 variants</article-title>
          <source>Genet. Med.</source>
          <year>2019</year>
          <volume>21</volume>
          <fpage>398</fpage>
          <lpage>408</lpage>
          <pub-id pub-id-type="doi">10.1038/s41436-018-0060-2</pub-id>
          <pub-id pub-id-type="pmid">30093711</pub-id>
        </element-citation>
      </ref>
      <ref id="B95-ijms-24-04223">
        <label>95.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Weckhuysen</surname><given-names>S.</given-names></name>
<name><surname>Marsan</surname><given-names>E.</given-names></name>
<name><surname>Lambrecq</surname><given-names>V.</given-names></name>
<name><surname>Marchal</surname><given-names>C.</given-names></name>
<name><surname>Morin-Brureau</surname><given-names>M.</given-names></name>
<name><surname>An-Gourfinkel</surname><given-names>I.</given-names></name>
<name><surname>Baulac</surname><given-names>M.</given-names></name>
<name><surname>Fohlen</surname><given-names>M.</given-names></name>
<name><surname>Kallay Zetchi</surname><given-names>C.</given-names></name>
<name><surname>Seeck</surname><given-names>M.</given-names></name>
<etal/>
</person-group>
          <article-title>Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia</article-title>
          <source>Epilepsia</source>
          <year>2016</year>
          <volume>57</volume>
          <fpage>994</fpage>
          <lpage>1003</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.13391</pub-id>
          <pub-id pub-id-type="pmid">27173016</pub-id>
        </element-citation>
      </ref>
      <ref id="B96-ijms-24-04223">
        <label>96.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ferguson</surname><given-names>S.M.</given-names></name>
<name><surname>De Camilli</surname><given-names>P.</given-names></name>
</person-group>
          <article-title>Dynamin, a membrane-remodelling GTPase</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>75</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="doi">10.1038/nrm3266</pub-id>
          <pub-id pub-id-type="pmid">22233676</pub-id>
        </element-citation>
      </ref>
      <ref id="B97-ijms-24-04223">
        <label>97.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Von Spiczak</surname><given-names>S.</given-names></name>
<name><surname>Helbig</surname><given-names>K.L.</given-names></name>
<name><surname>Shinde</surname><given-names>D.N.</given-names></name>
<name><surname>Huether</surname><given-names>R.</given-names></name>
<name><surname>Pendziwiat</surname><given-names>M.</given-names></name>
<name><surname>Louren&#xE7;o</surname><given-names>C.</given-names></name>
<name><surname>Nunes</surname><given-names>M.E.</given-names></name>
<name><surname>Sarco</surname><given-names>D.P.</given-names></name>
<name><surname>Kaplan</surname><given-names>R.A.</given-names></name>
<name><surname>Dlugos</surname><given-names>D.J.</given-names></name>
<etal/>
</person-group>
          <article-title>DNM1 encephalopathy: A new disease of vesicle fission</article-title>
          <source>Neurology</source>
          <year>2017</year>
          <volume>89</volume>
          <fpage>385</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0000000000004152</pub-id>
          <pub-id pub-id-type="pmid">28667181</pub-id>
        </element-citation>
      </ref>
      <ref id="B98-ijms-24-04223">
        <label>98.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Cali</surname><given-names>E.</given-names></name>
<name><surname>Rocca</surname><given-names>C.</given-names></name>
<name><surname>Salpietro</surname><given-names>V.</given-names></name>
<name><surname>Houlden</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Epileptic Phenotypes Associated with SNAREs and Related Synaptic Vesicle Exocytosis Machinery</article-title>
          <source>Front. Neurol.</source>
          <year>2021</year>
          <volume>12</volume>
          <fpage>806506</fpage>
          <pub-id pub-id-type="doi">10.3389/fneur.2021.806506</pub-id>
          <pub-id pub-id-type="pmid">35095745</pub-id>
        </element-citation>
      </ref>
      <ref id="B99-ijms-24-04223">
        <label>99.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wolking</surname><given-names>S.</given-names></name>
<name><surname>May</surname><given-names>P.</given-names></name>
<name><surname>Mei</surname><given-names>D.</given-names></name>
<name><surname>M&#xF8;ller</surname><given-names>R.S.</given-names></name>
<name><surname>Balestrini</surname><given-names>S.</given-names></name>
<name><surname>Helbig</surname><given-names>K.L.</given-names></name>
<name><surname>Altuzarra</surname><given-names>C.D.</given-names></name>
<name><surname>Chatron</surname><given-names>N.</given-names></name>
<name><surname>Kaiwar</surname><given-names>C.</given-names></name>
<name><surname>St&#xF6;hr</surname><given-names>K.</given-names></name>
<etal/>
</person-group>
          <article-title>Clinical spectrum of STX1B-related epileptic disorders</article-title>
          <source>Neurology</source>
          <year>2019</year>
          <volume>92</volume>
          <fpage>e1238</fpage>
          <lpage>e1249</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0000000000007089</pub-id>
          <pub-id pub-id-type="pmid">30737342</pub-id>
        </element-citation>
      </ref>
      <ref id="B100-ijms-24-04223">
        <label>100.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Str&#xF8;mme</surname><given-names>P.</given-names></name>
<name><surname>Mangelsdorf</surname><given-names>M.E.</given-names></name>
<name><surname>Shaw</surname><given-names>M.A.</given-names></name>
<name><surname>Lower</surname><given-names>K.M.</given-names></name>
<name><surname>Lewis</surname><given-names>S.M.</given-names></name>
<name><surname>Bruyere</surname><given-names>H.</given-names></name>
<name><surname>L&#xFC;tcherath</surname><given-names>V.</given-names></name>
<name><surname>Gedeon</surname><given-names>A.K.</given-names></name>
<name><surname>Wallace</surname><given-names>R.H.</given-names></name>
<name><surname>Scheffer</surname><given-names>I.E.</given-names></name>
<etal/>
</person-group>
          <article-title>Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy</article-title>
          <source>Nat. Genet.</source>
          <year>2002</year>
          <volume>30</volume>
          <fpage>441</fpage>
          <lpage>445</lpage>
          <pub-id pub-id-type="doi">10.1038/ng862</pub-id>
          <pub-id pub-id-type="pmid">11889467</pub-id>
        </element-citation>
      </ref>
      <ref id="B101-ijms-24-04223">
        <label>101.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Poeta</surname><given-names>L.</given-names></name>
<name><surname>Fusco</surname><given-names>F.</given-names></name>
<name><surname>Drongitis</surname><given-names>D.</given-names></name>
<name><surname>Shoubridge</surname><given-names>C.</given-names></name>
<name><surname>Manganelli</surname><given-names>G.</given-names></name>
<name><surname>Filosa</surname><given-names>S.</given-names></name>
<name><surname>Paciolla</surname><given-names>M.</given-names></name>
<name><surname>Courtney</surname><given-names>M.</given-names></name>
<name><surname>Collombat</surname><given-names>P.</given-names></name>
<name><surname>Lioi</surname><given-names>M.B.</given-names></name>
<etal/>
</person-group>
          <article-title>A regulatory path associated with X-linked intellectual disability and epilepsy links KDM5C to the polyalanine expansions in ARX</article-title>
          <source>Am. J. Hum. Genet.</source>
          <year>2013</year>
          <volume>92</volume>
          <fpage>114</fpage>
          <lpage>125</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.11.008</pub-id>
          <pub-id pub-id-type="pmid">23246292</pub-id>
        </element-citation>
      </ref>
      <ref id="B102-ijms-24-04223">
        <label>102.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Kato</surname><given-names>M.</given-names></name>
<name><surname>Saitoh</surname><given-names>S.</given-names></name>
<name><surname>Kamei</surname><given-names>A.</given-names></name>
<name><surname>Shiraishi</surname><given-names>H.</given-names></name>
<name><surname>Ueda</surname><given-names>Y.</given-names></name>
<name><surname>Akasaka</surname><given-names>M.</given-names></name>
<name><surname>Tohyama</surname><given-names>J.</given-names></name>
<name><surname>Akasaka</surname><given-names>N.</given-names></name>
<name><surname>Hayasaka</surname><given-names>K.</given-names></name>
</person-group>
          <article-title>A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome)</article-title>
          <source>Am. J. Hum. Genet.</source>
          <year>2007</year>
          <volume>81</volume>
          <fpage>361</fpage>
          <lpage>366</lpage>
          <pub-id pub-id-type="doi">10.1086/518903</pub-id>
          <pub-id pub-id-type="pmid">17668384</pub-id>
        </element-citation>
      </ref>
      <ref id="B103-ijms-24-04223">
        <label>103.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Van Esch</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>MECP2 Duplication Syndrome</article-title>
          <source>Mol. Syndromol.</source>
          <year>2012</year>
          <volume>2</volume>
          <fpage>128</fpage>
          <lpage>136</lpage>
          <pub-id pub-id-type="doi">10.1159/000329580</pub-id>
          <pub-id pub-id-type="pmid">22679399</pub-id>
        </element-citation>
      </ref>
      <ref id="B104-ijms-24-04223">
        <label>104.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Vignoli</surname><given-names>A.</given-names></name>
<name><surname>Borgatti</surname><given-names>R.</given-names></name>
<name><surname>Peron</surname><given-names>A.</given-names></name>
<name><surname>Zucca</surname><given-names>C.</given-names></name>
<name><surname>Ballarati</surname><given-names>L.</given-names></name>
<name><surname>Bonaglia</surname><given-names>C.</given-names></name>
<name><surname>Bellini</surname><given-names>M.</given-names></name>
<name><surname>Giordano</surname><given-names>L.</given-names></name>
<name><surname>Romaniello</surname><given-names>R.</given-names></name>
<name><surname>Bedeschi</surname><given-names>M.F.</given-names></name>
<etal/>
</person-group>
          <article-title>Electroclinical pattern in MECP2 duplication syndrome: Eight new reported cases and review of literature</article-title>
          <source>Epilepsia</source>
          <year>2012</year>
          <volume>53</volume>
          <fpage>1146</fpage>
          <lpage>1155</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03501.x</pub-id>
          <pub-id pub-id-type="pmid">22578097</pub-id>
        </element-citation>
      </ref>
      <ref id="B105-ijms-24-04223">
        <label>105.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sanchez</surname><given-names>R.E.A.</given-names></name>
<name><surname>Bussi</surname><given-names>I.L.</given-names></name>
<name><surname>Ben-Hamo</surname><given-names>M.</given-names></name>
<name><surname>Caldart</surname><given-names>C.S.</given-names></name>
<name><surname>Catterall</surname><given-names>W.A.</given-names></name>
<name><surname>De La Iglesia</surname><given-names>H.O.</given-names></name>
</person-group>
          <article-title>Circadian regulation of sleep in a pre-clinical model of Dravet syndrome: Dynamics of sleep stage and siesta re-entrainment</article-title>
          <source>Sleep</source>
          <year>2019</year>
          <volume>42</volume>
          <fpage>zsz173</fpage>
          <pub-id pub-id-type="doi">10.1093/sleep/zsz173</pub-id>
          <pub-id pub-id-type="pmid">31346614</pub-id>
        </element-citation>
      </ref>
      <ref id="B106-ijms-24-04223">
        <label>106.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ma</surname><given-names>Z.</given-names></name>
<name><surname>Eaton</surname><given-names>M.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Tu</surname><given-names>X.</given-names></name>
<name><surname>Shi</surname><given-names>Y.</given-names></name>
<name><surname>Que</surname><given-names>Z.</given-names></name>
<name><surname>Wettschurack</surname><given-names>K.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<etal/>
</person-group>
          <article-title>Deficiency of autism-related Scn2a gene in mice disrupts sleep patterns and circadian rhythms</article-title>
          <source>Neurobiol. Dis.</source>
          <year>2022</year>
          <volume>168</volume>
          <fpage>105690</fpage>
          <pub-id pub-id-type="doi">10.1016/j.nbd.2022.105690</pub-id>
          <pub-id pub-id-type="pmid">35301122</pub-id>
        </element-citation>
      </ref>
      <ref id="B107-ijms-24-04223">
        <label>107.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wallace</surname><given-names>E.</given-names></name>
<name><surname>Wright</surname><given-names>S.</given-names></name>
<name><surname>Schoenike</surname><given-names>B.</given-names></name>
<name><surname>Roopra</surname><given-names>A.</given-names></name>
<name><surname>Rho</surname><given-names>J.M.</given-names></name>
<name><surname>Maganti</surname><given-names>R.K.</given-names></name>
</person-group>
          <article-title>Altered circadian rhythms and oscillation of clock genes and sirtuin 1 in a model of sudden unexpected death in epilepsy</article-title>
          <source>Epilepsia</source>
          <year>2018</year>
          <volume>59</volume>
          <fpage>1527</fpage>
          <lpage>1539</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.14513</pub-id>
          <pub-id pub-id-type="pmid">30009381</pub-id>
        </element-citation>
      </ref>
      <ref id="B108-ijms-24-04223">
        <label>108.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Hidalgo</surname><given-names>S.</given-names></name>
<name><surname>Campusano</surname><given-names>J.M.</given-names></name>
<name><surname>Hodge</surname><given-names>J.J.L.</given-names></name>
</person-group>
          <article-title>The Drosophila ortholog of the schizophrenia-associated CACNA1A and CACNA1B voltage-gated calcium channels regulate memory, sleep and circadian rhythms</article-title>
          <source>Neurobiol. Dis.</source>
          <year>2021</year>
          <volume>155</volume>
          <fpage>105394</fpage>
          <pub-id pub-id-type="doi">10.1016/j.nbd.2021.105394</pub-id>
          <pub-id pub-id-type="pmid">34015490</pub-id>
        </element-citation>
      </ref>
      <ref id="B109-ijms-24-04223">
        <label>109.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Mart&#xED;nez de Paz</surname><given-names>A.</given-names></name>
<name><surname>Sanchez-Mut</surname><given-names>J.V.</given-names></name>
<name><surname>Samitier-Mart&#xED;</surname><given-names>M.</given-names></name>
<name><surname>Petazzi</surname><given-names>P.</given-names></name>
<name><surname>S&#xE1;ez</surname><given-names>M.</given-names></name>
<name><surname>Szczesna</surname><given-names>K.</given-names></name>
<name><surname>Huertas</surname><given-names>D.</given-names></name>
<name><surname>Esteller</surname><given-names>M.</given-names></name>
<name><surname>Ausi&#xF3;</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Circadian cycle-dependent MeCP2 and brain chromatin changes</article-title>
          <source>PLoS ONE</source>
          <year>2015</year>
          <volume>10</volume>
          <elocation-id>e0123693</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0123693</pub-id>
          <pub-id pub-id-type="pmid">25875630</pub-id>
        </element-citation>
      </ref>
      <ref id="B110-ijms-24-04223">
        <label>110.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Autret</surname><given-names>A.</given-names></name>
<name><surname>Lucas</surname><given-names>B.</given-names></name>
<name><surname>Laffont</surname><given-names>F.</given-names></name>
<name><surname>Bertrand</surname><given-names>P.</given-names></name>
<name><surname>Degiovanni</surname><given-names>E.</given-names></name>
<name><surname>De Toffol</surname><given-names>B.</given-names></name>
</person-group>
          <article-title>Two distinct classifications of adult epilepsies: By time of seizures and by sensitivity of the interictal paroxysmal activities to sleep and waking</article-title>
          <source>Electroencephalogr. Clin. Neurophysiol.</source>
          <year>1987</year>
          <volume>66</volume>
          <fpage>211</fpage>
          <lpage>218</lpage>
          <pub-id pub-id-type="doi">10.1016/0013-4694(87)90069-1</pub-id>
          <pub-id pub-id-type="pmid">2434304</pub-id>
        </element-citation>
      </ref>
      <ref id="B111-ijms-24-04223">
        <label>111.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Karoly</surname><given-names>P.</given-names></name>
<name><surname>Goldenholz</surname><given-names>D.</given-names></name>
<name><surname>Freestone</surname><given-names>D.</given-names></name>
<name><surname>Moss</surname><given-names>R.</given-names></name>
<name><surname>Grayden</surname><given-names>D.</given-names></name>
<name><surname>Theodore</surname><given-names>W.</given-names></name>
<name><surname>Cook</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Circadian and circaseptan rhythms in human epilepsy: A retrospective cohort study</article-title>
          <source>Lancet Neurol.</source>
          <year>2018</year>
          <volume>17</volume>
          <fpage>977</fpage>
          <lpage>985</lpage>
          <pub-id pub-id-type="doi">10.1016/S1474-4422(18)30274-6</pub-id>
          <pub-id pub-id-type="pmid">30219655</pub-id>
        </element-citation>
      </ref>
      <ref id="B112-ijms-24-04223">
        <label>112.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Berg</surname><given-names>A.T.</given-names></name>
<name><surname>Berkovic</surname><given-names>S.F.</given-names></name>
<name><surname>Brodie</surname><given-names>M.J.</given-names></name>
<name><surname>Buchhalter</surname><given-names>J.</given-names></name>
<name><surname>Cross</surname><given-names>J.H.</given-names></name>
<name><surname>Van Emde Boas</surname><given-names>W.</given-names></name>
<name><surname>Engel</surname><given-names>J.</given-names></name>
<name><surname>French</surname><given-names>J.</given-names></name>
<name><surname>Glauser</surname><given-names>T.A.</given-names></name>
<name><surname>Mathern</surname><given-names>G.W.</given-names></name>
</person-group>
          <article-title>Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005&#x2013;2009</article-title>
          <source>Epilepsia</source>
          <year>2010</year>
          <volume>51</volume>
          <fpage>676</fpage>
          <lpage>685</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2010.02522.x</pub-id>
          <pub-id pub-id-type="pmid">20196795</pub-id>
        </element-citation>
      </ref>
      <ref id="B113-ijms-24-04223">
        <label>113.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Mirzoev</surname><given-names>A.</given-names></name>
<name><surname>Bercovici</surname><given-names>E.</given-names></name>
<name><surname>Stewart</surname><given-names>L.S.</given-names></name>
<name><surname>Cortez</surname><given-names>M.A.</given-names></name>
<name><surname>Snead</surname><given-names>O.C.</given-names><suffix>3rd</suffix></name>
<name><surname>Desrocher</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Circadian profiles of focal epileptic seizures: A need for reappraisal</article-title>
          <source>Seizure</source>
          <year>2012</year>
          <volume>21</volume>
          <fpage>412</fpage>
          <lpage>416</lpage>
          <pub-id pub-id-type="doi">10.1016/j.seizure.2012.03.014</pub-id>
          <pub-id pub-id-type="pmid">22537415</pub-id>
        </element-citation>
      </ref>
      <ref id="B114-ijms-24-04223">
        <label>114.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Scheffer</surname><given-names>I.E.</given-names></name>
<name><surname>Berkovic</surname><given-names>S.</given-names></name>
<name><surname>Capovilla</surname><given-names>G.</given-names></name>
<name><surname>Connolly</surname><given-names>M.B.</given-names></name>
<name><surname>French</surname><given-names>J.</given-names></name>
<name><surname>Guilhoto</surname><given-names>L.</given-names></name>
<name><surname>Hirsch</surname><given-names>E.</given-names></name>
<name><surname>Jain</surname><given-names>S.</given-names></name>
<name><surname>Mathern</surname><given-names>G.W.</given-names></name>
<name><surname>Mosh&#xE9;</surname><given-names>S.L.</given-names></name>
<etal/>
</person-group>
          <article-title>ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology</article-title>
          <source>Epilepsia</source>
          <year>2017</year>
          <volume>58</volume>
          <fpage>512</fpage>
          <lpage>521</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.13709</pub-id>
          <pub-id pub-id-type="pmid">28276062</pub-id>
        </element-citation>
      </ref>
      <ref id="B115-ijms-24-04223">
        <label>115.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Fisher</surname><given-names>R.S.</given-names></name>
<name><surname>Cross</surname><given-names>J.H.</given-names></name>
<name><surname>French</surname><given-names>J.A.</given-names></name>
<name><surname>Higurashi</surname><given-names>N.</given-names></name>
<name><surname>Hirsch</surname><given-names>E.</given-names></name>
<name><surname>Jansen</surname><given-names>F.E.</given-names></name>
<name><surname>Lagae</surname><given-names>L.</given-names></name>
<name><surname>Mosh&#xE9;</surname><given-names>S.L.</given-names></name>
<name><surname>Peltola</surname><given-names>J.</given-names></name>
<name><surname>Roulet Perez</surname><given-names>E.</given-names></name>
<etal/>
</person-group>
          <article-title>Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology</article-title>
          <source>Epilepsia</source>
          <year>2017</year>
          <volume>58</volume>
          <fpage>522</fpage>
          <lpage>530</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.13670</pub-id>
          <pub-id pub-id-type="pmid">28276060</pub-id>
        </element-citation>
      </ref>
      <ref id="B116-ijms-24-04223">
        <label>116.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Labate</surname><given-names>A.</given-names></name>
<name><surname>Ambrosio</surname><given-names>R.</given-names></name>
<name><surname>Gambardella</surname><given-names>A.</given-names></name>
<name><surname>Sturniolo</surname><given-names>M.</given-names></name>
<name><surname>Pucci</surname><given-names>F.</given-names></name>
<name><surname>Quattrone</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Usefulness of a morning routine EEG recording in patients with juvenile myoclonic epilepsy</article-title>
          <source>Epilepsy Res.</source>
          <year>2007</year>
          <volume>77</volume>
          <fpage>17</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2007.07.010</pub-id>
          <pub-id pub-id-type="pmid">17851038</pub-id>
        </element-citation>
      </ref>
      <ref id="B117-ijms-24-04223">
        <label>117.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Hofstra</surname><given-names>W.A.</given-names></name>
<name><surname>Spetgens</surname><given-names>W.P.</given-names></name>
<name><surname>Leijten</surname><given-names>F.S.</given-names></name>
<name><surname>Van Rijen</surname><given-names>P.C.</given-names></name>
<name><surname>Gosselaar</surname><given-names>P.</given-names></name>
<name><surname>Van Der Palen</surname><given-names>J.</given-names></name>
<name><surname>De Weerd</surname><given-names>A.W.</given-names></name>
</person-group>
          <article-title>Diurnal rhythms in seizures detected by intracranial electrocorticographic monitoring: An observational study</article-title>
          <source>Epilepsy Behav.</source>
          <year>2009</year>
          <volume>14</volume>
          <fpage>617</fpage>
          <lpage>621</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yebeh.2009.01.020</pub-id>
          <pub-id pub-id-type="pmid">19435581</pub-id>
        </element-citation>
      </ref>
      <ref id="B118-ijms-24-04223">
        <label>118.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Hofstra</surname><given-names>W.A.</given-names></name>
<name><surname>Grootemarsink</surname><given-names>B.E.</given-names></name>
<name><surname>Dieker</surname><given-names>R.</given-names></name>
<name><surname>Van Der Palen</surname><given-names>J.</given-names></name>
<name><surname>De Weerd</surname><given-names>A.W.</given-names></name>
</person-group>
          <article-title>Temporal distribution of clinical seizures over the 24-h day: A retrospective observational study in a tertiary epilepsy clinic</article-title>
          <source>Epilepsia</source>
          <year>2009</year>
          <volume>50</volume>
          <fpage>2019</fpage>
          <lpage>2026</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2009.02044.x</pub-id>
          <pub-id pub-id-type="pmid">19260943</pub-id>
        </element-citation>
      </ref>
      <ref id="B119-ijms-24-04223">
        <label>119.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Karafin</surname><given-names>M.</given-names></name>
<name><surname>St Louis</surname><given-names>E.K.</given-names></name>
<name><surname>Zimmerman</surname><given-names>M.B.</given-names></name>
<name><surname>Sparks</surname><given-names>J.D.</given-names></name>
<name><surname>Granner</surname><given-names>M.A.</given-names></name>
</person-group>
          <article-title>Bimodal ultradian seizure periodicity in human mesial temporal lobe epilepsy</article-title>
          <source>Seizure</source>
          <year>2010</year>
          <volume>19</volume>
          <fpage>347</fpage>
          <lpage>351</lpage>
          <pub-id pub-id-type="doi">10.1016/j.seizure.2010.05.005</pub-id>
          <pub-id pub-id-type="pmid">20580271</pub-id>
        </element-citation>
      </ref>
      <ref id="B120-ijms-24-04223">
        <label>120.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Spencer</surname><given-names>D.C.</given-names></name>
<name><surname>Sun</surname><given-names>F.T.</given-names></name>
<name><surname>Brown</surname><given-names>S.N.</given-names></name>
<name><surname>Jobst</surname><given-names>B.C.</given-names></name>
<name><surname>Fountain</surname><given-names>N.B.</given-names></name>
<name><surname>Wong</surname><given-names>V.S.</given-names></name>
<name><surname>Mirro</surname><given-names>E.A.</given-names></name>
<name><surname>Quigg</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Circadian and ultradian patterns of epileptiform discharges differ by seizure-onset location during long-term ambulatory intracranial monitoring</article-title>
          <source>Epilepsia</source>
          <year>2016</year>
          <volume>57</volume>
          <fpage>1495</fpage>
          <lpage>1502</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.13455</pub-id>
          <pub-id pub-id-type="pmid">27396544</pub-id>
        </element-citation>
      </ref>
      <ref id="B121-ijms-24-04223">
        <label>121.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Daley</surname><given-names>J.T.</given-names></name>
<name><surname>DeWolfe</surname><given-names>J.L.</given-names></name>
</person-group>
          <article-title>Sleep, Circadian Rhythms, and Epilepsy</article-title>
          <source>Curr. Treat. Options Neurol.</source>
          <year>2018</year>
          <volume>20</volume>
          <fpage>47</fpage>
          <pub-id pub-id-type="doi">10.1007/s11940-018-0534-1</pub-id>
          <pub-id pub-id-type="pmid">30259254</pub-id>
        </element-citation>
      </ref>
      <ref id="B122-ijms-24-04223">
        <label>122.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Leguia</surname><given-names>M.G.</given-names></name>
<name><surname>Andrzejak</surname><given-names>R.G.</given-names></name>
<name><surname>Rummel</surname><given-names>C.</given-names></name>
<name><surname>Fan</surname><given-names>J.M.</given-names></name>
<name><surname>Mirro</surname><given-names>E.A.</given-names></name>
<name><surname>Tcheng</surname><given-names>T.K.</given-names></name>
<name><surname>Rao</surname><given-names>V.R.</given-names></name>
<name><surname>Baud</surname><given-names>M.O.</given-names></name>
</person-group>
          <article-title>Seizure Cycles in Focal Epilepsy</article-title>
          <source>JAMA Neurol.</source>
          <year>2021</year>
          <volume>78</volume>
          <fpage>454</fpage>
          <lpage>463</lpage>
          <pub-id pub-id-type="doi">10.1001/jamaneurol.2020.5370</pub-id>
          <pub-id pub-id-type="pmid">33555292</pub-id>
        </element-citation>
      </ref>
      <ref id="B123-ijms-24-04223">
        <label>123.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Baud</surname><given-names>M.O.</given-names></name>
<name><surname>Kleen</surname><given-names>J.K.</given-names></name>
<name><surname>Mirro</surname><given-names>E.A.</given-names></name>
<name><surname>Andrechak</surname><given-names>J.C.</given-names></name>
<name><surname>King-Stephens</surname><given-names>D.</given-names></name>
<name><surname>Chang</surname><given-names>E.F.</given-names></name>
<name><surname>Rao</surname><given-names>V.R.</given-names></name>
</person-group>
          <article-title>Multi-day rhythms modulate seizure risk in epilepsy</article-title>
          <source>Nat. Commun.</source>
          <year>2018</year>
          <volume>9</volume>
          <fpage>88</fpage>
          <pub-id pub-id-type="doi">10.1038/s41467-017-02577-y</pub-id>
          <pub-id pub-id-type="pmid">29311566</pub-id>
        </element-citation>
      </ref>
      <ref id="B124-ijms-24-04223">
        <label>124.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gregg</surname><given-names>N.M.</given-names></name>
<name><surname>Nasseri</surname><given-names>M.</given-names></name>
<name><surname>Kremen</surname><given-names>V.</given-names></name>
<name><surname>Patterson</surname><given-names>E.E.</given-names></name>
<name><surname>Sturges</surname><given-names>B.K.</given-names></name>
<name><surname>Denison</surname><given-names>T.J.</given-names></name>
<name><surname>Brinkmann</surname><given-names>B.H.</given-names></name>
<name><surname>Worrell</surname><given-names>G.A.</given-names></name>
</person-group>
          <article-title>Circadian and multiday seizure periodicities, and seizure clusters in canine epilepsy</article-title>
          <source>Brain Commun.</source>
          <year>2020</year>
          <volume>2</volume>
          <fpage>fcaa008</fpage>
          <pub-id pub-id-type="doi">10.1093/braincomms/fcaa008</pub-id>
          <pub-id pub-id-type="pmid">32161910</pub-id>
        </element-citation>
      </ref>
      <ref id="B125-ijms-24-04223">
        <label>125.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ronkainen</surname><given-names>E.</given-names></name>
<name><surname>Ansakorpi</surname><given-names>H.</given-names></name>
<name><surname>Huikuri</surname><given-names>H.V.</given-names></name>
<name><surname>Myllyl&#xE4;</surname><given-names>V.V.</given-names></name>
<name><surname>Isoj&#xE4;rvi</surname><given-names>J.I.</given-names></name>
<name><surname>Korpelainen</surname><given-names>J.T.</given-names></name>
</person-group>
          <article-title>Suppressed circadian heart rate dynamics in temporal lobe epilepsy</article-title>
          <source>J. Neurol. Neurosurg. Psychiatry</source>
          <year>2005</year>
          <volume>76</volume>
          <fpage>1382</fpage>
          <lpage>1386</lpage>
          <pub-id pub-id-type="doi">10.1136/jnnp.2004.053777</pub-id>
          <pub-id pub-id-type="pmid">16170081</pub-id>
        </element-citation>
      </ref>
      <ref id="B126-ijms-24-04223">
        <label>126.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Schapel</surname><given-names>G.J.</given-names></name>
<name><surname>Beran</surname><given-names>R.G.</given-names></name>
<name><surname>Kennaway</surname><given-names>D.L.</given-names></name>
<name><surname>McLoughney</surname><given-names>J.</given-names></name>
<name><surname>Matthews</surname><given-names>C.D.</given-names></name>
</person-group>
          <article-title>Melatonin response in active epilepsy</article-title>
          <source>Epilepsia</source>
          <year>1995</year>
          <volume>36</volume>
          <fpage>75</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1157.1995.tb01669.x</pub-id>
          <pub-id pub-id-type="pmid">8001514</pub-id>
        </element-citation>
      </ref>
      <ref id="B127-ijms-24-04223">
        <label>127.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Quigg</surname><given-names>M.</given-names></name>
<name><surname>Straume</surname><given-names>M.</given-names></name>
<name><surname>Menaker</surname><given-names>M.</given-names></name>
<name><surname>Bertram</surname><given-names>E.H.</given-names><suffix>3rd</suffix></name>
</person-group>
          <article-title>Temporal distribution of partial seizures: Comparison of an animal model with human partial epilepsy</article-title>
          <source>Ann. Neurol.</source>
          <year>1998</year>
          <volume>43</volume>
          <fpage>748</fpage>
          <lpage>755</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.410430609</pub-id>
          <pub-id pub-id-type="pmid">9629844</pub-id>
        </element-citation>
      </ref>
      <ref id="B128-ijms-24-04223">
        <label>128.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Crnko</surname><given-names>S.</given-names></name>
<name><surname>Du Pr&#xE9;</surname><given-names>B.C.</given-names></name>
<name><surname>Sluijter</surname><given-names>J.P.G.</given-names></name>
<name><surname>Van Laake</surname><given-names>L.W.</given-names></name>
</person-group>
          <article-title>Circadian rhythms and the molecular clock in cardiovascular biology and disease</article-title>
          <source>Nat. Rev. Cardiol.</source>
          <year>2019</year>
          <volume>16</volume>
          <fpage>437</fpage>
          <lpage>447</lpage>
          <pub-id pub-id-type="doi">10.1038/s41569-019-0167-4</pub-id>
          <pub-id pub-id-type="pmid">30796369</pub-id>
        </element-citation>
      </ref>
      <ref id="B129-ijms-24-04223">
        <label>129.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wang</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Perfect timing: A Nobel Prize in Physiology or Medicine for circadian clocks</article-title>
          <source>Sci. Bull.</source>
          <year>2018</year>
          <volume>63</volume>
          <fpage>398</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="doi">10.1016/j.scib.2018.02.009</pub-id>
        </element-citation>
      </ref>
      <ref id="B130-ijms-24-04223">
        <label>130.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Fagiani</surname><given-names>F.</given-names></name>
<name><surname>Di Marino</surname><given-names>D.</given-names></name>
<name><surname>Romagnoli</surname><given-names>A.</given-names></name>
<name><surname>Travelli</surname><given-names>C.</given-names></name>
<name><surname>Voltan</surname><given-names>D.</given-names></name>
<name><surname>Di Cesare Mannelli</surname><given-names>L.</given-names></name>
<name><surname>Racchi</surname><given-names>M.</given-names></name>
<name><surname>Govoni</surname><given-names>S.</given-names></name>
<name><surname>Lanni</surname><given-names>C.</given-names></name>
</person-group>
          <article-title>Molecular regulations of circadian rhythm and implications for physiology and diseases</article-title>
          <source>Signal Transduct. Target. Ther.</source>
          <year>2022</year>
          <volume>7</volume>
          <fpage>41</fpage>
          <pub-id pub-id-type="doi">10.1038/s41392-022-00899-y</pub-id>
          <pub-id pub-id-type="pmid">35136018</pub-id>
        </element-citation>
      </ref>
      <ref id="B131-ijms-24-04223">
        <label>131.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lee</surname><given-names>Y.</given-names></name>
<name><surname>Field</surname><given-names>J.M.</given-names></name>
<name><surname>Sehgal</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Circadian Rhythms, Disease and Chronotherapy</article-title>
          <source>J. Biol. Rhythm.</source>
          <year>2021</year>
          <volume>36</volume>
          <fpage>503</fpage>
          <lpage>531</lpage>
          <pub-id pub-id-type="doi">10.1177/07487304211044301</pub-id>
        </element-citation>
      </ref>
      <ref id="B132-ijms-24-04223">
        <label>132.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Buijs</surname><given-names>F.N.</given-names></name>
<name><surname>Le&#xF3;n-Mercado</surname><given-names>L.</given-names></name>
<name><surname>Guzm&#xE1;n-Ruiz</surname><given-names>M.</given-names></name>
<name><surname>Guerrero-Vargas</surname><given-names>N.N.</given-names></name>
<name><surname>Romo-Nava</surname><given-names>F.</given-names></name>
<name><surname>Buijs</surname><given-names>R.M.</given-names></name>
</person-group>
          <article-title>The Circadian System: A Regulatory Feedback Network of Periphery and Brain</article-title>
          <source>Physiology</source>
          <year>2016</year>
          <volume>31</volume>
          <fpage>170</fpage>
          <lpage>181</lpage>
          <pub-id pub-id-type="doi">10.1152/physiol.00037.2015</pub-id>
          <pub-id pub-id-type="pmid">27053731</pub-id>
        </element-citation>
      </ref>
      <ref id="B133-ijms-24-04223">
        <label>133.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Shin-ichi</surname><given-names>T.I.</given-names></name>
<name><surname>Kawamura</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Characteristics of a circadian pacemaker in the suprachiasmatic nucleus</article-title>
          <source>J. Comp. Physiol.</source>
          <year>1982</year>
          <volume>146</volume>
          <fpage>153</fpage>
          <lpage>160</lpage>
        </element-citation>
      </ref>
      <ref id="B134-ijms-24-04223">
        <label>134.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Schwartz</surname><given-names>W.J.</given-names></name>
<name><surname>Reppert</surname><given-names>S.M.</given-names></name>
<name><surname>Eagan</surname><given-names>S.M.</given-names></name>
<name><surname>Moore-Ede</surname><given-names>M.C.</given-names></name>
</person-group>
          <article-title>In vivo metabolic activity of the suprachiasmatic nuclei: A comparative study</article-title>
          <source>Brain Res.</source>
          <year>1983</year>
          <volume>274</volume>
          <fpage>184</fpage>
          <lpage>187</lpage>
          <pub-id pub-id-type="doi">10.1016/0006-8993(83)90538-3</pub-id>
          <pub-id pub-id-type="pmid">6684493</pub-id>
        </element-citation>
      </ref>
      <ref id="B135-ijms-24-04223">
        <label>135.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lucas</surname><given-names>R.J.</given-names></name>
<name><surname>Peirson</surname><given-names>S.N.</given-names></name>
<name><surname>Berson</surname><given-names>D.M.</given-names></name>
<name><surname>Brown</surname><given-names>T.M.</given-names></name>
<name><surname>Cooper</surname><given-names>H.M.</given-names></name>
<name><surname>Czeisler</surname><given-names>C.A.</given-names></name>
<name><surname>Figueiro</surname><given-names>M.G.</given-names></name>
<name><surname>Gamlin</surname><given-names>P.D.</given-names></name>
<name><surname>Lockley</surname><given-names>S.W.</given-names></name>
<name><surname>O&#x2019;Hagan</surname><given-names>J.B.</given-names></name>
<etal/>
</person-group>
          <article-title>Measuring and using light in the melanopsin age</article-title>
          <source>Trends Neurosci.</source>
          <year>2014</year>
          <volume>37</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tins.2013.10.004</pub-id>
          <pub-id pub-id-type="pmid">24287308</pub-id>
        </element-citation>
      </ref>
      <ref id="B136-ijms-24-04223">
        <label>136.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Bilu</surname><given-names>C.</given-names></name>
<name><surname>Kronfeld-Schor</surname><given-names>N.</given-names></name>
</person-group>
          <article-title>Effects of circadian phase and melatonin injection on anxiety-like behavior in nocturnal and diurnal rodents</article-title>
          <source>Chronobiol. Int.</source>
          <year>2013</year>
          <volume>30</volume>
          <fpage>828</fpage>
          <lpage>836</lpage>
          <pub-id pub-id-type="doi">10.3109/07420528.2013.773439</pub-id>
          <pub-id pub-id-type="pmid">23750894</pub-id>
        </element-citation>
      </ref>
      <ref id="B137-ijms-24-04223">
        <label>137.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Vivanco</surname><given-names>P.</given-names></name>
<name><surname>Ortiz</surname><given-names>V.</given-names></name>
<name><surname>Rol</surname><given-names>M.A.</given-names></name>
<name><surname>Madrid</surname><given-names>J.A.</given-names></name>
</person-group>
          <article-title>Looking for the keys to diurnality downstream from the circadian clock: Role of melatonin in a dual-phasing rodent, Octodon degus</article-title>
          <source>J. Pineal Res.</source>
          <year>2007</year>
          <volume>42</volume>
          <fpage>280</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-079X.2007.00418.x</pub-id>
          <pub-id pub-id-type="pmid">17349027</pub-id>
        </element-citation>
      </ref>
      <ref id="B138-ijms-24-04223">
        <label>138.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Partch</surname><given-names>C.L.</given-names></name>
<name><surname>Green</surname><given-names>C.B.</given-names></name>
<name><surname>Takahashi</surname><given-names>J.S.</given-names></name>
</person-group>
          <article-title>Molecular architecture of the mammalian circadian clock</article-title>
          <source>Trends Cell Biol.</source>
          <year>2014</year>
          <volume>24</volume>
          <fpage>90</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tcb.2013.07.002</pub-id>
          <pub-id pub-id-type="pmid">23916625</pub-id>
        </element-citation>
      </ref>
      <ref id="B139-ijms-24-04223">
        <label>139.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Brown</surname><given-names>S.A.</given-names></name>
<name><surname>Azzi</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Peripheral circadian oscillators in mammals</article-title>
          <source>Handb. Exp. Pharmacol.</source>
          <year>2013</year>
          <volume>217</volume>
          <fpage>45</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1007/978-3-642-25950-0_3</pub-id>
        </element-citation>
      </ref>
      <ref id="B140-ijms-24-04223">
        <label>140.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gerstner</surname><given-names>J.R.</given-names></name>
<name><surname>Smith</surname><given-names>G.G.</given-names></name>
<name><surname>Lenz</surname><given-names>O.</given-names></name>
<name><surname>Perron</surname><given-names>I.J.</given-names></name>
<name><surname>Buono</surname><given-names>R.J.</given-names></name>
<name><surname>Ferraro</surname><given-names>T.N.</given-names></name>
</person-group>
          <article-title>BMAL1 controls the diurnal rhythm and set point for electrical seizure threshold in mice</article-title>
          <source>Front. Syst. Neurosci.</source>
          <year>2014</year>
          <volume>8</volume>
          <fpage>121</fpage>
          <pub-id pub-id-type="doi">10.3389/fnsys.2014.00121</pub-id>
          <pub-id pub-id-type="pmid">25018707</pub-id>
        </element-citation>
      </ref>
      <ref id="B141-ijms-24-04223">
        <label>141.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Li</surname><given-names>P.</given-names></name>
<name><surname>Fu</surname><given-names>X.</given-names></name>
<name><surname>Smith</surname><given-names>N.A.</given-names></name>
<name><surname>Ziobro</surname><given-names>J.</given-names></name>
<name><surname>Curiel</surname><given-names>J.</given-names></name>
<name><surname>Tenga</surname><given-names>M.J.</given-names></name>
<name><surname>Martin</surname><given-names>B.</given-names></name>
<name><surname>Freedman</surname><given-names>S.</given-names></name>
<name><surname>Cea-Del Rio</surname><given-names>C.A.</given-names></name>
<name><surname>Oboti</surname><given-names>L.</given-names></name>
<etal/>
</person-group>
          <article-title>Loss of CLOCK Results in Dysfunction of Brain Circuits Underlying Focal Epilepsy</article-title>
          <source>Neuron</source>
          <year>2017</year>
          <volume>96</volume>
          <fpage>387</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2017.09.044</pub-id>
          <pub-id pub-id-type="pmid">29024662</pub-id>
        </element-citation>
      </ref>
      <ref id="B142-ijms-24-04223">
        <label>142.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gekakis</surname><given-names>N.</given-names></name>
<name><surname>Staknis</surname><given-names>D.</given-names></name>
<name><surname>Nguyen</surname><given-names>H.B.</given-names></name>
<name><surname>Davis</surname><given-names>F.C.</given-names></name>
<name><surname>Wilsbacher</surname><given-names>L.D.</given-names></name>
<name><surname>King</surname><given-names>D.P.</given-names></name>
<name><surname>Takahashi</surname><given-names>J.S.</given-names></name>
<name><surname>Weitz</surname><given-names>C.J.</given-names></name>
</person-group>
          <article-title>Role of the CLOCK protein in the mammalian circadian mechanism</article-title>
          <source>Science</source>
          <year>1998</year>
          <volume>280</volume>
          <fpage>1564</fpage>
          <lpage>1569</lpage>
          <pub-id pub-id-type="doi">10.1126/science.280.5369.1564</pub-id>
          <pub-id pub-id-type="pmid">9616112</pub-id>
        </element-citation>
      </ref>
      <ref id="B143-ijms-24-04223">
        <label>143.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sato</surname><given-names>T.K.</given-names></name>
<name><surname>Yamada</surname><given-names>R.G.</given-names></name>
<name><surname>Ukai</surname><given-names>H.</given-names></name>
<name><surname>Baggs</surname><given-names>J.E.</given-names></name>
<name><surname>Miraglia</surname><given-names>L.J.</given-names></name>
<name><surname>Kobayashi</surname><given-names>T.J.</given-names></name>
<name><surname>Welsh</surname><given-names>D.K.</given-names></name>
<name><surname>Kay</surname><given-names>S.A.</given-names></name>
<name><surname>Ueda</surname><given-names>H.R.</given-names></name>
<name><surname>Hogenesch</surname><given-names>J.B.</given-names></name>
</person-group>
          <article-title>Feedback repression is required for mammalian circadian clock function</article-title>
          <source>Nat. Genet.</source>
          <year>2006</year>
          <volume>38</volume>
          <fpage>312</fpage>
          <lpage>319</lpage>
          <pub-id pub-id-type="doi">10.1038/ng1745</pub-id>
          <pub-id pub-id-type="pmid">16474406</pub-id>
        </element-citation>
      </ref>
      <ref id="B144-ijms-24-04223">
        <label>144.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gachon</surname><given-names>F.</given-names></name>
<name><surname>Fonjallaz</surname><given-names>P.</given-names></name>
<name><surname>Damiola</surname><given-names>F.</given-names></name>
<name><surname>Gos</surname><given-names>P.</given-names></name>
<name><surname>Kodama</surname><given-names>T.</given-names></name>
<name><surname>Zakany</surname><given-names>J.</given-names></name>
<name><surname>Duboule</surname><given-names>D.</given-names></name>
<name><surname>Petit</surname><given-names>B.</given-names></name>
<name><surname>Tafti</surname><given-names>M.</given-names></name>
<name><surname>Schibler</surname><given-names>U.</given-names></name>
</person-group>
          <article-title>The loss of circadian PAR bZip transcription factors results in epilepsy</article-title>
          <source>Genes Dev.</source>
          <year>2004</year>
          <volume>18</volume>
          <fpage>1397</fpage>
          <lpage>1412</lpage>
          <pub-id pub-id-type="doi">10.1101/gad.301404</pub-id>
          <pub-id pub-id-type="pmid">15175240</pub-id>
        </element-citation>
      </ref>
      <ref id="B145-ijms-24-04223">
        <label>145.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ueda</surname><given-names>H.R.</given-names></name>
<name><surname>Hayashi</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>W.</given-names></name>
<name><surname>Sano</surname><given-names>M.</given-names></name>
<name><surname>Machida</surname><given-names>M.</given-names></name>
<name><surname>Shigeyoshi</surname><given-names>Y.</given-names></name>
<name><surname>Iino</surname><given-names>M.</given-names></name>
<name><surname>Hashimoto</surname><given-names>S.</given-names></name>
</person-group>
          <article-title>System-level identification of transcriptional circuits underlying mammalian circadian clocks</article-title>
          <source>Nat. Genet.</source>
          <year>2005</year>
          <volume>37</volume>
          <fpage>187</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="doi">10.1038/ng1504</pub-id>
          <pub-id pub-id-type="pmid">15665827</pub-id>
        </element-citation>
      </ref>
      <ref id="B146-ijms-24-04223">
        <label>146.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ukai-Tadenuma</surname><given-names>M.</given-names></name>
<name><surname>Yamada</surname><given-names>R.G.</given-names></name>
<name><surname>Xu</surname><given-names>H.</given-names></name>
<name><surname>Ripperger</surname><given-names>J.A.</given-names></name>
<name><surname>Liu</surname><given-names>A.C.</given-names></name>
<name><surname>Ueda</surname><given-names>H.R.</given-names></name>
</person-group>
          <article-title>Delay in feedback repression by cryptochrome 1 is required for circadian clock function</article-title>
          <source>Cell</source>
          <year>2011</year>
          <volume>144</volume>
          <fpage>268</fpage>
          <lpage>281</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2010.12.019</pub-id>
          <pub-id pub-id-type="pmid">21236481</pub-id>
        </element-citation>
      </ref>
      <ref id="B147-ijms-24-04223">
        <label>147.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Minami</surname><given-names>Y.</given-names></name>
<name><surname>Ode</surname><given-names>K.L.</given-names></name>
<name><surname>Ueda</surname><given-names>H.R.</given-names></name>
</person-group>
          <article-title>Mammalian circadian clock: The roles of transcriptional repression and delay</article-title>
          <source>Handb. Exp. Pharmacol.</source>
          <year>2013</year>
          <volume>217</volume>
          <fpage>359</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="doi">10.1007/978-3-642-25950-0_15</pub-id>
        </element-citation>
      </ref>
      <ref id="B148-ijms-24-04223">
        <label>148.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lipton</surname><given-names>J.O.</given-names></name>
<name><surname>Yuan</surname><given-names>E.D.</given-names></name>
<name><surname>Boyle</surname><given-names>L.M.</given-names></name>
<name><surname>Ebrahimi-Fakhari</surname><given-names>D.</given-names></name>
<name><surname>Kwiatkowski</surname><given-names>E.</given-names></name>
<name><surname>Nathan</surname><given-names>A.</given-names></name>
<name><surname>Guttler</surname><given-names>T.</given-names></name>
<name><surname>Davis</surname><given-names>F.</given-names></name>
<name><surname>Asara</surname><given-names>J.M.</given-names></name>
<name><surname>Sahin</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>The Circadian Protein BMAL1 Regulates Translation in Response to S6K1-Mediated Phosphorylation</article-title>
          <source>Cell</source>
          <year>2015</year>
          <volume>161</volume>
          <fpage>1138</fpage>
          <lpage>1151</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2015.04.002</pub-id>
          <pub-id pub-id-type="pmid">25981667</pub-id>
        </element-citation>
      </ref>
      <ref id="B149-ijms-24-04223">
        <label>149.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ramanathan</surname><given-names>C.</given-names></name>
<name><surname>Kathale</surname><given-names>N.D.</given-names></name>
<name><surname>Liu</surname><given-names>D.</given-names></name>
<name><surname>Lee</surname><given-names>C.</given-names></name>
<name><surname>Freeman</surname><given-names>D.A.</given-names></name>
<name><surname>Hogenesch</surname><given-names>J.B.</given-names></name>
<name><surname>Cao</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>mTOR signaling regulates central and peripheral circadian clock function</article-title>
          <source>PLoS Genet.</source>
          <year>2018</year>
          <volume>14</volume>
          <elocation-id>e1007369</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1007369</pub-id>
          <pub-id pub-id-type="pmid">29750810</pub-id>
        </element-citation>
      </ref>
      <ref id="B150-ijms-24-04223">
        <label>150.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Liu</surname><given-names>D.</given-names></name>
<name><surname>Stowie</surname><given-names>A.</given-names></name>
<name><surname>De Zavalia</surname><given-names>N.</given-names></name>
<name><surname>Leise</surname><given-names>T.</given-names></name>
<name><surname>Pathak</surname><given-names>S.S.</given-names></name>
<name><surname>Drewes</surname><given-names>L.R.</given-names></name>
<name><surname>Davidson</surname><given-names>A.J.</given-names></name>
<name><surname>Amir</surname><given-names>S.</given-names></name>
<name><surname>Sonenberg</surname><given-names>N.</given-names></name>
<name><surname>Cao</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>mTOR signaling in VIP neurons regulates circadian clock synchrony and olfaction</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2018</year>
          <volume>115</volume>
          <fpage>E3296</fpage>
          <lpage>E3304</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1721578115</pub-id>
          <pub-id pub-id-type="pmid">29555746</pub-id>
        </element-citation>
      </ref>
      <ref id="B151-ijms-24-04223">
        <label>151.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Khan</surname><given-names>S.</given-names></name>
<name><surname>Nobili</surname><given-names>L.</given-names></name>
<name><surname>Khatami</surname><given-names>R.</given-names></name>
<name><surname>Loddenkemper</surname><given-names>T.</given-names></name>
<name><surname>Cajochen</surname><given-names>C.</given-names></name>
<name><surname>Dijk</surname><given-names>D.J.</given-names></name>
<name><surname>Eriksson</surname><given-names>S.H.</given-names></name>
</person-group>
          <article-title>Circadian rhythm and epilepsy</article-title>
          <source>Lancet Neurol.</source>
          <year>2018</year>
          <volume>17</volume>
          <fpage>1098</fpage>
          <lpage>1108</lpage>
          <pub-id pub-id-type="doi">10.1016/S1474-4422(18)30335-1</pub-id>
          <pub-id pub-id-type="pmid">30366868</pub-id>
        </element-citation>
      </ref>
      <ref id="B152-ijms-24-04223">
        <label>152.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sahar</surname><given-names>S.</given-names></name>
<name><surname>Zocchi</surname><given-names>L.</given-names></name>
<name><surname>Kinoshita</surname><given-names>C.</given-names></name>
<name><surname>Borrelli</surname><given-names>E.</given-names></name>
<name><surname>Sassone-Corsi</surname><given-names>P.</given-names></name>
</person-group>
          <article-title>Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation</article-title>
          <source>PLoS ONE</source>
          <year>2010</year>
          <volume>5</volume>
          <elocation-id>e8561</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0008561</pub-id>
          <pub-id pub-id-type="pmid">20049328</pub-id>
        </element-citation>
      </ref>
      <ref id="B153-ijms-24-04223">
        <label>153.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>S.K.</given-names></name>
<name><surname>Dakshinamurti</surname><given-names>K.</given-names></name>
</person-group>
          <article-title>Seizure activity in pyridoxine-deficient adult rats</article-title>
          <source>Epilepsia</source>
          <year>1992</year>
          <volume>33</volume>
          <fpage>235</fpage>
          <lpage>247</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1157.1992.tb02312.x</pub-id>
          <pub-id pub-id-type="pmid">1547753</pub-id>
        </element-citation>
      </ref>
      <ref id="B154-ijms-24-04223">
        <label>154.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wu</surname><given-names>H.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>Meng</surname><given-names>Q.</given-names></name>
<name><surname>Du</surname><given-names>C.</given-names></name>
<name><surname>Li</surname><given-names>K.</given-names></name>
<name><surname>Dong</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Decreased expression of the clock gene Bmal1 is involved in the pathogenesis of temporal lobe epilepsy</article-title>
          <source>Mol Brain</source>
          <year>2021</year>
          <volume>14</volume>
          <fpage>113</fpage>
          <pub-id pub-id-type="doi">10.1186/s13041-021-00824-4</pub-id>
          <pub-id pub-id-type="pmid">34261484</pub-id>
        </element-citation>
      </ref>
      <ref id="B155-ijms-24-04223">
        <label>155.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>T.</given-names></name>
<name><surname>Yu</surname><given-names>F.</given-names></name>
<name><surname>Xu</surname><given-names>H.</given-names></name>
<name><surname>Chen</surname><given-names>M.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Guo</surname><given-names>L.</given-names></name>
<name><surname>Zhou</surname><given-names>C.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>F.</given-names></name>
<name><surname>Yu</surname><given-names>J.</given-names></name>
<etal/>
</person-group>
          <article-title>Dysregulation of REV-ERB&#x3B1; impairs GABAergic function and promotes epileptic seizures in preclinical models</article-title>
          <source>Nat. Commun.</source>
          <year>2021</year>
          <volume>12</volume>
          <fpage>1216</fpage>
          <pub-id pub-id-type="doi">10.1038/s41467-021-21477-w</pub-id>
          <pub-id pub-id-type="pmid">33619249</pub-id>
        </element-citation>
      </ref>
      <ref id="B156-ijms-24-04223">
        <label>156.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ng</surname><given-names>M.</given-names></name>
<name><surname>Pavlova</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Why are seizures rare in rapid eye movement sleep? Review of the frequency of seizures in different sleep stages</article-title>
          <source>Epilepsy Res. Treat.</source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>932790</fpage>
          <pub-id pub-id-type="doi">10.1155/2013/932790</pub-id>
          <pub-id pub-id-type="pmid">23853720</pub-id>
        </element-citation>
      </ref>
      <ref id="B157-ijms-24-04223">
        <label>157.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Frauscher</surname><given-names>B.</given-names></name>
<name><surname>Von Ellenrieder</surname><given-names>N.</given-names></name>
<name><surname>Dubeau</surname><given-names>F.</given-names></name>
<name><surname>Gotman</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>EEG desynchronization during phasic REM sleep suppresses interictal epileptic activity in humans</article-title>
          <source>Epilepsia</source>
          <year>2016</year>
          <volume>57</volume>
          <fpage>879</fpage>
          <lpage>888</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.13389</pub-id>
          <pub-id pub-id-type="pmid">27112123</pub-id>
        </element-citation>
      </ref>
      <ref id="B158-ijms-24-04223">
        <label>158.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Saper</surname><given-names>C.B.</given-names></name>
<name><surname>Scammell</surname><given-names>T.E.</given-names></name>
<name><surname>Lu</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Hypothalamic regulation of sleep and circadian rhythms</article-title>
          <source>Nature</source>
          <year>2005</year>
          <volume>437</volume>
          <fpage>1257</fpage>
          <lpage>1263</lpage>
          <pub-id pub-id-type="doi">10.1038/nature04284</pub-id>
          <pub-id pub-id-type="pmid">16251950</pub-id>
        </element-citation>
      </ref>
      <ref id="B159-ijms-24-04223">
        <label>159.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Bazhenov</surname><given-names>M.</given-names></name>
<name><surname>Timofeev</surname><given-names>I.</given-names></name>
<name><surname>Steriade</surname><given-names>M.</given-names></name>
<name><surname>Sejnowski</surname><given-names>T.</given-names></name>
</person-group>
          <article-title>Spiking-bursting activity in the thalamic reticular nucleus initiates sequences of spindle oscillations in thalamic networks</article-title>
          <source>J. Neurophysiol.</source>
          <year>2000</year>
          <volume>84</volume>
          <fpage>1076</fpage>
          <lpage>1087</lpage>
          <pub-id pub-id-type="doi">10.1152/jn.2000.84.2.1076</pub-id>
          <pub-id pub-id-type="pmid">10938329</pub-id>
        </element-citation>
      </ref>
      <ref id="B160-ijms-24-04223">
        <label>160.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Minecan</surname><given-names>D.</given-names></name>
<name><surname>Natarajan</surname><given-names>A.</given-names></name>
<name><surname>Marzec</surname><given-names>M.</given-names></name>
<name><surname>Malow</surname><given-names>B.</given-names></name>
</person-group>
          <article-title>Relationship of epileptic seizures to sleep stage and sleep depth</article-title>
          <source>Sleep</source>
          <year>2002</year>
          <volume>25</volume>
          <fpage>899</fpage>
          <lpage>904</lpage>
          <pub-id pub-id-type="doi">10.1093/sleep/25.8.56</pub-id>
          <pub-id pub-id-type="pmid">12489898</pub-id>
        </element-citation>
      </ref>
      <ref id="B161-ijms-24-04223">
        <label>161.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Jin</surname><given-names>B.</given-names></name>
<name><surname>Hu</surname><given-names>W.</given-names></name>
<name><surname>Ye</surname><given-names>L.</given-names></name>
<name><surname>Krishnan</surname><given-names>B.</given-names></name>
<name><surname>Aung</surname><given-names>T.</given-names></name>
<name><surname>Jones</surname><given-names>S.E.</given-names></name>
<name><surname>Najm</surname><given-names>I.M.</given-names></name>
<name><surname>Alexopoulos</surname><given-names>A.V.</given-names></name>
<name><surname>Zhang</surname><given-names>K.</given-names></name>
<name><surname>Zhu</surname><given-names>J.</given-names></name>
<etal/>
</person-group>
          <article-title>Small Lesion Size Is Associated with Sleep-Related Epilepsy in Focal Cortical Dysplasia Type II</article-title>
          <source>Front. Neurol.</source>
          <year>2018</year>
          <volume>9</volume>
          <fpage>106</fpage>
          <pub-id pub-id-type="doi">10.3389/fneur.2018.00106</pub-id>
          <pub-id pub-id-type="pmid">29541057</pub-id>
        </element-citation>
      </ref>
      <ref id="B162-ijms-24-04223">
        <label>162.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Da Silva Louren&#xE7;o</surname><given-names>C.</given-names></name>
<name><surname>Tjepkema-Cloostermans</surname><given-names>M.C.</given-names></name>
<name><surname>Van Putten</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Machine learning for detection of interictal epileptiform discharges</article-title>
          <source>Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol.</source>
          <year>2021</year>
          <volume>132</volume>
          <fpage>1433</fpage>
          <lpage>1443</lpage>
          <pub-id pub-id-type="doi">10.1016/j.clinph.2021.02.403</pub-id>
          <pub-id pub-id-type="pmid">34023625</pub-id>
        </element-citation>
      </ref>
      <ref id="B163-ijms-24-04223">
        <label>163.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>De Berardis</surname><given-names>D.</given-names></name>
<name><surname>Orsolini</surname><given-names>L.</given-names></name>
<name><surname>Serroni</surname><given-names>N.</given-names></name>
<name><surname>Girinelli</surname><given-names>G.</given-names></name>
<name><surname>Iasevoli</surname><given-names>F.</given-names></name>
<name><surname>Tomasetti</surname><given-names>C.</given-names></name>
<name><surname>Mazza</surname><given-names>M.</given-names></name>
<name><surname>Valchera</surname><given-names>A.</given-names></name>
<name><surname>Fornaro</surname><given-names>M.</given-names></name>
<name><surname>Perna</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>The role of melatonin in mood disorders</article-title>
          <source>ChronoPhysiology Ther.</source>
          <year>2015</year>
          <volume>5</volume>
          <fpage>65</fpage>
          <pub-id pub-id-type="doi">10.2147/CPT.S41761</pub-id>
        </element-citation>
      </ref>
      <ref id="B164-ijms-24-04223">
        <label>164.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Bazil</surname><given-names>C.W.</given-names></name>
<name><surname>Short</surname><given-names>D.</given-names></name>
<name><surname>Crispin</surname><given-names>D.</given-names></name>
<name><surname>Zheng</surname><given-names>W.</given-names></name>
</person-group>
          <article-title>Patients with intractable epilepsy have low melatonin, which increases following seizures</article-title>
          <source>Neurology</source>
          <year>2000</year>
          <volume>55</volume>
          <fpage>1746</fpage>
          <lpage>1748</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.55.11.1746</pub-id>
          <pub-id pub-id-type="pmid">11113238</pub-id>
        </element-citation>
      </ref>
      <ref id="B165-ijms-24-04223">
        <label>165.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Molina-Carballo</surname><given-names>A.</given-names></name>
<name><surname>Acuna-Castroviejo</surname><given-names>D.</given-names></name>
<name><surname>Rodriguez-Cabezas</surname><given-names>T.</given-names></name>
<name><surname>Munoz-Hoyos</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Effects of febrile and epileptic convulsions on daily variations in plasma melatonin concentration in children</article-title>
          <source>J. Pineal Res.</source>
          <year>1994</year>
          <volume>16</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-079X.1994.tb00075.x</pub-id>
          <pub-id pub-id-type="pmid">8158517</pub-id>
        </element-citation>
      </ref>
      <ref id="B166-ijms-24-04223">
        <label>166.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Kothare</surname><given-names>S.V.</given-names></name>
<name><surname>Kaleyias</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Sleep and epilepsy in children and adolescents</article-title>
          <source>Sleep Med.</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>674</fpage>
          <lpage>685</lpage>
          <pub-id pub-id-type="doi">10.1016/j.sleep.2010.01.012</pub-id>
          <pub-id pub-id-type="pmid">20620102</pub-id>
        </element-citation>
      </ref>
      <ref id="B167-ijms-24-04223">
        <label>167.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Xu</surname><given-names>L.</given-names></name>
<name><surname>Guo</surname><given-names>D.</given-names></name>
<name><surname>Liu</surname><given-names>Y.Y.</given-names></name>
<name><surname>Qiao</surname><given-names>D.D.</given-names></name>
<name><surname>Ye</surname><given-names>J.Y.</given-names></name>
<name><surname>Xue</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>Juvenile myoclonic epilepsy and sleep</article-title>
          <source>Epilepsy Behav.</source>
          <year>2018</year>
          <volume>80</volume>
          <fpage>326</fpage>
          <lpage>330</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yebeh.2017.11.008</pub-id>
          <pub-id pub-id-type="pmid">29358100</pub-id>
        </element-citation>
      </ref>
      <ref id="B168-ijms-24-04223">
        <label>168.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Malow</surname><given-names>B.A.</given-names></name>
<name><surname>Levy</surname><given-names>K.</given-names></name>
<name><surname>Maturen</surname><given-names>K.</given-names></name>
<name><surname>Bowes</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>Obstructive sleep apnea is common in medically refractory epilepsy patients</article-title>
          <source>Neurology</source>
          <year>2000</year>
          <volume>55</volume>
          <fpage>1002</fpage>
          <lpage>1007</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.55.7.1002</pub-id>
          <pub-id pub-id-type="pmid">11061259</pub-id>
        </element-citation>
      </ref>
      <ref id="B169-ijms-24-04223">
        <label>169.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Dell</surname><given-names>K.L.</given-names></name>
<name><surname>Payne</surname><given-names>D.E.</given-names></name>
<name><surname>Kremen</surname><given-names>V.</given-names></name>
<name><surname>Maturana</surname><given-names>M.I.</given-names></name>
<name><surname>Gerla</surname><given-names>V.</given-names></name>
<name><surname>Nejedly</surname><given-names>P.</given-names></name>
<name><surname>Worrell</surname><given-names>G.A.</given-names></name>
<name><surname>Lenka</surname><given-names>L.</given-names></name>
<name><surname>Mivalt</surname><given-names>F.</given-names></name>
<name><surname>Boston</surname><given-names>R.C.</given-names></name>
<etal/>
</person-group>
          <article-title>Seizure likelihood varies with day-to-day variations in sleep duration in patients with refractory focal epilepsy: A longitudinal electroencephalography investigation</article-title>
          <source>EClinicalMedicine</source>
          <year>2021</year>
          <volume>37</volume>
          <fpage>100934</fpage>
          <pub-id pub-id-type="doi">10.1016/j.eclinm.2021.100934</pub-id>
          <pub-id pub-id-type="pmid">34386736</pub-id>
        </element-citation>
      </ref>
      <ref id="B170-ijms-24-04223">
        <label>170.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Staniszewska</surname><given-names>A.</given-names></name>
<name><surname>Maka</surname><given-names>A.</given-names></name>
<name><surname>Religioni</surname><given-names>U.</given-names></name>
<name><surname>Olejniczak</surname><given-names>D.</given-names></name>
</person-group>
          <article-title>Sleep disturbances among patients with epilepsy</article-title>
          <source>Neuropsychiatr. Dis. Treat.</source>
          <year>2017</year>
          <volume>13</volume>
          <fpage>1797</fpage>
          <lpage>1803</lpage>
          <pub-id pub-id-type="doi">10.2147/NDT.S136868</pub-id>
          <pub-id pub-id-type="pmid">28744129</pub-id>
        </element-citation>
      </ref>
      <ref id="B171-ijms-24-04223">
        <label>171.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Leschziner</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>Seizures and Sleep: Not such strange bedfellows</article-title>
          <source>Adv. Clin. Neurosci. Rehabil.</source>
          <year>2022</year>
          <volume>21</volume>
          <fpage>19</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.47795/QTGN2231</pub-id>
        </element-citation>
      </ref>
      <ref id="B172-ijms-24-04223">
        <label>172.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Bazil</surname><given-names>C.W.</given-names></name>
<name><surname>Castro</surname><given-names>L.H.</given-names></name>
<name><surname>Walczak</surname><given-names>T.S.</given-names></name>
</person-group>
          <article-title>Reduction of rapid eye movement sleep by diurnal and nocturnal seizures in temporal lobe epilepsy</article-title>
          <source>Arch. Neurol.</source>
          <year>2000</year>
          <volume>57</volume>
          <fpage>363</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.57.3.363</pub-id>
          <pub-id pub-id-type="pmid">10714662</pub-id>
        </element-citation>
      </ref>
      <ref id="B173-ijms-24-04223">
        <label>173.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gelinas</surname><given-names>J.N.</given-names></name>
<name><surname>Khodagholy</surname><given-names>D.</given-names></name>
<name><surname>Thesen</surname><given-names>T.</given-names></name>
<name><surname>Devinsky</surname><given-names>O.</given-names></name>
<name><surname>Buzs&#xE1;ki</surname><given-names>G.</given-names></name>
</person-group>
          <article-title>Interictal epileptiform discharges induce hippocampal-cortical coupling in temporal lobe epilepsy</article-title>
          <source>Nat. Med.</source>
          <year>2016</year>
          <volume>22</volume>
          <fpage>641</fpage>
          <lpage>648</lpage>
          <pub-id pub-id-type="doi">10.1038/nm.4084</pub-id>
          <pub-id pub-id-type="pmid">27111281</pub-id>
        </element-citation>
      </ref>
      <ref id="B174-ijms-24-04223">
        <label>174.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Mekky</surname><given-names>J.F.</given-names></name>
<name><surname>Elbhrawy</surname><given-names>S.M.</given-names></name>
<name><surname>Boraey</surname><given-names>M.F.</given-names></name>
<name><surname>Omar</surname><given-names>H.M.</given-names></name>
</person-group>
          <article-title>Sleep architecture in patients with Juvenile Myoclonic Epilepsy</article-title>
          <source>Sleep Med.</source>
          <year>2017</year>
          <volume>38</volume>
          <fpage>116</fpage>
          <lpage>121</lpage>
          <pub-id pub-id-type="doi">10.1016/j.sleep.2017.02.013</pub-id>
          <pub-id pub-id-type="pmid">29031745</pub-id>
        </element-citation>
      </ref>
      <ref id="B175-ijms-24-04223">
        <label>175.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Shvarts</surname><given-names>V.</given-names></name>
<name><surname>Chung</surname><given-names>S.</given-names></name>
</person-group>
          <article-title>Epilepsy, antiseizure therapy, and sleep cycle parameters</article-title>
          <source>Epilepsy Res. Treat.</source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>670682</fpage>
          <pub-id pub-id-type="doi">10.1155/2013/670682</pub-id>
          <pub-id pub-id-type="pmid">23997949</pub-id>
        </element-citation>
      </ref>
      <ref id="B176-ijms-24-04223">
        <label>176.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>L&#xF6;scher</surname><given-names>W.</given-names></name>
</person-group>
          <article-title>Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs</article-title>
          <source>Neurochem. Res.</source>
          <year>2017</year>
          <volume>42</volume>
          <fpage>1873</fpage>
          <lpage>1888</lpage>
          <pub-id pub-id-type="doi">10.1007/s11064-017-2222-z</pub-id>
          <pub-id pub-id-type="pmid">28290134</pub-id>
        </element-citation>
      </ref>
      <ref id="B177-ijms-24-04223">
        <label>177.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Marshall</surname><given-names>G.F.</given-names></name>
<name><surname>Gonzalez-Sulser</surname><given-names>A.</given-names></name>
<name><surname>Abbott</surname><given-names>C.M.</given-names></name>
</person-group>
          <article-title>Modelling epilepsy in the mouse: Challenges and solutions</article-title>
          <source>Dis. Model. Mech.</source>
          <year>2021</year>
          <volume>14</volume>
          <fpage>dmm047449</fpage>
          <pub-id pub-id-type="doi">10.1242/dmm.047449</pub-id>
          <pub-id pub-id-type="pmid">33619078</pub-id>
        </element-citation>
      </ref>
      <ref id="B178-ijms-24-04223">
        <label>178.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Porter</surname><given-names>R.J.</given-names></name>
<name><surname>Cereghino</surname><given-names>J.J.</given-names></name>
<name><surname>Gladding</surname><given-names>G.D.</given-names></name>
<name><surname>Hessie</surname><given-names>B.</given-names></name>
<name><surname>Kupferberg</surname><given-names>H.J.</given-names></name>
<name><surname>Scoville</surname><given-names>B.</given-names></name>
<name><surname>White</surname><given-names>B.G.</given-names></name>
</person-group>
          <article-title>Antiepileptic Drug Development Program</article-title>
          <source>Clevel. Clin. J. Med.</source>
          <year>1984</year>
          <volume>51</volume>
          <fpage>293</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="doi">10.3949/ccjm.51.2.293</pub-id>
        </element-citation>
      </ref>
      <ref id="B179-ijms-24-04223">
        <label>179.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Leclercq</surname><given-names>K.</given-names></name>
<name><surname>Afrikanova</surname><given-names>T.</given-names></name>
<name><surname>Langlois</surname><given-names>M.</given-names></name>
<name><surname>De Prins</surname><given-names>A.</given-names></name>
<name><surname>Buenafe</surname><given-names>O.E.</given-names></name>
<name><surname>Rospo</surname><given-names>C.C.</given-names></name>
<name><surname>Van Eeckhaut</surname><given-names>A.</given-names></name>
<name><surname>de Witte</surname><given-names>P.A.</given-names></name>
<name><surname>Crawford</surname><given-names>A.D.</given-names></name>
<name><surname>Smolders</surname><given-names>I.</given-names></name>
<etal/>
</person-group>
          <article-title>Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish</article-title>
          <source>Epilepsy Behav.</source>
          <year>2015</year>
          <volume>45</volume>
          <fpage>53</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yebeh.2015.03.019</pub-id>
          <pub-id pub-id-type="pmid">25845493</pub-id>
        </element-citation>
      </ref>
      <ref id="B180-ijms-24-04223">
        <label>180.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Baxendale</surname><given-names>S.</given-names></name>
<name><surname>Holdsworth</surname><given-names>C.J.</given-names></name>
<name><surname>Meza Santoscoy</surname><given-names>P.L.</given-names></name>
<name><surname>Harrison</surname><given-names>M.R.M.</given-names></name>
<name><surname>Fox</surname><given-names>J.</given-names></name>
<name><surname>Parkin</surname><given-names>C.A.</given-names></name>
<name><surname>Ingham</surname><given-names>P.W.</given-names></name>
<name><surname>Cunliffe</surname><given-names>V.T.</given-names></name>
</person-group>
          <article-title>Identification of compounds with anti-convulsant properties in a zebrafish model of epileptic seizures</article-title>
          <source>Dis. Model. Mech.</source>
          <year>2012</year>
          <volume>5</volume>
          <fpage>773</fpage>
          <lpage>784</lpage>
          <pub-id pub-id-type="doi">10.1242/dmm.010090</pub-id>
          <pub-id pub-id-type="pmid">22730455</pub-id>
        </element-citation>
      </ref>
      <ref id="B181-ijms-24-04223">
        <label>181.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Reza</surname><given-names>H.M.</given-names></name>
<name><surname>Mohammad</surname><given-names>H.</given-names></name>
<name><surname>Golnaz</surname><given-names>E.</given-names></name>
<name><surname>Gholamreza</surname><given-names>S.</given-names></name>
</person-group>
          <article-title>Effect of methanolic extract of Hyoscymus niger L. on the seizure induced by picritoxin in mice</article-title>
          <source>Pak. J. Pharm. Sci.</source>
          <year>2009</year>
          <volume>22</volume>
          <fpage>308</fpage>
          <lpage>312</lpage>
          <pub-id pub-id-type="pmid">19553180</pub-id>
        </element-citation>
      </ref>
      <ref id="B182-ijms-24-04223">
        <label>182.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Alfaro</surname><given-names>J.M.</given-names></name>
<name><surname>Ripoll-G&#xF3;mez</surname><given-names>J.</given-names></name>
<name><surname>Burgos</surname><given-names>J.S.</given-names></name>
</person-group>
          <article-title>Kainate administered to adult zebrafish causes seizures similar to those in rodent models</article-title>
          <source>Eur. J. Neurosci.</source>
          <year>2011</year>
          <volume>33</volume>
          <fpage>1252</fpage>
          <lpage>1255</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07622.x</pub-id>
          <pub-id pub-id-type="pmid">21375600</pub-id>
        </element-citation>
      </ref>
      <ref id="B183-ijms-24-04223">
        <label>183.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>L&#xE9;vesque</surname><given-names>M.</given-names></name>
<name><surname>Avoli</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>The kainic acid model of temporal lobe epilepsy</article-title>
          <source>Neurosci. Biobehav. Rev.</source>
          <year>2013</year>
          <volume>37</volume>
          <fpage>2887</fpage>
          <lpage>2899</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.10.011</pub-id>
          <pub-id pub-id-type="pmid">24184743</pub-id>
        </element-citation>
      </ref>
      <ref id="B184-ijms-24-04223">
        <label>184.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Debski</surname><given-names>K.J.</given-names></name>
<name><surname>Ceglia</surname><given-names>N.</given-names></name>
<name><surname>Ghestem</surname><given-names>A.</given-names></name>
<name><surname>Ivanov</surname><given-names>A.I.</given-names></name>
<name><surname>Brancati</surname><given-names>G.E.</given-names></name>
<name><surname>Broer</surname><given-names>S.</given-names></name>
<name><surname>Bot</surname><given-names>A.M.</given-names></name>
<name><surname>Muller</surname><given-names>J.A.</given-names></name>
<name><surname>Schoch</surname><given-names>S.</given-names></name>
<name><surname>Becker</surname><given-names>A.</given-names></name>
<etal/>
</person-group>
          <article-title>The circadian dynamics of the hippocampal transcriptome and proteome is altered in experimental temporal lobe epilepsy</article-title>
          <source>Sci. Adv.</source>
          <year>2020</year>
          <volume>6</volume>
          <fpage>eaat5979</fpage>
          <pub-id pub-id-type="doi">10.1126/sciadv.aat5979</pub-id>
          <pub-id pub-id-type="pmid">33036982</pub-id>
        </element-citation>
      </ref>
      <ref id="B185-ijms-24-04223">
        <label>185.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Hong</surname><given-names>S.</given-names></name>
<name><surname>Lee</surname><given-names>P.</given-names></name>
<name><surname>Baraban</surname><given-names>S.C.</given-names></name>
<name><surname>Lee</surname><given-names>L.P.</given-names></name>
</person-group>
          <article-title>A Novel Long-term, Multi-Channel and Non-invasive Electrophysiology Platform for Zebrafish</article-title>
          <source>Sci. Rep.</source>
          <year>2016</year>
          <volume>6</volume>
          <fpage>28248</fpage>
          <pub-id pub-id-type="doi">10.1038/srep28248</pub-id>
          <pub-id pub-id-type="pmid">27305978</pub-id>
        </element-citation>
      </ref>
      <ref id="B186-ijms-24-04223">
        <label>186.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gawel</surname><given-names>K.</given-names></name>
<name><surname>Turski</surname><given-names>W.A.</given-names></name>
<name><surname>Van Der Ent</surname><given-names>W.</given-names></name>
<name><surname>Mathai</surname><given-names>B.J.</given-names></name>
<name><surname>Kirstein-Smardzewska</surname><given-names>K.J.</given-names></name>
<name><surname>Simonsen</surname><given-names>A.</given-names></name>
<name><surname>Esguerra</surname><given-names>C.V.</given-names></name>
</person-group>
          <article-title>Phenotypic Characterization of Larval Zebrafish (Danio rerio) with Partial Knockdown of the cacna1a Gene</article-title>
          <source>Mol. Neurobiol.</source>
          <year>2020</year>
          <volume>57</volume>
          <fpage>1904</fpage>
          <lpage>1916</lpage>
          <pub-id pub-id-type="doi">10.1007/s12035-019-01860-x</pub-id>
          <pub-id pub-id-type="pmid">31875924</pub-id>
        </element-citation>
      </ref>
      <ref id="B187-ijms-24-04223">
        <label>187.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lee</surname><given-names>G.-H.</given-names></name>
<name><surname>Sung</surname><given-names>S.-Y.</given-names></name>
<name><surname>Chang</surname><given-names>W.-N.</given-names></name>
<name><surname>Kao</surname><given-names>T.-T.</given-names></name>
<name><surname>Du</surname><given-names>H.-C.</given-names></name>
<name><surname>Hsiao</surname><given-names>T.-H.</given-names></name>
<name><surname>Safo</surname><given-names>M.K.</given-names></name>
<name><surname>Fu</surname><given-names>T.-F.</given-names></name>
</person-group>
          <article-title>Zebrafish larvae exposed to ginkgotoxin exhibit seizure-like behavior that is relieved by pyridoxal-5&#x2032;-phosphate, GABA and anti-epileptic drugs</article-title>
          <source>Dis. Model. Mech.</source>
          <year>2012</year>
          <volume>5</volume>
          <fpage>785</fpage>
          <lpage>795</lpage>
          <pub-id pub-id-type="doi">10.1242/dmm.009449</pub-id>
          <pub-id pub-id-type="pmid">22736461</pub-id>
        </element-citation>
      </ref>
      <ref id="B188-ijms-24-04223">
        <label>188.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Benke</surname><given-names>T.A.</given-names></name>
<name><surname>Swann</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>The tetanus toxin model of chronic epilepsy</article-title>
          <source>Adv. Exp. Med. Biol.</source>
          <year>2004</year>
          <volume>548</volume>
          <fpage>226</fpage>
          <lpage>238</lpage>
          <pub-id pub-id-type="doi">10.1007/978-1-4757-6376-8_16</pub-id>
          <pub-id pub-id-type="pmid">15250597</pub-id>
        </element-citation>
      </ref>
      <ref id="B189-ijms-24-04223">
        <label>189.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Mitchell</surname><given-names>J.</given-names></name>
<name><surname>Gatherer</surname><given-names>M.</given-names></name>
<name><surname>Sundstrom</surname><given-names>L.E.</given-names></name>
</person-group>
          <article-title>Loss of hilar somatostatin neurons following tetanus toxin-induced seizures</article-title>
          <source>Acta Neuropathol.</source>
          <year>1995</year>
          <volume>89</volume>
          <fpage>425</fpage>
          <lpage>430</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00307647</pub-id>
          <pub-id pub-id-type="pmid">7542423</pub-id>
        </element-citation>
      </ref>
      <ref id="B190-ijms-24-04223">
        <label>190.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Chro&#x15B;ci&#x144;ska-Krawczyk</surname><given-names>M.</given-names></name>
<name><surname>Jargie&#x142;&#x142;o-Baszak</surname><given-names>M.</given-names></name>
<name><surname>Wa&#x142;ek</surname><given-names>M.</given-names></name>
<name><surname>Tylus</surname><given-names>B.</given-names></name>
<name><surname>Czuczwar</surname><given-names>S.J.</given-names></name>
</person-group>
          <article-title>Caffeine and the anticonvulsant potency of antiepileptic drugs: Experimental and clinical data</article-title>
          <source>Pharmacol. Rep.</source>
          <year>2011</year>
          <volume>63</volume>
          <fpage>12</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="doi">10.1016/S1734-1140(11)70394-2</pub-id>
          <pub-id pub-id-type="pmid">21441607</pub-id>
        </element-citation>
      </ref>
      <ref id="B191-ijms-24-04223">
        <label>191.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Garba</surname><given-names>K.</given-names></name>
<name><surname>Yaro</surname><given-names>A.H.</given-names></name>
<name><surname>Ya&#x2019;u</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Anticonvulsant effects of ethanol stem bark extract of Lannea barteri (Anacardiaceae) in mice and chicks</article-title>
          <source>J. Ethnopharmacol.</source>
          <year>2015</year>
          <volume>172</volume>
          <fpage>227</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jep.2015.06.039</pub-id>
          <pub-id pub-id-type="pmid">26129937</pub-id>
        </element-citation>
      </ref>
      <ref id="B192-ijms-24-04223">
        <label>192.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>White</surname><given-names>H.S.</given-names></name>
</person-group>
          <article-title>Clinical Significance of Animal Seizure Models and Mechanism of Action Studies of Potential Antiepileptic Drugs</article-title>
          <source>Epilepsia</source>
          <year>1997</year>
          <volume>38</volume>
          <fpage>S9</fpage>
          <lpage>S17</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1157.1997.tb04523.x</pub-id>
        </element-citation>
      </ref>
      <ref id="B193-ijms-24-04223">
        <label>193.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>St&#xF6;hr</surname><given-names>T.</given-names></name>
<name><surname>Kupferberg</surname><given-names>H.J.</given-names></name>
<name><surname>Stables</surname><given-names>J.P.</given-names></name>
<name><surname>Choi</surname><given-names>D.</given-names></name>
<name><surname>Harris</surname><given-names>R.H.</given-names></name>
<name><surname>Kohn</surname><given-names>H.</given-names></name>
<name><surname>Walton</surname><given-names>N.</given-names></name>
<name><surname>White</surname><given-names>H.S.</given-names></name>
</person-group>
          <article-title>Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy</article-title>
          <source>Epilepsy Res.</source>
          <year>2007</year>
          <volume>74</volume>
          <fpage>147</fpage>
          <lpage>154</lpage>
          <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2007.03.004</pub-id>
          <pub-id pub-id-type="pmid">17433624</pub-id>
        </element-citation>
      </ref>
      <ref id="B194-ijms-24-04223">
        <label>194.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Scholl</surname><given-names>U.I.</given-names></name>
<name><surname>Choi</surname><given-names>M.</given-names></name>
<name><surname>Liu</surname><given-names>T.</given-names></name>
<name><surname>Ramaekers</surname><given-names>V.T.</given-names></name>
<name><surname>H&#xE4;usler</surname><given-names>M.G.</given-names></name>
<name><surname>Grimmer</surname><given-names>J.</given-names></name>
<name><surname>Tobe</surname><given-names>S.W.</given-names></name>
<name><surname>Farhi</surname><given-names>A.</given-names></name>
<name><surname>Nelson-Williams</surname><given-names>C.</given-names></name>
<name><surname>Lifton</surname><given-names>R.P.</given-names></name>
</person-group>
          <article-title>Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2009</year>
          <volume>106</volume>
          <fpage>5842</fpage>
          <lpage>5847</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0901749106</pub-id>
          <pub-id pub-id-type="pmid">19289823</pub-id>
        </element-citation>
      </ref>
      <ref id="B195-ijms-24-04223">
        <label>195.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Al-Shekaili</surname><given-names>H.H.</given-names></name>
<name><surname>Petkau</surname><given-names>T.L.</given-names></name>
<name><surname>Pena</surname><given-names>I.</given-names></name>
<name><surname>Lengyell</surname><given-names>T.C.</given-names></name>
<name><surname>Verhoeven-Duif</surname><given-names>N.M.</given-names></name>
<name><surname>Ciapaite</surname><given-names>J.</given-names></name>
<name><surname>Bosma</surname><given-names>M.</given-names></name>
<name><surname>van Faassen</surname><given-names>M.</given-names></name>
<name><surname>Kema</surname><given-names>I.P.</given-names></name>
<name><surname>Horvath</surname><given-names>G.</given-names></name>
<etal/>
</person-group>
          <article-title>A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency</article-title>
          <source>Hum. Mol. Genet.</source>
          <year>2020</year>
          <volume>29</volume>
          <fpage>3266</fpage>
          <lpage>3284</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddaa202</pub-id>
          <pub-id pub-id-type="pmid">32969477</pub-id>
        </element-citation>
      </ref>
      <ref id="B196-ijms-24-04223">
        <label>196.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wither</surname><given-names>R.G.</given-names></name>
<name><surname>Colic</surname><given-names>S.</given-names></name>
<name><surname>Bardakjian</surname><given-names>B.L.</given-names></name>
<name><surname>Snead</surname><given-names>O.C.</given-names><suffix>3rd</suffix></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Eubanks</surname><given-names>J.H.</given-names></name>
</person-group>
          <article-title>Electrographic and pharmacological characterization of a progressive epilepsy phenotype in female MeCP2-deficient mice</article-title>
          <source>Epilepsy Res.</source>
          <year>2018</year>
          <volume>140</volume>
          <fpage>177</fpage>
          <lpage>183</lpage>
          <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2018.01.015</pub-id>
          <pub-id pub-id-type="pmid">29414525</pub-id>
        </element-citation>
      </ref>
      <ref id="B197-ijms-24-04223">
        <label>197.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Yu</surname><given-names>F.H.</given-names></name>
<name><surname>Mantegazza</surname><given-names>M.</given-names></name>
<name><surname>Westenbroek</surname><given-names>R.E.</given-names></name>
<name><surname>Robbins</surname><given-names>C.A.</given-names></name>
<name><surname>Kalume</surname><given-names>F.</given-names></name>
<name><surname>Burton</surname><given-names>K.A.</given-names></name>
<name><surname>Spain</surname><given-names>W.J.</given-names></name>
<name><surname>McKnight</surname><given-names>G.S.</given-names></name>
<name><surname>Scheuer</surname><given-names>T.</given-names></name>
<name><surname>Catterall</surname><given-names>W.A.</given-names></name>
</person-group>
          <article-title>Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy</article-title>
          <source>Nat. Neurosci.</source>
          <year>2006</year>
          <volume>9</volume>
          <fpage>1142</fpage>
          <lpage>1149</lpage>
          <pub-id pub-id-type="doi">10.1038/nn1754</pub-id>
          <pub-id pub-id-type="pmid">16921370</pub-id>
        </element-citation>
      </ref>
      <ref id="B198-ijms-24-04223">
        <label>198.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Okuda</surname><given-names>K.</given-names></name>
<name><surname>Kobayashi</surname><given-names>S.</given-names></name>
<name><surname>Fukaya</surname><given-names>M.</given-names></name>
<name><surname>Watanabe</surname><given-names>A.</given-names></name>
<name><surname>Murakami</surname><given-names>T.</given-names></name>
<name><surname>Hagiwara</surname><given-names>M.</given-names></name>
<name><surname>Sato</surname><given-names>T.</given-names></name>
<name><surname>Ueno</surname><given-names>H.</given-names></name>
<name><surname>Ogonuki</surname><given-names>N.</given-names></name>
<name><surname>Komano-Inoue</surname><given-names>S.</given-names></name>
<etal/>
</person-group>
          <article-title>CDKL5 controls postsynaptic localization of GluN2B-containing NMDA receptors in the hippocampus and regulates seizure susceptibility</article-title>
          <source>Neurobiol. Dis.</source>
          <year>2017</year>
          <volume>106</volume>
          <fpage>158</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="doi">10.1016/j.nbd.2017.07.002</pub-id>
          <pub-id pub-id-type="pmid">28688852</pub-id>
        </element-citation>
      </ref>
      <ref id="B199-ijms-24-04223">
        <label>199.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gonzalez-Sulser</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Rodent genetic models of neurodevelopmental disorders and epilepsy</article-title>
          <source>Eur. J. Paediatr. Neurol.</source>
          <year>2020</year>
          <volume>24</volume>
          <fpage>66</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejpn.2019.12.012</pub-id>
          <pub-id pub-id-type="pmid">31870697</pub-id>
        </element-citation>
      </ref>
      <ref id="B200-ijms-24-04223">
        <label>200.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Chabrol</surname><given-names>E.</given-names></name>
<name><surname>Navarro</surname><given-names>V.</given-names></name>
<name><surname>Provenzano</surname><given-names>G.</given-names></name>
<name><surname>Cohen</surname><given-names>I.</given-names></name>
<name><surname>Dinocourt</surname><given-names>C.</given-names></name>
<name><surname>Rivaud-P&#xE9;choux</surname><given-names>S.</given-names></name>
<name><surname>Fricker</surname><given-names>D.</given-names></name>
<name><surname>Baulac</surname><given-names>M.</given-names></name>
<name><surname>Miles</surname><given-names>R.</given-names></name>
<name><surname>LeGuern</surname><given-names>E.</given-names></name>
<etal/>
</person-group>
          <article-title>Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1-deficient mice</article-title>
          <source>Brain</source>
          <year>2010</year>
          <volume>133</volume>
          <fpage>2749</fpage>
          <lpage>2762</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awq171</pub-id>
          <pub-id pub-id-type="pmid">20659958</pub-id>
        </element-citation>
      </ref>
      <ref id="B201-ijms-24-04223">
        <label>201.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Miura</surname><given-names>K.</given-names></name>
<name><surname>Kishino</surname><given-names>T.</given-names></name>
<name><surname>Li</surname><given-names>E.</given-names></name>
<name><surname>Webber</surname><given-names>H.</given-names></name>
<name><surname>Dikkes</surname><given-names>P.</given-names></name>
<name><surname>Holmes</surname><given-names>G.L.</given-names></name>
<name><surname>Wagstaff</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Neurobehavioral and Electroencephalographic Abnormalities in Ube3aMaternal-Deficient Mice</article-title>
          <source>Neurobiol. Dis.</source>
          <year>2002</year>
          <volume>9</volume>
          <fpage>149</fpage>
          <lpage>159</lpage>
          <pub-id pub-id-type="doi">10.1006/nbdi.2001.0463</pub-id>
          <pub-id pub-id-type="pmid">11895368</pub-id>
        </element-citation>
      </ref>
      <ref id="B202-ijms-24-04223">
        <label>202.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Shin</surname><given-names>W.</given-names></name>
<name><surname>Kweon</surname><given-names>H.</given-names></name>
<name><surname>Kang</surname><given-names>R.</given-names></name>
<name><surname>Kim</surname><given-names>D.</given-names></name>
<name><surname>Kim</surname><given-names>K.</given-names></name>
<name><surname>Kang</surname><given-names>M.</given-names></name>
<name><surname>Kim</surname><given-names>S.Y.</given-names></name>
<name><surname>Hwang</surname><given-names>S.N.</given-names></name>
<name><surname>Kim</surname><given-names>J.Y.</given-names></name>
<name><surname>Yang</surname><given-names>E.</given-names></name>
<etal/>
</person-group>
          <article-title>Scn2a Haploinsufficiency in Mice Suppresses Hippocampal Neuronal Excitability, Excitatory Synaptic Drive, and Long-Term Potentiation, and Spatial Learning and Memory</article-title>
          <source>Front. Mol. Neurosci.</source>
          <year>2019</year>
          <volume>12</volume>
          <fpage>145</fpage>
          <pub-id pub-id-type="doi">10.3389/fnmol.2019.00145</pub-id>
          <pub-id pub-id-type="pmid">31249508</pub-id>
        </element-citation>
      </ref>
      <ref id="B203-ijms-24-04223">
        <label>203.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wagnon</surname><given-names>J.L.</given-names></name>
<name><surname>Korn</surname><given-names>M.J.</given-names></name>
<name><surname>Parent</surname><given-names>R.</given-names></name>
<name><surname>Tarpey</surname><given-names>T.A.</given-names></name>
<name><surname>Jones</surname><given-names>J.M.</given-names></name>
<name><surname>Hammer</surname><given-names>M.F.</given-names></name>
<name><surname>Murphy</surname><given-names>G.G.</given-names></name>
<name><surname>Parent</surname><given-names>J.M.</given-names></name>
<name><surname>Meisler</surname><given-names>M.H.</given-names></name>
</person-group>
          <article-title>Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy</article-title>
          <source>Hum. Mol. Genet.</source>
          <year>2015</year>
          <volume>24</volume>
          <fpage>506</fpage>
          <lpage>515</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddu470</pub-id>
          <pub-id pub-id-type="pmid">25227913</pub-id>
        </element-citation>
      </ref>
      <ref id="B204-ijms-24-04223">
        <label>204.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>O&#x2019;Malley</surname><given-names>H.A.</given-names></name>
<name><surname>Hull</surname><given-names>J.M.</given-names></name>
<name><surname>Clawson</surname><given-names>B.C.</given-names></name>
<name><surname>Chen</surname><given-names>C.</given-names></name>
<name><surname>Owens-Fiestan</surname><given-names>G.</given-names></name>
<name><surname>Jameson</surname><given-names>M.B.</given-names></name>
<name><surname>Aton</surname><given-names>S.J.</given-names></name>
<name><surname>Parent</surname><given-names>J.M.</given-names></name>
<name><surname>Isom</surname><given-names>L.L.</given-names></name>
</person-group>
          <article-title>Scn1b deletion in adult mice results in seizures and SUDEP</article-title>
          <source>Ann. Clin. Transl. Neurol.</source>
          <year>2019</year>
          <volume>6</volume>
          <fpage>1121</fpage>
          <lpage>1126</lpage>
          <pub-id pub-id-type="doi">10.1002/acn3.785</pub-id>
          <pub-id pub-id-type="pmid">31211177</pub-id>
        </element-citation>
      </ref>
      <ref id="B205-ijms-24-04223">
        <label>205.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Singh</surname><given-names>N.A.</given-names></name>
<name><surname>Otto</surname><given-names>J.F.</given-names></name>
<name><surname>Dahle</surname><given-names>E.J.</given-names></name>
<name><surname>Pappas</surname><given-names>C.</given-names></name>
<name><surname>Leslie</surname><given-names>J.D.</given-names></name>
<name><surname>Vilaythong</surname><given-names>A.</given-names></name>
<name><surname>Noebels</surname><given-names>J.L.</given-names></name>
<name><surname>White</surname><given-names>H.S.</given-names></name>
<name><surname>Wilcox</surname><given-names>K.S.</given-names></name>
<name><surname>Leppert</surname><given-names>M.F.</given-names></name>
</person-group>
          <article-title>Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization</article-title>
          <source>J. Physiol.</source>
          <year>2008</year>
          <volume>586</volume>
          <fpage>3405</fpage>
          <lpage>3423</lpage>
          <pub-id pub-id-type="doi">10.1113/jphysiol.2008.154971</pub-id>
          <pub-id pub-id-type="pmid">18483067</pub-id>
        </element-citation>
      </ref>
      <ref id="B206-ijms-24-04223">
        <label>206.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Simeone</surname><given-names>K.A.</given-names></name>
<name><surname>Hallgren</surname><given-names>J.</given-names></name>
<name><surname>Bockman</surname><given-names>C.S.</given-names></name>
<name><surname>Aggarwal</surname><given-names>A.</given-names></name>
<name><surname>Kansal</surname><given-names>V.</given-names></name>
<name><surname>Netzel</surname><given-names>L.</given-names></name>
<name><surname>Iyer</surname><given-names>S.H.</given-names></name>
<name><surname>Matthews</surname><given-names>S.A.</given-names></name>
<name><surname>Deodhar</surname><given-names>M.</given-names></name>
<name><surname>Oldenburg</surname><given-names>P.J.</given-names></name>
<etal/>
</person-group>
          <article-title>Respiratory dysfunction progresses with age in Kcna1-null mice, a model of sudden unexpected death in epilepsy</article-title>
          <source>Epilepsia</source>
          <year>2018</year>
          <volume>59</volume>
          <fpage>345</fpage>
          <lpage>357</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.13971</pub-id>
          <pub-id pub-id-type="pmid">29327348</pub-id>
        </element-citation>
      </ref>
      <ref id="B207-ijms-24-04223">
        <label>207.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Robbins</surname><given-names>C.A.</given-names></name>
<name><surname>Tempel</surname><given-names>B.L.</given-names></name>
</person-group>
          <article-title>Kv1.1 and Kv1.2: Similar channels, different seizure models</article-title>
          <source>Epilepsia</source>
          <year>2012</year>
          <volume>53</volume>
          <issue>(Suppl. 1)</issue>
          <fpage>134</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03484.x</pub-id>
        </element-citation>
      </ref>
      <ref id="B208-ijms-24-04223">
        <label>208.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Whitmire</surname><given-names>L.E.</given-names></name>
<name><surname>Ling</surname><given-names>L.</given-names></name>
<name><surname>Bugay</surname><given-names>V.</given-names></name>
<name><surname>Carver</surname><given-names>C.M.</given-names></name>
<name><surname>Timilsina</surname><given-names>S.</given-names></name>
<name><surname>Chuang</surname><given-names>H.H.</given-names></name>
<name><surname>Jaffe</surname><given-names>D.B.</given-names></name>
<name><surname>Shapiro</surname><given-names>M.S.</given-names></name>
<name><surname>Cavazos</surname><given-names>J.E.</given-names></name>
<name><surname>Brenner</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>Downregulation of KCNMB4 expression and changes in BK channel subtype in hippocampal granule neurons following seizure activity</article-title>
          <source>PLoS ONE</source>
          <year>2017</year>
          <volume>12</volume>
          <elocation-id>e0188064</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0188064</pub-id>
          <pub-id pub-id-type="pmid">29145442</pub-id>
        </element-citation>
      </ref>
      <ref id="B209-ijms-24-04223">
        <label>209.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Mark</surname><given-names>M.D.</given-names></name>
<name><surname>Maejima</surname><given-names>T.</given-names></name>
<name><surname>Kuckelsberg</surname><given-names>D.</given-names></name>
<name><surname>Yoo</surname><given-names>J.W.</given-names></name>
<name><surname>Hyde</surname><given-names>R.A.</given-names></name>
<name><surname>Shah</surname><given-names>V.</given-names></name>
<name><surname>Gutierrez</surname><given-names>D.</given-names></name>
<name><surname>Moreno</surname><given-names>R.L.</given-names></name>
<name><surname>Kruse</surname><given-names>W.</given-names></name>
<name><surname>Noebels</surname><given-names>J.L.</given-names></name>
<etal/>
</person-group>
          <article-title>Delayed postnatal loss of P/Q-type calcium channels recapitulates the absence epilepsy, dyskinesia, and ataxia phenotypes of genomic Cacna1a mutations</article-title>
          <source>J. Neurosci.</source>
          <year>2011</year>
          <volume>31</volume>
          <fpage>4311</fpage>
          <lpage>4326</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5342-10.2011</pub-id>
          <pub-id pub-id-type="pmid">21411672</pub-id>
        </element-citation>
      </ref>
      <ref id="B210-ijms-24-04223">
        <label>210.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Machnes</surname><given-names>Z.M.</given-names></name>
<name><surname>Huang</surname><given-names>T.C.</given-names></name>
<name><surname>Chang</surname><given-names>P.K.</given-names></name>
<name><surname>Gill</surname><given-names>R.</given-names></name>
<name><surname>Reist</surname><given-names>N.</given-names></name>
<name><surname>Dezsi</surname><given-names>G.</given-names></name>
<name><surname>Ozturk</surname><given-names>E.</given-names></name>
<name><surname>Charron</surname><given-names>F.</given-names></name>
<name><surname>O&#x2019;Brien</surname><given-names>T.J.</given-names></name>
<name><surname>Jones</surname><given-names>N.C.</given-names></name>
<etal/>
</person-group>
          <article-title>DNA methylation mediates persistent epileptiform activity in vitro and in vivo</article-title>
          <source>PLoS ONE</source>
          <year>2013</year>
          <volume>8</volume>
          <elocation-id>e76299</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0076299</pub-id>
          <pub-id pub-id-type="pmid">24098468</pub-id>
        </element-citation>
      </ref>
      <ref id="B211-ijms-24-04223">
        <label>211.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>G.</given-names></name>
<name><surname>Okada</surname><given-names>M.</given-names></name>
<name><surname>Yoshida</surname><given-names>S.</given-names></name>
<name><surname>Ueno</surname><given-names>S.</given-names></name>
<name><surname>Mori</surname><given-names>F.</given-names></name>
<name><surname>Takahara</surname><given-names>T.</given-names></name>
<name><surname>Saito</surname><given-names>R.</given-names></name>
<name><surname>Miura</surname><given-names>Y.</given-names></name>
<name><surname>Kishi</surname><given-names>A.</given-names></name>
<name><surname>Tomiyama</surname><given-names>M.</given-names></name>
<etal/>
</person-group>
          <article-title>Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype</article-title>
          <source>J. Neurosci.</source>
          <year>2008</year>
          <volume>28</volume>
          <fpage>12465</fpage>
          <lpage>12476</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2961-08.2008</pub-id>
          <pub-id pub-id-type="pmid">19020039</pub-id>
        </element-citation>
      </ref>
      <ref id="B212-ijms-24-04223">
        <label>212.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Warner</surname><given-names>T.A.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Macdonald</surname><given-names>R.L.</given-names></name>
<name><surname>Kang</surname><given-names>J.Q.</given-names></name>
</person-group>
          <article-title>Heat induced temperature dysregulation and seizures in Dravet Syndrome/GEFS+ Gabrg2(+/Q390X) mice</article-title>
          <source>Epilepsy Res.</source>
          <year>2017</year>
          <volume>134</volume>
          <fpage>1</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2017.04.020</pub-id>
          <pub-id pub-id-type="pmid">28505490</pub-id>
        </element-citation>
      </ref>
      <ref id="B213-ijms-24-04223">
        <label>213.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Puranam</surname><given-names>R.S.</given-names></name>
<name><surname>He</surname><given-names>X.P.</given-names></name>
<name><surname>Yao</surname><given-names>L.</given-names></name>
<name><surname>Le</surname><given-names>T.</given-names></name>
<name><surname>Jang</surname><given-names>W.</given-names></name>
<name><surname>Rehder</surname><given-names>C.W.</given-names></name>
<name><surname>Lewis</surname><given-names>D.V.</given-names></name>
<name><surname>McNamara</surname><given-names>J.O.</given-names></name>
</person-group>
          <article-title>Disruption of Fgf13 causes synaptic excitatory-inhibitory imbalance and genetic epilepsy and febrile seizures plus</article-title>
          <source>J. Neurosci.</source>
          <year>2015</year>
          <volume>35</volume>
          <fpage>8866</fpage>
          <lpage>8881</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3470-14.2015</pub-id>
          <pub-id pub-id-type="pmid">26063919</pub-id>
        </element-citation>
      </ref>
      <ref id="B214-ijms-24-04223">
        <label>214.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Vogt</surname><given-names>D.L.</given-names></name>
<name><surname>Thomas</surname><given-names>D.</given-names></name>
<name><surname>Galvan</surname><given-names>V.</given-names></name>
<name><surname>Bredesen</surname><given-names>D.E.</given-names></name>
<name><surname>Lamb</surname><given-names>B.T.</given-names></name>
<name><surname>Pimplikar</surname><given-names>S.W.</given-names></name>
</person-group>
          <article-title>Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain</article-title>
          <source>Neurobiol. Aging</source>
          <year>2011</year>
          <volume>32</volume>
          <fpage>1725</fpage>
          <lpage>1729</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2009.09.002</pub-id>
          <pub-id pub-id-type="pmid">19828212</pub-id>
        </element-citation>
      </ref>
      <ref id="B215-ijms-24-04223">
        <label>215.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Grier</surname><given-names>M.D.</given-names></name>
<name><surname>Carson</surname><given-names>R.P.</given-names></name>
<name><surname>Lagrange</surname><given-names>A.H.</given-names></name>
</person-group>
          <article-title>Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells</article-title>
          <source>PLoS ONE</source>
          <year>2015</year>
          <volume>10</volume>
          <elocation-id>e0124649</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0124649</pub-id>
          <pub-id pub-id-type="pmid">25894543</pub-id>
        </element-citation>
      </ref>
      <ref id="B216-ijms-24-04223">
        <label>216.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Jin</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Kim</surname><given-names>S.</given-names></name>
<name><surname>Kim</surname><given-names>Y.</given-names></name>
<name><surname>Lee</surname><given-names>Y.</given-names></name>
<name><surname>Han</surname><given-names>K.</given-names></name>
</person-group>
          <article-title>Spontaneous seizure and partial lethality of juvenile Shank3-overexpressing mice in C57BL/6 J background</article-title>
          <source>Mol. Brain</source>
          <year>2018</year>
          <volume>11</volume>
          <fpage>57</fpage>
          <pub-id pub-id-type="doi">10.1186/s13041-018-0403-6</pub-id>
          <pub-id pub-id-type="pmid">30305163</pub-id>
        </element-citation>
      </ref>
      <ref id="B217-ijms-24-04223">
        <label>217.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Pe&#xF1;agarikano</surname><given-names>O.</given-names></name>
<name><surname>Abrahams</surname><given-names>B.S.</given-names></name>
<name><surname>Herman</surname><given-names>E.I.</given-names></name>
<name><surname>Winden</surname><given-names>K.D.</given-names></name>
<name><surname>Gdalyahu</surname><given-names>A.</given-names></name>
<name><surname>Dong</surname><given-names>H.</given-names></name>
<name><surname>Sonnenblick</surname><given-names>L.I.</given-names></name>
<name><surname>Gruver</surname><given-names>R.</given-names></name>
<name><surname>Almajano</surname><given-names>J.</given-names></name>
<name><surname>Bragin</surname><given-names>A.</given-names></name>
<etal/>
</person-group>
          <article-title>Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits</article-title>
          <source>Cell</source>
          <year>2011</year>
          <volume>147</volume>
          <fpage>235</fpage>
          <lpage>246</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2011.08.040</pub-id>
          <pub-id pub-id-type="pmid">21962519</pub-id>
        </element-citation>
      </ref>
      <ref id="B218-ijms-24-04223">
        <label>218.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ganesh</surname><given-names>S.</given-names></name>
<name><surname>Delgado-Escueta</surname><given-names>A.V.</given-names></name>
<name><surname>Sakamoto</surname><given-names>T.</given-names></name>
<name><surname>Avila</surname><given-names>M.R.</given-names></name>
<name><surname>Machado-Salas</surname><given-names>J.</given-names></name>
<name><surname>Hoshii</surname><given-names>Y.</given-names></name>
<name><surname>Akagi</surname><given-names>T.</given-names></name>
<name><surname>Gomi</surname><given-names>H.</given-names></name>
<name><surname>Suzuki</surname><given-names>T.</given-names></name>
<name><surname>Amano</surname><given-names>K.</given-names></name>
<etal/>
</person-group>
          <article-title>Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice</article-title>
          <source>Hum. Mol. Genet.</source>
          <year>2002</year>
          <volume>11</volume>
          <fpage>1251</fpage>
          <lpage>1262</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/11.11.1251</pub-id>
          <pub-id pub-id-type="pmid">12019206</pub-id>
        </element-citation>
      </ref>
      <ref id="B219-ijms-24-04223">
        <label>219.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wagnon</surname><given-names>J.L.</given-names></name>
<name><surname>Mahaffey</surname><given-names>C.L.</given-names></name>
<name><surname>Sun</surname><given-names>W.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Chao</surname><given-names>H.T.</given-names></name>
<name><surname>Frankel</surname><given-names>W.N.</given-names></name>
</person-group>
          <article-title>Etiology of a genetically complex seizure disorder in Celf4 mutant mice</article-title>
          <source>Genes Brain Behav.</source>
          <year>2011</year>
          <volume>10</volume>
          <fpage>765</fpage>
          <lpage>777</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1601-183X.2011.00717.x</pub-id>
          <pub-id pub-id-type="pmid">21745337</pub-id>
        </element-citation>
      </ref>
      <ref id="B220-ijms-24-04223">
        <label>220.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Acampora</surname><given-names>D.</given-names></name>
<name><surname>Mazan</surname><given-names>S.</given-names></name>
<name><surname>Avantaggiato</surname><given-names>V.</given-names></name>
<name><surname>Barone</surname><given-names>P.</given-names></name>
<name><surname>Tuorto</surname><given-names>F.</given-names></name>
<name><surname>Lallemand</surname><given-names>Y.</given-names></name>
<name><surname>Br&#xFB;let</surname><given-names>P.</given-names></name>
<name><surname>Simeone</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Epilepsy and brain abnormalities in mice lacking the Otx1 gene</article-title>
          <source>Nat. Genet.</source>
          <year>1996</year>
          <volume>14</volume>
          <fpage>218</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="doi">10.1038/ng1096-218</pub-id>
          <pub-id pub-id-type="pmid">8841200</pub-id>
        </element-citation>
      </ref>
      <ref id="B221-ijms-24-04223">
        <label>221.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Menten-Dedoyart</surname><given-names>C.</given-names></name>
<name><surname>Serrano Navacerrada</surname><given-names>M.E.</given-names></name>
<name><surname>Bartholome</surname><given-names>O.</given-names></name>
<name><surname>S&#xE1;nchez Gil</surname><given-names>J.</given-names></name>
<name><surname>Neirinckx</surname><given-names>V.</given-names></name>
<name><surname>Wislet</surname><given-names>S.</given-names></name>
<name><surname>Becker</surname><given-names>G.</given-names></name>
<name><surname>Plenevaux</surname><given-names>A.</given-names></name>
<name><surname>Van den Ackerveken</surname><given-names>P.</given-names></name>
<name><surname>Rogister</surname><given-names>B.</given-names></name>
</person-group>
          <article-title>Development and Validation of a New Mouse Model to Investigate the Role of SV2A in Epilepsy</article-title>
          <source>PLoS ONE</source>
          <year>2016</year>
          <volume>11</volume>
          <elocation-id>e0166525</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0166525</pub-id>
          <pub-id pub-id-type="pmid">27861538</pub-id>
        </element-citation>
      </ref>
      <ref id="B222-ijms-24-04223">
        <label>222.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Hu</surname><given-names>H.</given-names></name>
<name><surname>Zhu</surname><given-names>T.</given-names></name>
<name><surname>Gong</surname><given-names>L.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.</given-names></name>
<name><surname>Shao</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Sun</surname><given-names>Z.</given-names></name>
<name><surname>Ling</surname><given-names>Y.</given-names></name>
<name><surname>Tao</surname><given-names>Y.</given-names></name>
<name><surname>Ying</surname><given-names>Y.</given-names></name>
<etal/>
</person-group>
          <article-title>Transient receptor potential melastatin 2 contributes to neuroinflammation and negatively regulates cognitive outcomes in a pilocarpine-induced mouse model of epilepsy</article-title>
          <source>Int. Immunopharmacol.</source>
          <year>2020</year>
          <volume>87</volume>
          <fpage>106824</fpage>
          <pub-id pub-id-type="doi">10.1016/j.intimp.2020.106824</pub-id>
          <pub-id pub-id-type="pmid">32731181</pub-id>
        </element-citation>
      </ref>
      <ref id="B223-ijms-24-04223">
        <label>223.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>D.</given-names></name>
<name><surname>Yuan</surname><given-names>C.</given-names></name>
<name><surname>Liu</surname><given-names>M.</given-names></name>
<name><surname>Zhou</surname><given-names>X.</given-names></name>
<name><surname>Ge</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Luo</surname><given-names>G.</given-names></name>
<name><surname>Hou</surname><given-names>M.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>Q.K.</given-names></name>
<etal/>
</person-group>
          <article-title>Deficiency of SCAMP5 leads to pediatric epilepsy and dysregulation of neurotransmitter release in the brain</article-title>
          <source>Hum. Genet.</source>
          <year>2020</year>
          <volume>139</volume>
          <fpage>545</fpage>
          <lpage>555</lpage>
          <pub-id pub-id-type="doi">10.1007/s00439-020-02123-9</pub-id>
          <pub-id pub-id-type="pmid">32020363</pub-id>
        </element-citation>
      </ref>
      <ref id="B224-ijms-24-04223">
        <label>224.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Mota Vieira</surname><given-names>M.</given-names></name>
<name><surname>Nguyen</surname><given-names>T.A.</given-names></name>
<name><surname>Wu</surname><given-names>K.</given-names></name>
<name><surname>Badger</surname><given-names>J.D.</given-names><suffix>2nd</suffix></name>
<name><surname>Collins</surname><given-names>B.M.</given-names></name>
<name><surname>Anggono</surname><given-names>V.</given-names></name>
<name><surname>Lu</surname><given-names>W.</given-names></name>
<name><surname>Roche</surname><given-names>K.W.</given-names></name>
</person-group>
          <article-title>An Epilepsy-Associated GRIN2A Rare Variant Disrupts CaMKII&#x3B1; Phosphorylation of GluN2A and NMDA Receptor Trafficking</article-title>
          <source>Cell Rep.</source>
          <year>2020</year>
          <volume>32</volume>
          <fpage>108104</fpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2020.108104</pub-id>
          <pub-id pub-id-type="pmid">32877683</pub-id>
        </element-citation>
      </ref>
      <ref id="B225-ijms-24-04223">
        <label>225.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Klofas</surname><given-names>L.K.</given-names></name>
<name><surname>Short</surname><given-names>B.P.</given-names></name>
<name><surname>Zhou</surname><given-names>C.</given-names></name>
<name><surname>Carson</surname><given-names>R.P.</given-names></name>
</person-group>
          <article-title>Prevention of premature death and seizures in a Depdc5 mouse epilepsy model through inhibition of mTORC1</article-title>
          <source>Hum. Mol. Genet.</source>
          <year>2020</year>
          <volume>29</volume>
          <fpage>1365</fpage>
          <lpage>1377</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddaa068</pub-id>
          <pub-id pub-id-type="pmid">32280987</pub-id>
        </element-citation>
      </ref>
      <ref id="B226-ijms-24-04223">
        <label>226.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Huo</surname><given-names>J.</given-names></name>
<name><surname>Ren</surname><given-names>S.</given-names></name>
<name><surname>Gao</surname><given-names>P.</given-names></name>
<name><surname>Wan</surname><given-names>D.</given-names></name>
<name><surname>Rong</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Xu</surname><given-names>S.</given-names></name>
<name><surname>Sun</surname><given-names>K.</given-names></name>
<name><surname>Guo</surname><given-names>B.</given-names></name>
<etal/>
</person-group>
          <article-title>ALG13 participates in epileptogenesis via regulation of GABA(A) receptors in mouse models</article-title>
          <source>Cell Death Discov.</source>
          <year>2020</year>
          <volume>6</volume>
          <fpage>87</fpage>
          <pub-id pub-id-type="doi">10.1038/s41420-020-00319-6</pub-id>
          <pub-id pub-id-type="pmid">33014431</pub-id>
        </element-citation>
      </ref>
      <ref id="B227-ijms-24-04223">
        <label>227.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Nishitani</surname><given-names>A.</given-names></name>
<name><surname>Kunisawa</surname><given-names>N.</given-names></name>
<name><surname>Sugimura</surname><given-names>T.</given-names></name>
<name><surname>Sato</surname><given-names>K.</given-names></name>
<name><surname>Yoshida</surname><given-names>Y.</given-names></name>
<name><surname>Suzuki</surname><given-names>T.</given-names></name>
<name><surname>Sakuma</surname><given-names>T.</given-names></name>
<name><surname>Yamamoto</surname><given-names>T.</given-names></name>
<name><surname>Asano</surname><given-names>M.</given-names></name>
<name><surname>Saito</surname><given-names>Y.</given-names></name>
<etal/>
</person-group>
          <article-title>Loss of HCN1 subunits causes absence epilepsy in rats</article-title>
          <source>Brain Res.</source>
          <year>2019</year>
          <volume>1706</volume>
          <fpage>209</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2018.11.004</pub-id>
          <pub-id pub-id-type="pmid">30408474</pub-id>
        </element-citation>
      </ref>
      <ref id="B228-ijms-24-04223">
        <label>228.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Baraban</surname><given-names>S.</given-names></name>
<name><surname>Taylor</surname><given-names>M.</given-names></name>
<name><surname>Castro</surname><given-names>P.</given-names></name>
<name><surname>Baier</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression</article-title>
          <source>Neuroscience</source>
          <year>2005</year>
          <volume>131</volume>
          <fpage>759</fpage>
          <lpage>768</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.11.031</pub-id>
          <pub-id pub-id-type="pmid">15730879</pub-id>
        </element-citation>
      </ref>
      <ref id="B229-ijms-24-04223">
        <label>229.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lopes</surname><given-names>M.W.</given-names></name>
<name><surname>Sapio</surname><given-names>M.R.</given-names></name>
<name><surname>Leal</surname><given-names>R.B.</given-names></name>
<name><surname>Fricker</surname><given-names>L.D.</given-names></name>
</person-group>
          <article-title>Knockdown of Carboxypeptidase A6 in Zebrafish Larvae Reduces Response to Seizure-Inducing Drugs and Causes Changes in the Level of mRNAs Encoding Signaling Molecules</article-title>
          <source>PLoS ONE</source>
          <year>2016</year>
          <volume>11</volume>
          <elocation-id>e0152905</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0152905</pub-id>
          <pub-id pub-id-type="pmid">27050163</pub-id>
        </element-citation>
      </ref>
      <ref id="B230-ijms-24-04223">
        <label>230.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Vermoesen</surname><given-names>K.</given-names></name>
<name><surname>Serruys</surname><given-names>A.-S.K.</given-names></name>
<name><surname>Loyens</surname><given-names>E.</given-names></name>
<name><surname>Afrikanova</surname><given-names>T.</given-names></name>
<name><surname>Massie</surname><given-names>A.</given-names></name>
<name><surname>Schallier</surname><given-names>A.</given-names></name>
<name><surname>Michotte</surname><given-names>Y.</given-names></name>
<name><surname>Crawford</surname><given-names>A.D.</given-names></name>
<name><surname>Esguerra</surname><given-names>C.V.</given-names></name>
<name><surname>de Witte</surname><given-names>P.A.M.</given-names></name>
<etal/>
</person-group>
          <article-title>Assessment of the convulsant liability of antidepressants using zebrafish and mouse seizure models</article-title>
          <source>Epilepsy Behav.</source>
          <year>2011</year>
          <volume>22</volume>
          <fpage>450</fpage>
          <lpage>460</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yebeh.2011.08.016</pub-id>
          <pub-id pub-id-type="pmid">21962757</pub-id>
        </element-citation>
      </ref>
      <ref id="B231-ijms-24-04223">
        <label>231.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gawel</surname><given-names>K.</given-names></name>
<name><surname>Langlois</surname><given-names>M.</given-names></name>
<name><surname>Martins</surname><given-names>T.</given-names></name>
<name><surname>van der Ent</surname><given-names>W.</given-names></name>
<name><surname>Tiraboschi</surname><given-names>E.</given-names></name>
<name><surname>Jacmin</surname><given-names>M.</given-names></name>
<name><surname>Crawford</surname><given-names>A.D.</given-names></name>
<name><surname>Esguerra</surname><given-names>C.V.</given-names></name>
</person-group>
          <article-title>Seizing the moment: Zebrafish epilepsy models</article-title>
          <source>Neurosci. Biobehav. Rev.</source>
          <year>2020</year>
          <volume>116</volume>
          <fpage>1</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neubiorev.2020.06.010</pub-id>
          <pub-id pub-id-type="pmid">32544542</pub-id>
        </element-citation>
      </ref>
      <ref id="B232-ijms-24-04223">
        <label>232.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Baraban</surname><given-names>S.C.</given-names></name>
<name><surname>Dinday</surname><given-names>M.T.</given-names></name>
<name><surname>Hortopan</surname><given-names>G.A.</given-names></name>
</person-group>
          <article-title>Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment</article-title>
          <source>Nat. Commun.</source>
          <year>2013</year>
          <volume>4</volume>
          <fpage>2410</fpage>
          <pub-id pub-id-type="doi">10.1038/ncomms3410</pub-id>
          <pub-id pub-id-type="pmid">24002024</pub-id>
        </element-citation>
      </ref>
      <ref id="B233-ijms-24-04223">
        <label>233.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Samarut</surname><given-names>E.</given-names></name>
<name><surname>Swaminathan</surname><given-names>A.</given-names></name>
<name><surname>Riche</surname><given-names>R.</given-names></name>
<name><surname>Liao</surname><given-names>M.</given-names></name>
<name><surname>Hassan-Abdi</surname><given-names>R.</given-names></name>
<name><surname>Renault</surname><given-names>S.</given-names></name>
<name><surname>Allard</surname><given-names>M.</given-names></name>
<name><surname>Dufour</surname><given-names>L.</given-names></name>
<name><surname>Cossette</surname><given-names>P.</given-names></name>
<name><surname>Soussi-Yanicostas</surname><given-names>N.</given-names></name>
<etal/>
</person-group>
          <article-title>gamma-Aminobutyric acid receptor alpha 1 subunit loss of function causes genetic generalized epilepsy by impairing inhibitory network neurodevelopment</article-title>
          <source>Epilepsia</source>
          <year>2018</year>
          <volume>59</volume>
          <fpage>2061</fpage>
          <lpage>2074</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.14576</pub-id>
          <pub-id pub-id-type="pmid">30324621</pub-id>
        </element-citation>
      </ref>
      <ref id="B234-ijms-24-04223">
        <label>234.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Liao</surname><given-names>M.</given-names></name>
<name><surname>Kundap</surname><given-names>U.</given-names></name>
<name><surname>Rosch</surname><given-names>R.E.</given-names></name>
<name><surname>Burrows</surname><given-names>D.R.W.</given-names></name>
<name><surname>Meyer</surname><given-names>M.P.</given-names></name>
<name><surname>Bencheikh</surname><given-names>B.O.A.</given-names></name>
<name><surname>Cossette</surname><given-names>P.</given-names></name>
<name><surname>Samarut</surname><given-names>&#xC9;.</given-names></name>
</person-group>
          <article-title>Targeted knockout of GABA receptor gamma 2 subunit provokes transient light-induced reflex seizures in zebrafish larvae</article-title>
          <source>Dis. Model. Mech.</source>
          <year>2019</year>
          <volume>12</volume>
          <fpage>dmm.040782</fpage>
          <pub-id pub-id-type="doi">10.1242/dmm.040782</pub-id>
          <pub-id pub-id-type="pmid">31582559</pub-id>
        </element-citation>
      </ref>
      <ref id="B235-ijms-24-04223">
        <label>235.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Mahmood</surname><given-names>F.</given-names></name>
<name><surname>Mozere</surname><given-names>M.</given-names></name>
<name><surname>Zdebik</surname><given-names>A.A.</given-names></name>
<name><surname>Stanescu</surname><given-names>H.C.</given-names></name>
<name><surname>Tobin</surname><given-names>J.</given-names></name>
<name><surname>Beales</surname><given-names>P.L.</given-names></name>
<name><surname>Kleta</surname><given-names>R.</given-names></name>
<name><surname>Bockenhauer</surname><given-names>D.</given-names></name>
<name><surname>Russell</surname><given-names>C.</given-names></name>
</person-group>
          <article-title>Generation and validation of a zebrafish model of EAST (epilepsy, ataxia, sensorineural deafness and tubulopathy) syndrome</article-title>
          <source>Dis. Model. Mech.</source>
          <year>2013</year>
          <volume>6</volume>
          <fpage>652</fpage>
          <lpage>660</lpage>
          <pub-id pub-id-type="doi">10.1242/dmm.009480</pub-id>
          <pub-id pub-id-type="pmid">23471908</pub-id>
        </element-citation>
      </ref>
      <ref id="B236-ijms-24-04223">
        <label>236.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Chege</surname><given-names>S.W.</given-names></name>
<name><surname>Hortopan</surname><given-names>G.A.</given-names></name>
<name><surname>Dinday</surname><given-names>M.T.</given-names></name>
<name><surname>Baraban</surname><given-names>S.C.</given-names></name>
</person-group>
          <article-title>Expression and function of KCNQ channels in larval zebrafish</article-title>
          <source>Dev. Neurobiol.</source>
          <year>2012</year>
          <volume>72</volume>
          <fpage>186</fpage>
          <lpage>198</lpage>
          <pub-id pub-id-type="doi">10.1002/dneu.20937</pub-id>
          <pub-id pub-id-type="pmid">21692188</pub-id>
        </element-citation>
      </ref>
      <ref id="B237-ijms-24-04223">
        <label>237.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Schubert</surname><given-names>J.</given-names></name>
<name><surname>Siekierska</surname><given-names>A.</given-names></name>
<name><surname>Langlois</surname><given-names>M.</given-names></name>
<name><surname>May</surname><given-names>P.</given-names></name>
<name><surname>Huneau</surname><given-names>C.</given-names></name>
<name><surname>Becker</surname><given-names>F.</given-names></name>
<name><surname>Muhle</surname><given-names>H.</given-names></name>
<name><surname>Suls</surname><given-names>A.</given-names></name>
<name><surname>Lemke</surname><given-names>J.R.</given-names></name>
<name><surname>de Kovel</surname><given-names>C.G.F.</given-names></name>
<etal/>
</person-group>
          <article-title>Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes</article-title>
          <source>Nat. Genet.</source>
          <year>2014</year>
          <volume>46</volume>
          <fpage>1327</fpage>
          <lpage>1332</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.3130</pub-id>
          <pub-id pub-id-type="pmid">25362483</pub-id>
        </element-citation>
      </ref>
      <ref id="B238-ijms-24-04223">
        <label>238.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Carvill</surname><given-names>G.L.</given-names></name>
<name><surname>Heavin</surname><given-names>S.B.</given-names></name>
<name><surname>Yendle</surname><given-names>S.C.</given-names></name>
<name><surname>McMahon</surname><given-names>J.M.</given-names></name>
<name><surname>O&#x2019;Roak</surname><given-names>B.J.</given-names></name>
<name><surname>Cook</surname><given-names>J.</given-names></name>
<name><surname>Khan</surname><given-names>A.</given-names></name>
<name><surname>Dorschner</surname><given-names>M.O.</given-names></name>
<name><surname>Weaver</surname><given-names>M.</given-names></name>
<name><surname>Calvert</surname><given-names>S.</given-names></name>
<etal/>
</person-group>
          <article-title>Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1</article-title>
          <source>Nat. Genet.</source>
          <year>2013</year>
          <volume>45</volume>
          <fpage>825</fpage>
          <lpage>830</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.2646</pub-id>
          <pub-id pub-id-type="pmid">23708187</pub-id>
        </element-citation>
      </ref>
      <ref id="B239-ijms-24-04223">
        <label>239.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Griffin</surname><given-names>A.</given-names></name>
<name><surname>Carpenter</surname><given-names>C.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Paterno</surname><given-names>R.</given-names></name>
<name><surname>Grone</surname><given-names>B.</given-names></name>
<name><surname>Hamling</surname><given-names>K.</given-names></name>
<name><surname>Moog</surname><given-names>M.</given-names></name>
<name><surname>Dinday</surname><given-names>M.T.</given-names></name>
<name><surname>Figueroa</surname><given-names>F.</given-names></name>
<name><surname>Anvar</surname><given-names>M.</given-names></name>
<etal/>
</person-group>
          <article-title>Phenotypic analysis of catastrophic childhood epilepsy genes</article-title>
          <source>Commun. Biol.</source>
          <year>2021</year>
          <volume>4</volume>
          <fpage>680</fpage>
          <pub-id pub-id-type="doi">10.1038/s42003-021-02221-y</pub-id>
          <pub-id pub-id-type="pmid">34083748</pub-id>
        </element-citation>
      </ref>
      <ref id="B240-ijms-24-04223">
        <label>240.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Teng</surname><given-names>Y.</given-names></name>
<name><surname>Xie</surname><given-names>X.</given-names></name>
<name><surname>Walker</surname><given-names>S.</given-names></name>
<name><surname>Rempala</surname><given-names>G.</given-names></name>
<name><surname>Kozlowski</surname><given-names>D.J.</given-names></name>
<name><surname>Mumm</surname><given-names>J.S.</given-names></name>
<name><surname>Cowell</surname><given-names>J.K.</given-names></name>
</person-group>
          <article-title>Knockdown of zebrafish Lgi1a results in abnormal development, brain defects and a seizure-like behavioral phenotype</article-title>
          <source>Hum. Mol. Genet.</source>
          <year>2010</year>
          <volume>19</volume>
          <fpage>4409</fpage>
          <lpage>4420</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddq364</pub-id>
          <pub-id pub-id-type="pmid">20819949</pub-id>
        </element-citation>
      </ref>
      <ref id="B241-ijms-24-04223">
        <label>241.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Swaminathan</surname><given-names>A.</given-names></name>
<name><surname>Hassan-Abdi</surname><given-names>R.</given-names></name>
<name><surname>Renault</surname><given-names>S.</given-names></name>
<name><surname>Siekierska</surname><given-names>A.</given-names></name>
<name><surname>Rich&#xE9;</surname><given-names>R.</given-names></name>
<name><surname>Liao</surname><given-names>M.</given-names></name>
<name><surname>de Witte</surname><given-names>P.A.M.</given-names></name>
<name><surname>Yanicostas</surname><given-names>C.</given-names></name>
<name><surname>Soussi-Yanicostas</surname><given-names>N.</given-names></name>
<name><surname>Drapeau</surname><given-names>P.</given-names></name>
<etal/>
</person-group>
          <article-title>Non-canonical mTOR-Independent Role of DEPDC5 in Regulating GABAergic Network Development</article-title>
          <source>Curr. Biol.</source>
          <year>2018</year>
          <volume>28</volume>
          <fpage>1924</fpage>
          <lpage>1937</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cub.2018.04.061</pub-id>
          <pub-id pub-id-type="pmid">29861134</pub-id>
        </element-citation>
      </ref>
      <ref id="B242-ijms-24-04223">
        <label>242.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Weckhuysen</surname><given-names>S.</given-names></name>
<name><surname>Korff</surname><given-names>C.M.</given-names></name>
</person-group>
          <article-title>Epilepsy: Old syndromes, new genes</article-title>
          <source>Curr. Neurol. Neurosci. Rep.</source>
          <year>2014</year>
          <volume>14</volume>
          <fpage>447</fpage>
          <pub-id pub-id-type="doi">10.1007/s11910-014-0447-7</pub-id>
          <pub-id pub-id-type="pmid">24740805</pub-id>
        </element-citation>
      </ref>
      <ref id="B243-ijms-24-04223">
        <label>243.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Harkin</surname><given-names>L.A.</given-names></name>
<name><surname>McMahon</surname><given-names>J.M.</given-names></name>
<name><surname>Iona</surname><given-names>X.</given-names></name>
<name><surname>Dibbens</surname><given-names>L.</given-names></name>
<name><surname>Pelekanos</surname><given-names>J.T.</given-names></name>
<name><surname>Zuberi</surname><given-names>S.M.</given-names></name>
<name><surname>Sadleir</surname><given-names>L.G.</given-names></name>
<name><surname>Andermann</surname><given-names>E.</given-names></name>
<name><surname>Gill</surname><given-names>D.</given-names></name>
<name><surname>Farrell</surname><given-names>K.</given-names></name>
<etal/>
</person-group>
          <article-title>The spectrum of SCN1A-related infantile epileptic encephalopathies</article-title>
          <source>Brain</source>
          <year>2007</year>
          <volume>130</volume>
          <fpage>843</fpage>
          <lpage>852</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awm002</pub-id>
          <pub-id pub-id-type="pmid">17347258</pub-id>
        </element-citation>
      </ref>
      <ref id="B244-ijms-24-04223">
        <label>244.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Yamakawa</surname><given-names>K.</given-names></name>
</person-group>
          <article-title>Molecular and cellular basis: Insights from experimental models of Dravet syndrome</article-title>
          <source>Epilepsia</source>
          <year>2011</year>
          <volume>52</volume>
          <issue>(Suppl. 2)</issue>
          <fpage>70</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03006.x</pub-id>
          <pub-id pub-id-type="pmid">21463284</pub-id>
        </element-citation>
      </ref>
      <ref id="B245-ijms-24-04223">
        <label>245.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Jansen</surname><given-names>N.A.</given-names></name>
<name><surname>Dehghani</surname><given-names>A.</given-names></name>
<name><surname>Breukel</surname><given-names>C.</given-names></name>
<name><surname>Tolner</surname><given-names>E.A.</given-names></name>
<name><surname>Van Den Maagdenberg</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Focal and generalized seizure activity after local hippocampal or cortical ablation of Na(V) 1.1 channels in mice</article-title>
          <source>Epilepsia</source>
          <year>2020</year>
          <volume>61</volume>
          <fpage>e30</fpage>
          <lpage>e36</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.16482</pub-id>
          <pub-id pub-id-type="pmid">32190912</pub-id>
        </element-citation>
      </ref>
      <ref id="B246-ijms-24-04223">
        <label>246.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Grone</surname><given-names>B.P.</given-names></name>
<name><surname>Qu</surname><given-names>T.</given-names></name>
<name><surname>Baraban</surname><given-names>S.C.</given-names></name>
</person-group>
          <article-title>Behavioral Comorbidities and Drug Treatments in a Zebrafish scn1lab Model of Dravet Syndrome</article-title>
          <source>eNeuro</source>
          <year>2017</year>
          <volume>4</volume>
          <fpage>eneuro.0066</fpage>
          <pub-id pub-id-type="doi">10.1523/ENEURO.0066-17.2017</pub-id>
          <pub-id pub-id-type="pmid">28812061</pub-id>
        </element-citation>
      </ref>
      <ref id="B247-ijms-24-04223">
        <label>247.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Calhoun</surname><given-names>J.D.</given-names></name>
<name><surname>Hawkins</surname><given-names>N.A.</given-names></name>
<name><surname>Zachwieja</surname><given-names>N.J.</given-names></name>
<name><surname>Kearney</surname><given-names>J.A.</given-names></name>
</person-group>
          <article-title>Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a</article-title>
          <source>Epilepsia</source>
          <year>2016</year>
          <volume>57</volume>
          <fpage>e103</fpage>
          <lpage>e107</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.13390</pub-id>
          <pub-id pub-id-type="pmid">27112236</pub-id>
        </element-citation>
      </ref>
      <ref id="B248-ijms-24-04223">
        <label>248.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Makinson</surname><given-names>C.D.</given-names></name>
<name><surname>Tanaka</surname><given-names>B.S.</given-names></name>
<name><surname>Sorokin</surname><given-names>J.M.</given-names></name>
<name><surname>Wong</surname><given-names>J.C.</given-names></name>
<name><surname>Christian</surname><given-names>C.A.</given-names></name>
<name><surname>Goldin</surname><given-names>A.L.</given-names></name>
<name><surname>Escayg</surname><given-names>A.</given-names></name>
<name><surname>Huguenard</surname><given-names>J.R.</given-names></name>
</person-group>
          <article-title>Regulation of Thalamic and Cortical Network Synchrony by Scn8a</article-title>
          <source>Neuron</source>
          <year>2017</year>
          <volume>93</volume>
          <fpage>1165</fpage>
          <lpage>1179</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2017.01.031</pub-id>
          <pub-id pub-id-type="pmid">28238546</pub-id>
        </element-citation>
      </ref>
      <ref id="B249-ijms-24-04223">
        <label>249.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Allen</surname><given-names>N.M.</given-names></name>
<name><surname>Mannion</surname><given-names>M.</given-names></name>
<name><surname>Conroy</surname><given-names>J.</given-names></name>
<name><surname>Lynch</surname><given-names>S.A.</given-names></name>
<name><surname>Shahwan</surname><given-names>A.</given-names></name>
<name><surname>Lynch</surname><given-names>B.</given-names></name>
<name><surname>King</surname><given-names>M.D.</given-names></name>
</person-group>
          <article-title>The variable phenotypes of KCNQ-related epilepsy</article-title>
          <source>Epilepsia</source>
          <year>2014</year>
          <volume>55</volume>
          <fpage>e99</fpage>
          <lpage>e105</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.12715</pub-id>
          <pub-id pub-id-type="pmid">25052858</pub-id>
        </element-citation>
      </ref>
      <ref id="B250-ijms-24-04223">
        <label>250.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Olsen</surname><given-names>M.L.</given-names></name>
<name><surname>Sontheimer</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Functional implications for Kir4.1 channels in glial biology: From K+ buffering to cell differentiation</article-title>
          <source>J. Neurochem.</source>
          <year>2008</year>
          <volume>107</volume>
          <fpage>589</fpage>
          <lpage>601</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05615.x</pub-id>
          <pub-id pub-id-type="pmid">18691387</pub-id>
        </element-citation>
      </ref>
      <ref id="B251-ijms-24-04223">
        <label>251.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Reichold</surname><given-names>M.</given-names></name>
<name><surname>Zdebik</surname><given-names>A.A.</given-names></name>
<name><surname>Lieberer</surname><given-names>E.</given-names></name>
<name><surname>Rapedius</surname><given-names>M.</given-names></name>
<name><surname>Schmidt</surname><given-names>K.</given-names></name>
<name><surname>Bandulik</surname><given-names>S.</given-names></name>
<name><surname>Sterner</surname><given-names>C.</given-names></name>
<name><surname>Tegtmeier</surname><given-names>I.</given-names></name>
<name><surname>Penton</surname><given-names>D.</given-names></name>
<name><surname>Baukrowitz</surname><given-names>T.</given-names></name>
<etal/>
</person-group>
          <article-title>KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2010</year>
          <volume>107</volume>
          <fpage>14490</fpage>
          <lpage>14495</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1003072107</pub-id>
          <pub-id pub-id-type="pmid">20651251</pub-id>
        </element-citation>
      </ref>
      <ref id="B252-ijms-24-04223">
        <label>252.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Raol</surname><given-names>Y.H.</given-names></name>
<name><surname>Lund</surname><given-names>I.V.</given-names></name>
<name><surname>Bandyopadhyay</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>G.</given-names></name>
<name><surname>Roberts</surname><given-names>D.S.</given-names></name>
<name><surname>Wolfe</surname><given-names>J.H.</given-names></name>
<name><surname>Russek</surname><given-names>S.J.</given-names></name>
<name><surname>Brooks-Kayal</surname><given-names>A.R.</given-names></name>
</person-group>
          <article-title>Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy</article-title>
          <source>J. Neurosci.</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>11342</fpage>
          <lpage>11346</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3329-06.2006</pub-id>
          <pub-id pub-id-type="pmid">17079662</pub-id>
        </element-citation>
      </ref>
      <ref id="B253-ijms-24-04223">
        <label>253.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gregg</surname><given-names>N.M.</given-names></name>
<name><surname>Sladky</surname><given-names>V.</given-names></name>
<name><surname>Nejedly</surname><given-names>P.</given-names></name>
<name><surname>Mivalt</surname><given-names>F.</given-names></name>
<name><surname>Kim</surname><given-names>I.</given-names></name>
<name><surname>Balzekas</surname><given-names>I.</given-names></name>
<name><surname>Sturges</surname><given-names>B.K.</given-names></name>
<name><surname>Crowe</surname><given-names>C.</given-names></name>
<name><surname>Patterson</surname><given-names>E.E.</given-names></name>
<name><surname>Van Gompel</surname><given-names>J.J.</given-names></name>
<etal/>
</person-group>
          <article-title>Thalamic deep brain stimulation modulates cycles of seizure risk in epilepsy</article-title>
          <source>Sci. Rep.</source>
          <year>2021</year>
          <volume>11</volume>
          <fpage>24250</fpage>
          <pub-id pub-id-type="doi">10.1038/s41598-021-03555-7</pub-id>
          <pub-id pub-id-type="pmid">34930926</pub-id>
        </element-citation>
      </ref>
      <ref id="B254-ijms-24-04223">
        <label>254.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Bajorat</surname><given-names>R.</given-names></name>
<name><surname>Wilde</surname><given-names>M.</given-names></name>
<name><surname>Sellmann</surname><given-names>T.</given-names></name>
<name><surname>Kirschstein</surname><given-names>T.</given-names></name>
<name><surname>K&#xF6;hling</surname><given-names>R.</given-names></name>
</person-group>
          <article-title>Seizure frequency in pilocarpine-treated rats is independent of circadian rhythm</article-title>
          <source>Epilepsia</source>
          <year>2011</year>
          <volume>52</volume>
          <fpage>e118</fpage>
          <lpage>e122</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03200.x</pub-id>
          <pub-id pub-id-type="pmid">21801169</pub-id>
        </element-citation>
      </ref>
      <ref id="B255-ijms-24-04223">
        <label>255.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Quigg</surname><given-names>M.</given-names></name>
<name><surname>Clayburn</surname><given-names>H.</given-names></name>
<name><surname>Straume</surname><given-names>M.</given-names></name>
<name><surname>Menaker</surname><given-names>M.</given-names></name>
<name><surname>Bertram</surname><given-names>E.H.</given-names><suffix>3rd</suffix></name>
</person-group>
          <article-title>Effects of circadian regulation and rest-activity state on spontaneous seizures in a rat model of limbic epilepsy</article-title>
          <source>Epilepsia</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>502</fpage>
          <lpage>509</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1157.2000.tb00202.x</pub-id>
          <pub-id pub-id-type="pmid">10802754</pub-id>
        </element-citation>
      </ref>
      <ref id="B256-ijms-24-04223">
        <label>256.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Quigg</surname><given-names>M.</given-names></name>
<name><surname>Straume</surname><given-names>M.</given-names></name>
<name><surname>Smith</surname><given-names>T.</given-names></name>
<name><surname>Menaker</surname><given-names>M.</given-names></name>
<name><surname>Bertram</surname><given-names>E.H.</given-names></name>
</person-group>
          <article-title>Seizures induce phase shifts of rat circadian rhythms</article-title>
          <source>Brain Res.</source>
          <year>2001</year>
          <volume>913</volume>
          <fpage>165</fpage>
          <lpage>169</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-8993(01)02780-9</pub-id>
          <pub-id pub-id-type="pmid">11549381</pub-id>
        </element-citation>
      </ref>
      <ref id="B257-ijms-24-04223">
        <label>257.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Matzen</surname><given-names>J.</given-names></name>
<name><surname>Buchheim</surname><given-names>K.</given-names></name>
<name><surname>Holtkamp</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Circadian dentate gyrus excitability in a rat model of temporal lobe epilepsy</article-title>
          <source>Exp. Neurol.</source>
          <year>2012</year>
          <volume>234</volume>
          <fpage>105</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="doi">10.1016/j.expneurol.2011.12.029</pub-id>
          <pub-id pub-id-type="pmid">22226597</pub-id>
        </element-citation>
      </ref>
      <ref id="B258-ijms-24-04223">
        <label>258.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Strand</surname><given-names>A.</given-names></name>
<name><surname>Aragaki</surname><given-names>A.</given-names></name>
<name><surname>Baquet</surname><given-names>Z.</given-names></name>
<name><surname>Hodges</surname><given-names>A.</given-names></name>
<name><surname>Cunningham</surname><given-names>P.</given-names></name>
<name><surname>Holmans</surname><given-names>P.</given-names></name>
<name><surname>Jones</surname><given-names>K.</given-names></name>
<name><surname>Kooperberg</surname><given-names>C.</given-names></name>
<name><surname>Olson</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Conservation of Regional Gene Expression in Mouse and Human Brain</article-title>
          <source>PLoS Genet.</source>
          <year>2007</year>
          <volume>3</volume>
          <elocation-id>e59</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.0030059</pub-id>
          <pub-id pub-id-type="pmid">17447843</pub-id>
        </element-citation>
      </ref>
      <ref id="B259-ijms-24-04223">
        <label>259.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Waterston</surname><given-names>R.</given-names></name>
<name><surname>Lindblad-Toh</surname><given-names>K.</given-names></name>
<name><surname>Birney</surname><given-names>E.</given-names></name>
<name><surname>Rogers</surname><given-names>J.</given-names></name>
<name><surname>Abril</surname><given-names>J.</given-names></name>
<name><surname>Agarwal</surname><given-names>P.</given-names></name>
<name><surname>Agarwala</surname><given-names>R.</given-names></name>
<name><surname>Ainscough</surname><given-names>R.</given-names></name>
<name><surname>Alexandersson</surname><given-names>M.</given-names></name>
<name><surname>An</surname><given-names>P.</given-names></name>
<etal/>
</person-group>
          <article-title>Initial sequencing and comparative analysis of the mouse genome</article-title>
          <source>Nature</source>
          <year>2003</year>
          <volume>420</volume>
          <fpage>520</fpage>
          <lpage>562</lpage>
          <pub-id pub-id-type="doi">10.1038/nature01262</pub-id>
        </element-citation>
      </ref>
      <ref id="B260-ijms-24-04223">
        <label>260.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Amendola</surname><given-names>E.</given-names></name>
<name><surname>Zhan</surname><given-names>Y.</given-names></name>
<name><surname>Mattucci</surname><given-names>C.</given-names></name>
<name><surname>Castroflorio</surname><given-names>E.</given-names></name>
<name><surname>Calcagno</surname><given-names>E.</given-names></name>
<name><surname>Fuchs</surname><given-names>C.</given-names></name>
<name><surname>Lonetti</surname><given-names>G.</given-names></name>
<name><surname>Silingardi</surname><given-names>D.</given-names></name>
<name><surname>Vyssotski</surname><given-names>A.</given-names></name>
<name><surname>Farley</surname><given-names>D.</given-names></name>
<etal/>
</person-group>
          <article-title>Mapping Pathological Phenotypes in a Mouse Model of CDKL5 Disorder</article-title>
          <source>PLoS ONE</source>
          <year>2014</year>
          <volume>9</volume>
          <elocation-id>e91613</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0091613</pub-id>
          <pub-id pub-id-type="pmid">24838000</pub-id>
        </element-citation>
      </ref>
      <ref id="B261-ijms-24-04223">
        <label>261.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Bunton-Stasyshyn</surname><given-names>R.K.A.</given-names></name>
<name><surname>Wagnon</surname><given-names>J.L.</given-names></name>
<name><surname>Wengert</surname><given-names>E.R.</given-names></name>
<name><surname>Barker</surname><given-names>B.S.</given-names></name>
<name><surname>Faulkner</surname><given-names>A.</given-names></name>
<name><surname>Wagley</surname><given-names>P.K.</given-names></name>
<name><surname>Bhatia</surname><given-names>K.</given-names></name>
<name><surname>Jones</surname><given-names>J.M.</given-names></name>
<name><surname>Maniaci</surname><given-names>M.R.</given-names></name>
<name><surname>Parent</surname><given-names>J.M.</given-names></name>
<etal/>
</person-group>
          <article-title>Prominent role of forebrain excitatory neurons in SCN8A encephalopathy</article-title>
          <source>Brain</source>
          <year>2019</year>
          <volume>142</volume>
          <fpage>362</fpage>
          <lpage>375</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awy324</pub-id>
          <pub-id pub-id-type="pmid">30601941</pub-id>
        </element-citation>
      </ref>
      <ref id="B262-ijms-24-04223">
        <label>262.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Kerjan</surname><given-names>G.</given-names></name>
<name><surname>Koizumi</surname><given-names>H.</given-names></name>
<name><surname>Han</surname><given-names>E.B.</given-names></name>
<name><surname>Dub&#xE9;</surname><given-names>C.M.</given-names></name>
<name><surname>Djakovic</surname><given-names>S.N.</given-names></name>
<name><surname>Patrick</surname><given-names>G.N.</given-names></name>
<name><surname>Baram</surname><given-names>T.Z.</given-names></name>
<name><surname>Heinemann</surname><given-names>S.F.</given-names></name>
<name><surname>Gleeson</surname><given-names>J.G.</given-names></name>
</person-group>
          <article-title>Mice lacking doublecortin and doublecortin-like kinase 2 display altered hippocampal neuronal maturation and spontaneous seizures</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2009</year>
          <volume>106</volume>
          <fpage>6766</fpage>
          <lpage>6771</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0812687106</pub-id>
          <pub-id pub-id-type="pmid">19342486</pub-id>
        </element-citation>
      </ref>
      <ref id="B263-ijms-24-04223">
        <label>263.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>MacRae</surname><given-names>C.A.</given-names></name>
<name><surname>Peterson</surname><given-names>R.T.</given-names></name>
</person-group>
          <article-title>Zebrafish as tools for drug discovery</article-title>
          <source>Nat. Reviews. Drug Discov.</source>
          <year>2015</year>
          <volume>14</volume>
          <fpage>721</fpage>
          <lpage>731</lpage>
          <pub-id pub-id-type="doi">10.1038/nrd4627</pub-id>
          <pub-id pub-id-type="pmid">26361349</pub-id>
        </element-citation>
      </ref>
      <ref id="B264-ijms-24-04223">
        <label>264.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Hortopan</surname><given-names>G.A.</given-names></name>
<name><surname>Dinday</surname><given-names>M.T.</given-names></name>
<name><surname>Baraban</surname><given-names>S.C.</given-names></name>
</person-group>
          <article-title>Zebrafish as a model for studying genetic aspects of epilepsy</article-title>
          <source>Dis. Model. Mech.</source>
          <year>2010</year>
          <volume>3</volume>
          <fpage>144</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="doi">10.1242/dmm.002139</pub-id>
          <pub-id pub-id-type="pmid">20212082</pub-id>
        </element-citation>
      </ref>
      <ref id="B265-ijms-24-04223">
        <label>265.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wong</surname><given-names>K.</given-names></name>
<name><surname>Stewart</surname><given-names>A.</given-names></name>
<name><surname>Gilder</surname><given-names>T.</given-names></name>
<name><surname>Wu</surname><given-names>N.</given-names></name>
<name><surname>Frank</surname><given-names>K.</given-names></name>
<name><surname>Gaikwad</surname><given-names>S.</given-names></name>
<name><surname>Suciu</surname><given-names>C.</given-names></name>
<name><surname>Dileo</surname><given-names>J.</given-names></name>
<name><surname>Utterback</surname><given-names>E.</given-names></name>
<name><surname>Chang</surname><given-names>K.</given-names></name>
<etal/>
</person-group>
          <article-title>Modeling seizure-related behavioral and endocrine phenotypes in adult zebrafish</article-title>
          <source>Brain Res.</source>
          <year>2010</year>
          <volume>1348</volume>
          <fpage>209</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2010.06.012</pub-id>
          <pub-id pub-id-type="pmid">20547142</pub-id>
        </element-citation>
      </ref>
      <ref id="B266-ijms-24-04223">
        <label>266.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Rosch</surname><given-names>R.E.</given-names></name>
<name><surname>Hunter</surname><given-names>P.R.</given-names></name>
<name><surname>Baldeweg</surname><given-names>T.</given-names></name>
<name><surname>Friston</surname><given-names>K.J.</given-names></name>
<name><surname>Meyer</surname><given-names>M.P.</given-names></name>
</person-group>
          <article-title>Calcium imaging and dynamic causal modelling reveal brain-wide changes in effective connectivity and synaptic dynamics during epileptic seizures</article-title>
          <source>PLoS Comput. Biol.</source>
          <year>2018</year>
          <volume>14</volume>
          <elocation-id>e1006375</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pcbi.1006375</pub-id>
          <pub-id pub-id-type="pmid">30138336</pub-id>
        </element-citation>
      </ref>
      <ref id="B267-ijms-24-04223">
        <label>267.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Randlett</surname><given-names>O.</given-names></name>
<name><surname>Wee</surname><given-names>C.L.</given-names></name>
<name><surname>Naumann</surname><given-names>E.A.</given-names></name>
<name><surname>Nnaemeka</surname><given-names>O.</given-names></name>
<name><surname>Schoppik</surname><given-names>D.</given-names></name>
<name><surname>Fitzgerald</surname><given-names>J.E.</given-names></name>
<name><surname>Portugues</surname><given-names>R.</given-names></name>
<name><surname>Lacoste</surname><given-names>A.M.</given-names></name>
<name><surname>Riegler</surname><given-names>C.</given-names></name>
<name><surname>Engert</surname><given-names>F.</given-names></name>
<etal/>
</person-group>
          <article-title>Whole-brain activity mapping onto a zebrafish brain atlas</article-title>
          <source>Nat. Methods</source>
          <year>2015</year>
          <volume>12</volume>
          <fpage>1039</fpage>
          <lpage>1046</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.3581</pub-id>
          <pub-id pub-id-type="pmid">26778924</pub-id>
        </element-citation>
      </ref>
      <ref id="B268-ijms-24-04223">
        <label>268.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Brunal</surname><given-names>A.A.</given-names></name>
<name><surname>Clark</surname><given-names>K.C.</given-names></name>
<name><surname>Ma</surname><given-names>M.</given-names></name>
<name><surname>Woods</surname><given-names>I.G.</given-names></name>
<name><surname>Pan</surname><given-names>Y.A.</given-names></name>
</person-group>
          <article-title>Effects of Constitutive and Acute Connexin 36 Deficiency on Brain-Wide Susceptibility to PTZ-Induced Neuronal Hyperactivity</article-title>
          <source>Front. Mol. Neurosci.</source>
          <year>2020</year>
          <volume>13</volume>
          <fpage>587978</fpage>
          <pub-id pub-id-type="doi">10.3389/fnmol.2020.587978</pub-id>
          <pub-id pub-id-type="pmid">33505244</pub-id>
        </element-citation>
      </ref>
      <ref id="B269-ijms-24-04223">
        <label>269.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Stewart</surname><given-names>A.M.</given-names></name>
<name><surname>Desmond</surname><given-names>D.</given-names></name>
<name><surname>Kyzar</surname><given-names>E.</given-names></name>
<name><surname>Gaikwad</surname><given-names>S.</given-names></name>
<name><surname>Roth</surname><given-names>A.</given-names></name>
<name><surname>Riehl</surname><given-names>R.</given-names></name>
<name><surname>Collins</surname><given-names>C.</given-names></name>
<name><surname>Monnig</surname><given-names>L.</given-names></name>
<name><surname>Green</surname><given-names>J.</given-names></name>
<name><surname>Kalueff</surname><given-names>A.V.</given-names></name>
</person-group>
          <article-title>Perspectives of zebrafish models of epilepsy: What, how and where next?</article-title>
          <source>Brain Res. Bull.</source>
          <year>2012</year>
          <volume>87</volume>
          <fpage>135</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainresbull.2011.11.020</pub-id>
          <pub-id pub-id-type="pmid">22155548</pub-id>
        </element-citation>
      </ref>
      <ref id="B270-ijms-24-04223">
        <label>270.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
<name><surname>Baraban</surname><given-names>S.</given-names></name>
</person-group>
          <article-title>Modeling Epilepsy and Seizures in Developing Zebrafish Larvae</article-title>
          <source>Models of Seizures and Epilepsy</source>
          <edition>1st ed.</edition>
          <person-group person-group-type="editor">
<name><surname>Asla Pitk&#xE4;nen</surname><given-names>A.</given-names></name>
<name><surname>Schwartzkroin</surname><given-names>P.</given-names></name>
<name><surname>Mosh&#xE9;</surname><given-names>S.</given-names></name>
</person-group>
          <publisher-name>Elsevier</publisher-name>
          <publisher-loc>Amsterdam, The Netherlands</publisher-loc>
          <year>2006</year>
          <fpage>189</fpage>
          <lpage>198</lpage>
          <pub-id pub-id-type="doi">10.1016/B978-012088554-1/50017-7</pub-id>
        </element-citation>
      </ref>
      <ref id="B271-ijms-24-04223">
        <label>271.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zhong</surname><given-names>X.L.</given-names></name>
<name><surname>Yu</surname><given-names>J.T.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Wang</surname><given-names>N.D.</given-names></name>
<name><surname>Tan</surname><given-names>L.</given-names></name>
</person-group>
          <article-title>Deep brain stimulation for epilepsy in clinical practice and in animal models</article-title>
          <source>Brain Res. Bull.</source>
          <year>2011</year>
          <volume>85</volume>
          <fpage>81</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainresbull.2011.03.020</pub-id>
          <pub-id pub-id-type="pmid">21457763</pub-id>
        </element-citation>
      </ref>
      <ref id="B272-ijms-24-04223">
        <label>272.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Yaksi</surname><given-names>E.</given-names></name>
<name><surname>Jamali</surname><given-names>A.</given-names></name>
<name><surname>Diaz Verdugo</surname><given-names>C.</given-names></name>
<name><surname>Jurisch-Yaksi</surname><given-names>N.</given-names></name>
</person-group>
          <article-title>Past, present and future of zebrafish in epilepsy research</article-title>
          <source>FEBS J.</source>
          <year>2021</year>
          <volume>288</volume>
          <fpage>7243</fpage>
          <lpage>7255</lpage>
          <pub-id pub-id-type="doi">10.1111/febs.15694</pub-id>
          <pub-id pub-id-type="pmid">33394550</pub-id>
        </element-citation>
      </ref>
      <ref id="B273-ijms-24-04223">
        <label>273.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Kalsbeek</surname><given-names>A.</given-names></name>
<name><surname>Van Der Spek</surname><given-names>R.</given-names></name>
<name><surname>Lei</surname><given-names>J.</given-names></name>
<name><surname>Endert</surname><given-names>E.</given-names></name>
<name><surname>Buijs</surname><given-names>R.M.</given-names></name>
<name><surname>Fliers</surname><given-names>E.</given-names></name>
</person-group>
          <article-title>Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis</article-title>
          <source>Mol. Cell. Endocrinol.</source>
          <year>2012</year>
          <volume>349</volume>
          <fpage>20</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="doi">10.1016/j.mce.2011.06.042</pub-id>
          <pub-id pub-id-type="pmid">21782883</pub-id>
        </element-citation>
      </ref>
      <ref id="B274-ijms-24-04223">
        <label>274.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Androulakis</surname><given-names>I.P.</given-names></name>
</person-group>
          <article-title>Circadian rhythms and the HPA axis: A systems view</article-title>
          <source>WIREs Mech. Dis.</source>
          <year>2021</year>
          <volume>13</volume>
          <fpage>e1518</fpage>
          <pub-id pub-id-type="doi">10.1002/wsbm.1518</pub-id>
          <pub-id pub-id-type="pmid">33438348</pub-id>
        </element-citation>
      </ref>
      <ref id="B275-ijms-24-04223">
        <label>275.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sen</surname><given-names>A.</given-names></name>
<name><surname>Sellix</surname><given-names>M.T.</given-names></name>
</person-group>
          <article-title>The Circadian Timing System and Environmental Circadian Disruption: From Follicles to Fertility</article-title>
          <source>Endocrinology</source>
          <year>2016</year>
          <volume>157</volume>
          <fpage>3366</fpage>
          <lpage>3373</lpage>
          <pub-id pub-id-type="doi">10.1210/en.2016-1450</pub-id>
          <pub-id pub-id-type="pmid">27501186</pub-id>
        </element-citation>
      </ref>
      <ref id="B276-ijms-24-04223">
        <label>276.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Shao</surname><given-names>S.</given-names></name>
<name><surname>Zhao</surname><given-names>H.</given-names></name>
<name><surname>Lu</surname><given-names>Z.</given-names></name>
<name><surname>Lei</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
</person-group>
          <article-title>Circadian Rhythms Within the Female HPG Axis: From Physiology to Etiology</article-title>
          <source>Endocrinology</source>
          <year>2021</year>
          <volume>162</volume>
          <fpage>bqab117</fpage>
          <pub-id pub-id-type="doi">10.1210/endocr/bqab117</pub-id>
          <pub-id pub-id-type="pmid">34125877</pub-id>
        </element-citation>
      </ref>
      <ref id="B277-ijms-24-04223">
        <label>277.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Fawley</surname><given-names>J.A.</given-names></name>
<name><surname>Pouliot</surname><given-names>W.A.</given-names></name>
<name><surname>Dudek</surname><given-names>F.E.</given-names></name>
</person-group>
          <article-title>Epilepsy and reproductive disorders: The role of the gonadotropin-releasing hormone network</article-title>
          <source>Epilepsy Behav.</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>477</fpage>
          <lpage>482</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yebeh.2006.01.019</pub-id>
          <pub-id pub-id-type="pmid">16504591</pub-id>
        </element-citation>
      </ref>
      <ref id="B278-ijms-24-04223">
        <label>278.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Peng</surname><given-names>B.W.</given-names></name>
<name><surname>Li</surname><given-names>X.J.</given-names></name>
<name><surname>Wu</surname><given-names>W.X.</given-names></name>
<name><surname>Zeng</surname><given-names>Y.R.</given-names></name>
<name><surname>Liao</surname><given-names>Y.T.</given-names></name>
<name><surname>Hou</surname><given-names>C.</given-names></name>
<name><surname>Liang</surname><given-names>H.C.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Wang</surname><given-names>X.Y.</given-names></name>
<name><surname>Chen</surname><given-names>W.X.</given-names></name>
</person-group>
          <article-title>The Possible Role of Hypothalamus-Pituitary-Adrenal Dysfunction in Epileptic Spasms</article-title>
          <source>Seizure</source>
          <year>2020</year>
          <volume>81</volume>
          <fpage>145</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="doi">10.1016/j.seizure.2020.07.032</pub-id>
          <pub-id pub-id-type="pmid">32805608</pub-id>
        </element-citation>
      </ref>
      <ref id="B279-ijms-24-04223">
        <label>279.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Basu</surname><given-names>T.</given-names></name>
<name><surname>Maguire</surname><given-names>J.</given-names></name>
<name><surname>Salpekar</surname><given-names>J.A.</given-names></name>
</person-group>
          <article-title>Hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy</article-title>
          <source>Neurosci. Lett.</source>
          <year>2021</year>
          <volume>746</volume>
          <fpage>135618</fpage>
          <pub-id pub-id-type="doi">10.1016/j.neulet.2020.135618</pub-id>
          <pub-id pub-id-type="pmid">33429002</pub-id>
        </element-citation>
      </ref>
      <ref id="B280-ijms-24-04223">
        <label>280.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Sun</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Disrupting the circadian dynamics of epileptic genes in mouse temporal lobe epilepsy</article-title>
          <source>Front. Mol. Neurosci.</source>
          <year>2022</year>
          <volume>11</volume>
          <fpage>751</fpage>
        </element-citation>
      </ref>
      <ref id="B281-ijms-24-04223">
        <label>281.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Wen</surname><given-names>Z.P.</given-names></name>
<name><surname>Fan</surname><given-names>S.S.</given-names></name>
<name><surname>Du</surname><given-names>C.</given-names></name>
<name><surname>Yin</surname><given-names>T.</given-names></name>
<name><surname>Zhou</surname><given-names>B.T.</given-names></name>
<name><surname>Peng</surname><given-names>Z.F.</given-names></name>
<name><surname>Xie</surname><given-names>Y.Y.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Tang</surname><given-names>J.</given-names></name>
<etal/>
</person-group>
          <article-title>Influence of acylpeptide hydrolase polymorphisms on valproic acid level in Chinese epilepsy patients</article-title>
          <source>Pharmacogenomics</source>
          <year>2016</year>
          <volume>17</volume>
          <fpage>1219</fpage>
          <lpage>1225</lpage>
          <pub-id pub-id-type="doi">10.2217/pgs-2016-0030</pub-id>
          <pub-id pub-id-type="pmid">27406852</pub-id>
        </element-citation>
      </ref>
      <ref id="B282-ijms-24-04223">
        <label>282.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Musiek</surname><given-names>E.S.</given-names></name>
<name><surname>Fitzgerald</surname><given-names>G.A.</given-names></name>
</person-group>
          <article-title>Molecular clocks in pharmacology</article-title>
          <source>Handb. Exp. Pharmacol.</source>
          <year>2013</year>
          <volume>217</volume>
          <fpage>243</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="doi">10.1007/978-3-642-25950-0_10</pub-id>
          <pub-id pub-id-type="pmid">23604482</pub-id>
        </element-citation>
      </ref>
      <ref id="B283-ijms-24-04223">
        <label>283.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lu</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Wu</surname><given-names>B.</given-names></name>
</person-group>
          <article-title>Pharmacokinetics-based Chronotherapy</article-title>
          <source>Curr. Drug. Metab.</source>
          <year>2022</year>
          <volume>23</volume>
          <fpage>2</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.2174/1389200223666220106124218</pub-id>
          <pub-id pub-id-type="pmid">34994324</pub-id>
        </element-citation>
      </ref>
      <ref id="B284-ijms-24-04223">
        <label>284.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ruben</surname><given-names>M.D.</given-names></name>
<name><surname>Smith</surname><given-names>D.F.</given-names></name>
<name><surname>FitzGerald</surname><given-names>G.A.</given-names></name>
<name><surname>Hogenesch</surname><given-names>J.B.</given-names></name>
</person-group>
          <article-title>Dosing time matters</article-title>
          <source>Science</source>
          <year>2019</year>
          <volume>365</volume>
          <fpage>547</fpage>
          <lpage>549</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aax7621</pub-id>
          <pub-id pub-id-type="pmid">31395773</pub-id>
        </element-citation>
      </ref>
      <ref id="B285-ijms-24-04223">
        <label>285.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Nicolas</surname><given-names>J.M.</given-names></name>
<name><surname>Bouzom</surname><given-names>F.</given-names></name>
<name><surname>Hugues</surname><given-names>C.</given-names></name>
<name><surname>Ungell</surname><given-names>A.L.</given-names></name>
</person-group>
          <article-title>Oral drug absorption in pediatrics: The intestinal wall, its developmental changes and current tools for predictions</article-title>
          <source>Biopharm. Drug Dispos.</source>
          <year>2017</year>
          <volume>38</volume>
          <fpage>209</fpage>
          <lpage>230</lpage>
          <pub-id pub-id-type="doi">10.1002/bdd.2052</pub-id>
          <pub-id pub-id-type="pmid">27976409</pub-id>
        </element-citation>
      </ref>
      <ref id="B286-ijms-24-04223">
        <label>286.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Konturek</surname><given-names>P.C.</given-names></name>
<name><surname>Brzozowski</surname><given-names>T.</given-names></name>
<name><surname>Konturek</surname><given-names>S.J.</given-names></name>
</person-group>
          <article-title>Gut clock: Implication of circadian rhythms in the gastrointestinal tract</article-title>
          <source>J. Physiol. Pharmacol.</source>
          <year>2011</year>
          <volume>62</volume>
          <fpage>139</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="pmid">21673361</pub-id>
        </element-citation>
      </ref>
      <ref id="B287-ijms-24-04223">
        <label>287.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Kurishima</surname><given-names>A.</given-names></name>
<name><surname>Hayashi</surname><given-names>M.</given-names></name>
<name><surname>Shimozato</surname><given-names>R.</given-names></name>
<name><surname>Isozaki</surname><given-names>R.</given-names></name>
<name><surname>Shioda</surname><given-names>T.</given-names></name>
<name><surname>Iijima</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome: A Case Report</article-title>
          <source>Intern. Med.</source>
          <year>2021</year>
          <volume>61</volume>
          <fpage>1457</fpage>
          <lpage>1461</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.7622-21</pub-id>
          <pub-id pub-id-type="pmid">34670882</pub-id>
        </element-citation>
      </ref>
      <ref id="B288-ijms-24-04223">
        <label>288.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Lee</surname><given-names>K.</given-names></name>
<name><surname>Kim</surname><given-names>N.</given-names></name>
<name><surname>Shim</surname><given-names>J.O.</given-names></name>
<name><surname>Kim</surname><given-names>G.H.</given-names></name>
</person-group>
          <article-title>Gut Bacterial Dysbiosis in Children with Intractable Epilepsy</article-title>
          <source>J. Clin. Med.</source>
          <year>2020</year>
          <volume>10</volume>
          <elocation-id>5</elocation-id>
          <pub-id pub-id-type="doi">10.3390/jcm10010005</pub-id>
          <pub-id pub-id-type="pmid">33375063</pub-id>
        </element-citation>
      </ref>
      <ref id="B289-ijms-24-04223">
        <label>289.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Patel</surname><given-names>I.H.</given-names></name>
<name><surname>Venkataramanan</surname><given-names>R.</given-names></name>
<name><surname>Levy</surname><given-names>R.H.</given-names></name>
<name><surname>Viswanathan</surname><given-names>C.T.</given-names></name>
<name><surname>Ojemann</surname><given-names>L.M.</given-names></name>
</person-group>
          <article-title>Diurnal oscillations in plasma protein binding of valproic acid</article-title>
          <source>Epilepsia</source>
          <year>1982</year>
          <volume>23</volume>
          <fpage>283</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1157.1982.tb06193.x</pub-id>
          <pub-id pub-id-type="pmid">6806086</pub-id>
        </element-citation>
      </ref>
      <ref id="B290-ijms-24-04223">
        <label>290.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Riva</surname><given-names>R.</given-names></name>
<name><surname>Albani</surname><given-names>F.</given-names></name>
<name><surname>Ambrosetto</surname><given-names>G.</given-names></name>
<name><surname>Contin</surname><given-names>M.</given-names></name>
<name><surname>Cortelli</surname><given-names>P.</given-names></name>
<name><surname>Perucca</surname><given-names>E.</given-names></name>
<name><surname>Baruzzi</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects</article-title>
          <source>Epilepsia</source>
          <year>1984</year>
          <volume>25</volume>
          <fpage>476</fpage>
          <lpage>481</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1157.1984.tb03446.x</pub-id>
          <pub-id pub-id-type="pmid">6540170</pub-id>
        </element-citation>
      </ref>
      <ref id="B291-ijms-24-04223">
        <label>291.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Ando</surname><given-names>H.</given-names></name>
<name><surname>Yanagihara</surname><given-names>H.</given-names></name>
<name><surname>Sugimoto</surname><given-names>K.</given-names></name>
<name><surname>Hayashi</surname><given-names>Y.</given-names></name>
<name><surname>Tsuruoka</surname><given-names>S.</given-names></name>
<name><surname>Takamura</surname><given-names>T.</given-names></name>
<name><surname>Kaneko</surname><given-names>S.</given-names></name>
<name><surname>Fujimura</surname><given-names>A.</given-names></name>
</person-group>
          <article-title>Daily rhythms of P-glycoprotein expression in mice</article-title>
          <source>Chronobiol. Int.</source>
          <year>2005</year>
          <volume>22</volume>
          <fpage>655</fpage>
          <lpage>665</lpage>
          <pub-id pub-id-type="doi">10.1080/07420520500180231</pub-id>
          <pub-id pub-id-type="pmid">16147897</pub-id>
        </element-citation>
      </ref>
      <ref id="B292-ijms-24-04223">
        <label>292.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>P&#xE1;cha</surname><given-names>J.</given-names></name>
<name><surname>Balounov&#xE1;</surname><given-names>K.</given-names></name>
<name><surname>Sot&#xE1;k</surname><given-names>M.</given-names></name>
</person-group>
          <article-title>Circadian regulation of transporter expression and implications for drug disposition</article-title>
          <source>Expert Opin. Drug Metab. Toxicol.</source>
          <year>2021</year>
          <volume>17</volume>
          <fpage>425</fpage>
          <lpage>439</lpage>
          <pub-id pub-id-type="doi">10.1080/17425255.2021.1868438</pub-id>
          <pub-id pub-id-type="pmid">33353445</pub-id>
        </element-citation>
      </ref>
      <ref id="B293-ijms-24-04223">
        <label>293.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>M.</given-names></name>
<name><surname>Xing</surname><given-names>H.</given-names></name>
<name><surname>Chen</surname><given-names>M.</given-names></name>
<name><surname>Dong</surname><given-names>D.</given-names></name>
<name><surname>Wu</surname><given-names>B.</given-names></name>
</person-group>
          <article-title>Circadian clock-controlled drug metabolism and transport</article-title>
          <source>Xenobiotica Fate Foreign Compd. Biol. Syst.</source>
          <year>2020</year>
          <volume>50</volume>
          <fpage>495</fpage>
          <lpage>505</lpage>
          <pub-id pub-id-type="doi">10.1080/00498254.2019.1672120</pub-id>
        </element-citation>
      </ref>
      <ref id="B294-ijms-24-04223">
        <label>294.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Gumz</surname><given-names>M.L.</given-names></name>
<name><surname>Stow</surname><given-names>L.R.</given-names></name>
<name><surname>Lynch</surname><given-names>I.J.</given-names></name>
<name><surname>Greenlee</surname><given-names>M.M.</given-names></name>
<name><surname>Rudin</surname><given-names>A.</given-names></name>
<name><surname>Cain</surname><given-names>B.D.</given-names></name>
<name><surname>Weaver</surname><given-names>D.R.</given-names></name>
<name><surname>Wingo</surname><given-names>C.S.</given-names></name>
</person-group>
          <article-title>The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice</article-title>
          <source>J. Clin. Investig.</source>
          <year>2009</year>
          <volume>119</volume>
          <fpage>2423</fpage>
          <lpage>2434</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI36908</pub-id>
          <pub-id pub-id-type="pmid">19587447</pub-id>
        </element-citation>
      </ref>
      <ref id="B295-ijms-24-04223">
        <label>295.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Zuber</surname><given-names>A.M.</given-names></name>
<name><surname>Centeno</surname><given-names>G.</given-names></name>
<name><surname>Pradervand</surname><given-names>S.</given-names></name>
<name><surname>Nikolaeva</surname><given-names>S.</given-names></name>
<name><surname>Maquelin</surname><given-names>L.</given-names></name>
<name><surname>Cardinaux</surname><given-names>L.</given-names></name>
<name><surname>Bonny</surname><given-names>O.</given-names></name>
<name><surname>Firsov</surname><given-names>D.</given-names></name>
</person-group>
          <article-title>Molecular clock is involved in predictive circadian adjustment of renal function</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2009</year>
          <volume>106</volume>
          <fpage>16523</fpage>
          <lpage>16528</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0904890106</pub-id>
          <pub-id pub-id-type="pmid">19805330</pub-id>
        </element-citation>
      </ref>
      <ref id="B296-ijms-24-04223">
        <label>296.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Henriksson</surname><given-names>E.</given-names></name>
<name><surname>Huber</surname><given-names>A.L.</given-names></name>
<name><surname>Soto</surname><given-names>E.K.</given-names></name>
<name><surname>Kriebs</surname><given-names>A.</given-names></name>
<name><surname>Vaughan</surname><given-names>M.E.</given-names></name>
<name><surname>Duglan</surname><given-names>D.</given-names></name>
<name><surname>Chan</surname><given-names>A.B.</given-names></name>
<name><surname>Papp</surname><given-names>S.J.</given-names></name>
<name><surname>Nguyen</surname><given-names>M.</given-names></name>
<name><surname>Afetian</surname><given-names>M.E.</given-names></name>
<etal/>
</person-group>
          <article-title>The Liver Circadian Clock Modulates Biochemical and Physiological Responses to Metformin</article-title>
          <source>J. Biol. Rhythm.</source>
          <year>2017</year>
          <volume>32</volume>
          <fpage>345</fpage>
          <lpage>358</lpage>
          <pub-id pub-id-type="doi">10.1177/0748730417710348</pub-id>
        </element-citation>
      </ref>
      <ref id="B297-ijms-24-04223">
        <label>297.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Fauteck</surname><given-names>J.</given-names></name>
<name><surname>Schmidt</surname><given-names>H.</given-names></name>
<name><surname>Lerchl</surname><given-names>A.</given-names></name>
<name><surname>Kurlemann</surname><given-names>G.</given-names></name>
<name><surname>Wittkowski</surname><given-names>W.</given-names></name>
</person-group>
          <article-title>Melatonin in epilepsy: First results of replacement therapy and first clinical results</article-title>
          <source>Biol. Signals Recept.</source>
          <year>1999</year>
          <volume>8</volume>
          <fpage>105</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="doi">10.1159/000014577</pub-id>
          <pub-id pub-id-type="pmid">10085471</pub-id>
        </element-citation>
      </ref>
      <ref id="B298-ijms-24-04223">
        <label>298.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Cederroth</surname><given-names>C.R.</given-names></name>
<name><surname>Albrecht</surname><given-names>U.</given-names></name>
<name><surname>Bass</surname><given-names>J.</given-names></name>
<name><surname>Brown</surname><given-names>S.A.</given-names></name>
<name><surname>Dyhrfjeld-Johnsen</surname><given-names>J.</given-names></name>
<name><surname>Gachon</surname><given-names>F.</given-names></name>
<name><surname>Green</surname><given-names>C.B.</given-names></name>
<name><surname>Hastings</surname><given-names>M.H.</given-names></name>
<name><surname>Helfrich-Forster</surname><given-names>C.</given-names></name>
<name><surname>Hogenesch</surname><given-names>J.B.</given-names></name>
<etal/>
</person-group>
          <article-title>Medicine in the Fourth Dimension</article-title>
          <source>Cell. Metab.</source>
          <year>2019</year>
          <volume>30</volume>
          <fpage>238</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cmet.2019.06.019</pub-id>
          <pub-id pub-id-type="pmid">31390550</pub-id>
        </element-citation>
      </ref>
      <ref id="B299-ijms-24-04223">
        <label>299.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Allada</surname><given-names>R.</given-names></name>
<name><surname>Bass</surname><given-names>J.</given-names></name>
</person-group>
          <article-title>Circadian Mechanisms in Medicine</article-title>
          <source>N. Engl. J. Med.</source>
          <year>2021</year>
          <volume>384</volume>
          <fpage>550</fpage>
          <lpage>561</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMra1802337</pub-id>
          <pub-id pub-id-type="pmid">33567194</pub-id>
        </element-citation>
      </ref>
      <ref id="B300-ijms-24-04223">
        <label>300.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Kramer</surname><given-names>A.</given-names></name>
<name><surname>Lange</surname><given-names>T.</given-names></name>
<name><surname>Spies</surname><given-names>C.</given-names></name>
<name><surname>Finger</surname><given-names>A.M.</given-names></name>
<name><surname>Berg</surname><given-names>D.</given-names></name>
<name><surname>Oster</surname><given-names>H.</given-names></name>
</person-group>
          <article-title>Foundations of circadian medicine</article-title>
          <source>PLoS Biol.</source>
          <year>2022</year>
          <volume>20</volume>
          <elocation-id>e3001567</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pbio.3001567</pub-id>
          <pub-id pub-id-type="pmid">35324893</pub-id>
        </element-citation>
      </ref>
      <ref id="B301-ijms-24-04223">
        <label>301.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Selfridge</surname><given-names>J.M.</given-names></name>
<name><surname>Gotoh</surname><given-names>T.</given-names></name>
<name><surname>Schiffhauer</surname><given-names>S.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Stauffer</surname><given-names>P.E.</given-names></name>
<name><surname>Li</surname><given-names>A.</given-names></name>
<name><surname>Capelluto</surname><given-names>D.G.</given-names></name>
<name><surname>Finkielstein</surname><given-names>C.V.</given-names></name>
</person-group>
          <article-title>Chronotherapy: Intuitive, Sound, Founded... But Not Broadly Applied</article-title>
          <source>Drugs</source>
          <year>2016</year>
          <volume>76</volume>
          <fpage>1507</fpage>
          <lpage>1521</lpage>
          <pub-id pub-id-type="doi">10.1007/s40265-016-0646-4</pub-id>
          <pub-id pub-id-type="pmid">27699644</pub-id>
        </element-citation>
      </ref>
      <ref id="B302-ijms-24-04223">
        <label>302.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Torres-Ruiz</surname><given-names>R.</given-names></name>
<name><surname>Rodriguez-Perales</surname><given-names>S.</given-names></name>
</person-group>
          <article-title>CRISPR-Cas9 technology: Applications and human disease modelling</article-title>
          <source>Brief. Funct. Genom.</source>
          <year>2017</year>
          <volume>16</volume>
          <fpage>4</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.1093/bfgp/elw025</pub-id>
        </element-citation>
      </ref>
      <ref id="B303-ijms-24-04223">
        <label>303.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Fuller</surname><given-names>P.M.</given-names></name>
<name><surname>Gooley</surname><given-names>J.J.</given-names></name>
<name><surname>Saper</surname><given-names>C.B.</given-names></name>
</person-group>
          <article-title>Neurobiology of the sleep-wake cycle: Sleep architecture, circadian regulation, and regulatory feedback</article-title>
          <source>J. Biol. Rhythm.</source>
          <year>2006</year>
          <volume>21</volume>
          <fpage>482</fpage>
          <lpage>493</lpage>
          <pub-id pub-id-type="doi">10.1177/0748730406294627</pub-id>
        </element-citation>
      </ref>
      <ref id="B304-ijms-24-04223">
        <label>304.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Fountain</surname><given-names>N.B.</given-names></name>
<name><surname>Kim</surname><given-names>J.S.</given-names></name>
<name><surname>Lee</surname><given-names>S.I.</given-names></name>
</person-group>
          <article-title>Sleep deprivation activates epileptiform discharges independent of the activating effects of sleep</article-title>
          <source>J. Clin. Neurophysiol.</source>
          <year>1998</year>
          <volume>15</volume>
          <fpage>69</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="doi">10.1097/00004691-199801000-00009</pub-id>
          <pub-id pub-id-type="pmid">9502515</pub-id>
        </element-citation>
      </ref>
      <ref id="B305-ijms-24-04223">
        <label>305.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Thijs</surname><given-names>R.D.</given-names></name>
<name><surname>Surges</surname><given-names>R.</given-names></name>
<name><surname>O&#x2019;Brien</surname><given-names>T.J.</given-names></name>
<name><surname>Sander</surname><given-names>J.W.</given-names></name>
</person-group>
          <article-title>Epilepsy in adults</article-title>
          <source>Lancet</source>
          <year>2019</year>
          <volume>393</volume>
          <fpage>689</fpage>
          <lpage>701</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(18)32596-0</pub-id>
          <pub-id pub-id-type="pmid">30686584</pub-id>
        </element-citation>
      </ref>
      <ref id="B306-ijms-24-04223">
        <label>306.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Yu</surname><given-names>W.</given-names></name>
<name><surname>Gwinn</surname><given-names>M.</given-names></name>
<name><surname>Dotson</surname><given-names>W.D.</given-names></name>
<name><surname>Green</surname><given-names>R.F.</given-names></name>
<name><surname>Clyne</surname><given-names>M.</given-names></name>
<name><surname>Wulf</surname><given-names>A.</given-names></name>
<name><surname>Bowen</surname><given-names>S.</given-names></name>
<name><surname>Kolor</surname><given-names>K.</given-names></name>
<name><surname>Khoury</surname><given-names>M.J.</given-names></name>
</person-group>
          <article-title>A knowledge base for tracking the impact of genomics on population health</article-title>
          <source>Genet. Med.</source>
          <year>2016</year>
          <volume>18</volume>
          <fpage>1312</fpage>
          <lpage>1314</lpage>
          <pub-id pub-id-type="doi">10.1038/gim.2016.63</pub-id>
          <pub-id pub-id-type="pmid">27280867</pub-id>
        </element-citation>
      </ref>
      <ref id="B307-ijms-24-04223">
        <label>307.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
<name><surname>Bu</surname><given-names>D.</given-names></name>
<name><surname>Luo</surname><given-names>H.</given-names></name>
<name><surname>Huo</surname><given-names>P.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>He</surname><given-names>Z.</given-names></name>
<name><surname>Wu</surname><given-names>Y.</given-names></name>
<name><surname>Zhao</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Guo</surname><given-names>J.</given-names></name>
<etal/>
</person-group>
          <article-title>KOBAS-i: Intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2021</year>
          <volume>49</volume>
          <fpage>W317</fpage>
          <lpage>W325</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkab447</pub-id>
          <pub-id pub-id-type="pmid">34086934</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig position="float" id="ijms-24-04223-f001">
      <label>Figure 1</label>
      <caption>
        <p>GO and KEGG analyses of human epilepsy-related genes. (<bold>A</bold>) The circadian rhythm pathway is enriched in the GO analysis of human epilepsy-related genes. These 661 epilepsy-related genes were classified into biological processes with ClueGO in Cytoscape. Those with Kappa scores higher than 0.4 are presented. Those with the circadian term are shown. The node size indicates the number of genes in each pathway, the lines between the nodes indicate the correlations between the terms, and dotted lines possible correlations between the terms. The same color in different nodes indicates the same sets of genes enriched in different pathways. The arrows indicate the affiliation between pathways. (<bold>B</bold>) The top 20 ranked KEGG pathways of the 192 driver genes are shown. Pathways with the same category were sorted and merged.</p>
      </caption>
      <graphic xlink:href="ijms-24-04223-g001" position="float"/>
    </fig>
    <fig position="float" id="ijms-24-04223-f002">
      <label>Figure 2</label>
      <caption>
        <p>The classification of seizure types proposed by the International League Against Epilepsy 2017. Focal seizures occur within one hemisphere, whereas generalized seizures occur in the bilateral hemisphere. The onset of some seizures is unknown, which may not be classified as focal or generalized seizures. A further classification of seizures highlights features of seizure onset, including awareness level, motor onset, or nonmotor onset symptoms. Drawn from Fisher et al., 2017 [<xref rid="B115-ijms-24-04223" ref-type="bibr">115</xref>].</p>
      </caption>
      <graphic xlink:href="ijms-24-04223-g002" position="float"/>
    </fig>
    <fig position="float" id="ijms-24-04223-f003">
      <label>Figure 3</label>
      <caption>
        <p>Mammalian circadian clockwork model. Three transcription-translation feedback loops are known to operate in the mammalian circadian clock. In the first loop, the CLOCK: BMAL1 heterodimer activates the expression of target genes, including Per genes (Per1, Per2, and Per3) and Cry genes (Cry1 and Cry2) via binding to E-box (5&#x2032;-CACGTG-3&#x2032;) in their promoter regions, whereas the PER: CRY heterodimer interferes with the transcriptional activity of the CLOCK-BMAL1 heterodimer and turns off their own expression. In the second loop, Ror&#x3B1;/&#x3B2; and Rev-erb&#x3B1;/&#x3B2; are regulated by CLOCK and BMAL1 via E-box, whereas their proteins ROR&#x3B1;/&#x3B2; and REV-ERB&#x3B1;/&#x3B2; activate and suppress Bmal1 by competing for binding to the RORE (retinoic-acid-related orphan receptor response element). In the third loop, Dbp, Hlf, Tef, and E4bp4/Nfil3 are all regulated by CLOCK and BMAL1 via E-box, whereas their proteins DBP, HIF, TEF, and E4BP4/NFIL3 bind to D-box in the promoter regions of their target genes, where DBP, HIF, and TEF activate D-box-containing genes and E4BP4/NFIL3 represses them. Among these three circadian clock-controlled cis-elements-mediated transcriptional feedback loops, the E/E&#x2019;-box-mediated loop plays the dominant role in the circadian clock. In addition, the mTOR pathway has been shown to contribute to circadian regulation. Color arrows indicate transcription or translation, black arrows transcription activation, and turnstile symbol suppression.</p>
      </caption>
      <graphic xlink:href="ijms-24-04223-g003" position="float"/>
    </fig>
    <fig position="float" id="ijms-24-04223-f004">
      <label>Figure 4</label>
      <caption>
        <p>Summary of epileptic publications using different animals. (<bold>A</bold>) Number of epileptic publications using animal models, compiled by the Web of Science&#x2122; (<uri xlink:href="https://clarivate.com/webofsciencegroup/solutions/web-of-science/">https://clarivate.com/webofsciencegroup/solutions/web-of-science/</uri>, accessed on 23 February 2022) during the past 5 years. (<bold>B</bold>) Tendency of using different animal models for epileptic studies. Percentages of the number of published articles annually in total literature for each animal model are shown.</p>
      </caption>
      <graphic xlink:href="ijms-24-04223-g004" position="float"/>
    </fig>
    <fig position="float" id="ijms-24-04223-f005">
      <label>Figure 5</label>
      <caption>
        <p>A chronomodulated strategy for epilepsy chronotherapy. Three lines of experiments are required for developing chronomodulated strategy-based epilepsy chronotherapy: (1) to investigate circadian mechanisms underlying time-of-day-specific dynamics of rhythmic epilepsies (red), (2) to investigate chronopharmacokinetics of specific AEDs (blue), and (3) to investigate chronopharmacodynamics of specific AEDs (green). The findings from these three lines of experiments should help develop chronomodulated strategy-based chronotherapy for specific rhythmic epilepsy. Mathematical/computational modeling is also needed to help select an optimal chronotherapy plan.</p>
      </caption>
      <graphic xlink:href="ijms-24-04223-g005" position="float"/>
    </fig>
    <table-wrap position="float" id="ijms-24-04223-t001">
      <object-id pub-id-type="pii">ijms-24-04223-t001_Table 1</object-id>
      <label>Table 1</label>
      <caption>
        <p>KEGG groups of epilepsy driver genes.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Terms</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Input Genes</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">Taste transduction</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">
<italic toggle="yes">CACNA1A, HCN4, GABRA5, SCN2A, GEFSP7, GABBR2, GABRA6, GABRA1, GABRA2</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GABAergic synapse</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">SLC6A1, GABRA6, SLC38A3, GABRG2, GAD1, SLC12A5, ABAT, CACNA1A, GABRA5, GABBR2, GABRB3, GABRA1, GABRB2, GABRA2</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">Synaptic vesicle cycle</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">
<italic toggle="yes">ATP6V0C, SLC6A1, STX1B, ATP6V1A, CACNA1A, STXBP1, CPLX1, DNM1, ATP6V0A1, SLC1A2</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrograde endocannabinoid signaling</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">PLCB1, GABRA6, GRIA2, GABRG2, CACNA1A, GABRA5, GABRB2, GABRB3, GABRA1, GABRA2</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">Glutamatergic synapse</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">
<italic toggle="yes">PLCB1, SLC38A3, GRIA2, CACNA1A, GRIK2, GRIN2A, PPP3CA, GRIN1, SLC1A2</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cholinergic synapse</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">PLCB1, CACNA1A, CHRNB2, KCNQ2, KCNQ3, CHRNA4</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">Long-term potentiation</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">
<italic toggle="yes">GRIA2, PPP3CA, GRIN1, GRIN2A, PLCB1</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dopaminergic synapse</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">PLCB1, GRIA2, CACNA1A, GRIN2A, SCN1A, PPP3CA</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">Thyroid hormone signaling pathway</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">
<italic toggle="yes">PDPK1, NOTCH3, MTOR, SLC2A1, PLCB1</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x3B2;-Alanine metabolism</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">ABAT, GAD1, ALDH2, ALDH7A1</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">Glycosylphosphatidylinositol (GPI)-anchor biosynthesis</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">
<italic toggle="yes">PIGP, PIGQ, PIGS, PIGA</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metabolic pathways</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">ST3GAL3, PIGA, ATP6V0C, ATP6V1A, ASAH1, PNPO,</italic>
<break/>
<italic toggle="yes">PLCB1, ATP6V0C, ACP1, ALDH2, PIGP, PIGQ, PIGS, SYNJ1, MDH2, ABAT, ALDH7A1, CAD, ALG14, GAD1, UGP2</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">Amyotrophic lateral sclerosis (ALS)</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">
<italic toggle="yes">GRIA2, PPP3CA, GRIN2A, SLC1A2, GRIN1</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nicotine addiction</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">GABRA6, GRIA2, GABRG2, CHRNB2, CHRNA4, GRIN2A, CACNA1A, GABRA5, GRIN1, GABRB3, GABRA1, GABRB2, GABRA2</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">Morphine addiction</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">
<italic toggle="yes">GABRA6, GABRG2, CACNA1A, GABRA5, GABBR2, GABRB3, GABRA1, GABRB2, GABRA2</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neuroactive ligand&#x2013;receptor interaction</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">GABRA6, GRIA2, GABRG2, GRIK2, CHRNB2, GABRB2, GLUD1, LEPR, CHRNA4, GRIN2A, CHRNA2, GABRA5, GRIN1, GABRB3, GABRA1, GABBR2, GABRA2</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">mTOR signaling pathway</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">
<italic toggle="yes">ATP6V1A, MTOR, DEPDC5, PDPK1, STRADA, NPRL3, NPRL2</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cAMP signaling pathway</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">GRIA2, HCN2, HCN4, GLI3, GRIN2A, GRIN1, GABBR2</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">MAPK signaling pathway</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">
<italic toggle="yes">RAPGEF2, CACNA1A, CACNA1E, NTRK2, CACNB4, MEF2C, EJM4, PPP3CA</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lysosome</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">MFSD8, AP3B2, ASAH1, ATP6V0C, SCARB2, ATP6V0A1, TPP1</italic>
</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">Others</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#D9E2F3" rowspan="1" colspan="1">
<italic toggle="yes">SZT2, DOCK7, HNRNPU, GEFSP4, GEFSP8, GEFSP6, SLC25A12, SLC25A22, LNPK, EJM9, EJM3, ETL6, ETL3, TRAK1, P4HTM, DALRD3, UBA5, YEATS2, TNRC6A, MARCH6, EPPS, HWE1, HWE2, SPATA5, CYFIP2, PHACTR1, CNPY3, ICK, ACTL6B, RHOBTB2, PLPBP, OXR1, EIG1, EIG2, EIG3, EIG4, EIG5, EIG7, ETL4, ETL2, FRRS1L, KCNC1, DENND5A, TRAPPC4, PACS2, DMXL2, AARS1, SEMA6B, SYN1, SIK1, EEF1A2, SCN8A, LGI1, ARHGEF9, HCN1, NHLRC1, ADAM22, ADAM10, KIF3C, SMS, PDPK1(PDK1), CDYL, KCNV2, MECP2, NIPA1, SYNGAP1, EJM1, EJM2, CYFIP1, PCDH19, TRAPPC6B, SAMD12, LGI4, TBC1D24, SETD1A, CDKL5, EFHC1, POLG, NRXN1, CNTNAP2, EPM2A, ARX, KCNA2, FOXG1, CSTB, CHRNA7, SLC9A6, KCNAB1, ZEB2, SMC1A, REST, NR2F1, MYH1, KCNT2, ARV1, CASR, GUF1, PRDM8, YWHAG, NECAP1, SLC13A5, GOSR2, LMNB2, KCNB1, CLN8, FGF12, SATB2, KCNMA1, SCN1B, KCNE1, KCNMB3, FGF12, NCDN, FBXO28, YIPF5, MED23, CELF2, KCNC2</italic>
</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap position="float" id="ijms-24-04223-t003">
      <object-id pub-id-type="pii">ijms-24-04223-t003_Table 3</object-id>
      <label>Table 3</label>
      <caption>
        <p>Pharmacological and genetic epileptic models in rodents and zebrafish.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin;background:#ED7D31" rowspan="1">Rodents</th>
            <th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin;background:#ED7D31" rowspan="1">Zebrafish</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">Pharmacological Models</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">Genetic Models</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">Pharmacological Models</td>
            <td align="center" valign="middle" style="border-bottom:solid thin;background:#FBE4D5" rowspan="1" colspan="1">Genetic Models</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pentylenetetrazol (PTZ) [<xref rid="B192-ijms-24-04223" ref-type="bibr">192</xref>],<break/>(D,L)-Allylglycine (AG) [<xref rid="B179-ijms-24-04223" ref-type="bibr">179</xref>],<break/>Kainic acid (KA) [<xref rid="B176-ijms-24-04223" ref-type="bibr">176</xref>,<xref rid="B183-ijms-24-04223" ref-type="bibr">183</xref>],<break/>Picrotoxin [<xref rid="B193-ijms-24-04223" ref-type="bibr">193</xref>],<break/>Bicuculline [<xref rid="B193-ijms-24-04223" ref-type="bibr">193</xref>],<break/>Pilocarpine [<xref rid="B184-ijms-24-04223" ref-type="bibr">184</xref>],<break/>Tetanus toxin [<xref rid="B188-ijms-24-04223" ref-type="bibr">188</xref>],<break/>Caffeine [<xref rid="B190-ijms-24-04223" ref-type="bibr">190</xref>],<break/>Strychnine [<xref rid="B191-ijms-24-04223" ref-type="bibr">191</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Kcnj10</italic> [<xref rid="B194-ijms-24-04223" ref-type="bibr">194</xref>], <italic toggle="yes">Aldh7a1</italic> [<xref rid="B195-ijms-24-04223" ref-type="bibr">195</xref>], <italic toggle="yes">Mecp2</italic> [<xref rid="B196-ijms-24-04223" ref-type="bibr">196</xref>], <italic toggle="yes">Scn1a</italic> [<xref rid="B197-ijms-24-04223" ref-type="bibr">197</xref>], <italic toggle="yes">Cdkl5</italic> [<xref rid="B198-ijms-24-04223" ref-type="bibr">198</xref>], <italic toggle="yes">Syngap1</italic> [<xref rid="B199-ijms-24-04223" ref-type="bibr">199</xref>], <italic toggle="yes">Lgi1</italic> [<xref rid="B200-ijms-24-04223" ref-type="bibr">200</xref>], <italic toggle="yes">Ube3a</italic> [<xref rid="B201-ijms-24-04223" ref-type="bibr">201</xref>], <italic toggle="yes">Scn2a</italic> [<xref rid="B202-ijms-24-04223" ref-type="bibr">202</xref>], <italic toggle="yes">Scn8a</italic> [<xref rid="B203-ijms-24-04223" ref-type="bibr">203</xref>], <italic toggle="yes">Scn1b</italic> [<xref rid="B204-ijms-24-04223" ref-type="bibr">204</xref>], <italic toggle="yes">Kcnq2/3</italic> [<xref rid="B205-ijms-24-04223" ref-type="bibr">205</xref>], <italic toggle="yes">Kcna1</italic> [<xref rid="B206-ijms-24-04223" ref-type="bibr">206</xref>], <italic toggle="yes">Kcna2</italic> [<xref rid="B207-ijms-24-04223" ref-type="bibr">207</xref>], <italic toggle="yes">Kcnmb4</italic> [<xref rid="B208-ijms-24-04223" ref-type="bibr">208</xref>], <italic toggle="yes">Cacna1a</italic> [<xref rid="B209-ijms-24-04223" ref-type="bibr">209</xref>], <italic toggle="yes">Gria2</italic> [<xref rid="B210-ijms-24-04223" ref-type="bibr">210</xref>], <italic toggle="yes">Chma4</italic> [<xref rid="B211-ijms-24-04223" ref-type="bibr">211</xref>], <italic toggle="yes">Gabrg2</italic> [<xref rid="B212-ijms-24-04223" ref-type="bibr">212</xref>], <italic toggle="yes">Fgf13</italic> [<xref rid="B213-ijms-24-04223" ref-type="bibr">213</xref>], <italic toggle="yes">App</italic> [<xref rid="B214-ijms-24-04223" ref-type="bibr">214</xref>], <italic toggle="yes">Ube3a</italic> [<xref rid="B215-ijms-24-04223" ref-type="bibr">215</xref>], <italic toggle="yes">Shank3</italic> [<xref rid="B216-ijms-24-04223" ref-type="bibr">216</xref>], <italic toggle="yes">Cntnap2</italic> [<xref rid="B217-ijms-24-04223" ref-type="bibr">217</xref>], <italic toggle="yes">Epm2a</italic> [<xref rid="B218-ijms-24-04223" ref-type="bibr">218</xref>], <italic toggle="yes">Celf4</italic> [<xref rid="B219-ijms-24-04223" ref-type="bibr">219</xref>], <italic toggle="yes">Otx1</italic> [<xref rid="B220-ijms-24-04223" ref-type="bibr">220</xref>], <italic toggle="yes">Sv2a</italic> [<xref rid="B221-ijms-24-04223" ref-type="bibr">221</xref>], <italic toggle="yes">Trpm2</italic> [<xref rid="B222-ijms-24-04223" ref-type="bibr">222</xref>], <italic toggle="yes">Scamp5</italic> [<xref rid="B223-ijms-24-04223" ref-type="bibr">223</xref>], <italic toggle="yes">Grin2a</italic> [<xref rid="B224-ijms-24-04223" ref-type="bibr">224</xref>], <italic toggle="yes">Depdc5</italic> [<xref rid="B225-ijms-24-04223" ref-type="bibr">225</xref>], <italic toggle="yes">Alg13</italic> [<xref rid="B226-ijms-24-04223" ref-type="bibr">226</xref>], <italic toggle="yes">Hcn1</italic> [<xref rid="B227-ijms-24-04223" ref-type="bibr">227</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pentylenetetrazol (PTZ) [<xref rid="B228-ijms-24-04223" ref-type="bibr">228</xref>],<break/>(D,L)-Allylglycine (AG) [<xref rid="B179-ijms-24-04223" ref-type="bibr">179</xref>],<break/>Kainic acid (KA) [<xref rid="B182-ijms-24-04223" ref-type="bibr">182</xref>],<break/>Picrotoxin [<xref rid="B180-ijms-24-04223" ref-type="bibr">180</xref>],<break/>Pilocarpine [<xref rid="B229-ijms-24-04223" ref-type="bibr">229</xref>,<xref rid="B230-ijms-24-04223" ref-type="bibr">230</xref>],<break/>Ginkgotoxin [<xref rid="B187-ijms-24-04223" ref-type="bibr">187</xref>,<xref rid="B231-ijms-24-04223" ref-type="bibr">231</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">scn1lab</italic> [<xref rid="B232-ijms-24-04223" ref-type="bibr">232</xref>], <italic toggle="yes">gabra1</italic> [<xref rid="B233-ijms-24-04223" ref-type="bibr">233</xref>], <italic toggle="yes">gabrg2</italic> [<xref rid="B234-ijms-24-04223" ref-type="bibr">234</xref>], <italic toggle="yes">kcnj10</italic> [<xref rid="B235-ijms-24-04223" ref-type="bibr">235</xref>], <italic toggle="yes">kcnq2/3</italic> [<xref rid="B236-ijms-24-04223" ref-type="bibr">236</xref>], <italic toggle="yes">stx1b</italic> [<xref rid="B237-ijms-24-04223" ref-type="bibr">237</xref>],<break/><italic toggle="yes">chd2</italic> [<xref rid="B238-ijms-24-04223" ref-type="bibr">238</xref>], <italic toggle="yes">arxa</italic> [<xref rid="B239-ijms-24-04223" ref-type="bibr">239</xref>], <italic toggle="yes">eef1a2</italic> [<xref rid="B239-ijms-24-04223" ref-type="bibr">239</xref>], <italic toggle="yes">gabrb3</italic> [<xref rid="B239-ijms-24-04223" ref-type="bibr">239</xref>], <italic toggle="yes">pnpo</italic> [<xref rid="B239-ijms-24-04223" ref-type="bibr">239</xref>], <italic toggle="yes">strada</italic> [<xref rid="B239-ijms-24-04223" ref-type="bibr">239</xref>], <italic toggle="yes">lgi1a</italic> [<xref rid="B240-ijms-24-04223" ref-type="bibr">240</xref>], <italic toggle="yes">cacna1a/b</italic> [<xref rid="B186-ijms-24-04223" ref-type="bibr">186</xref>],<break/><italic toggle="yes">depdc5</italic> [<xref rid="B241-ijms-24-04223" ref-type="bibr">241</xref>]</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>